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Abstract
The aim of the project was to investigate methods of imposing conformational constraint 
upon peptide libraries and to synthesise such libraries to generate protein binding 
inhibitors. An initial attempt to utilise metal ion coordination to induce peptides to form 
cyclic structures was abandoned after test sequences failed to yield stable complexes of 
the anticipated geometry. Covalent cyclic structures were used in later library syntheses.
A novel library displaying fixed residues on variable cyclic scaffolds was synthesised, 
and a second generation version is described which offers an improved population of 
desired peptides while excluding the unwanted duplicates inherent in head-to-tail cyclic 
peptide libraries. Though no active molecules were discovered for the chosen target, 
some useful general principles were established.
A more conventional approach in the form of synthesis of large sections of the chosen 
protein target failed to yield active structures. An active structure reported later was used 
as a lead structure for a combinatorial approach to deduce the minimum functional 
requirements of the ligand. The library became obsolete when during deconvolution the 
activity of the lead structure could not be repeated. Lessons learned from the minimising 
library were applied to a speculative library of unnatural amino acids which employed 
binary synthesis to induce frameshift variation of a chosen pharmacophore. No active 
molecules resulted.
Discussion of the relevance of conventional solution assay techniques for mixture 
libraries led to the investigation of mass spectrometric methods of ligand selection.
I might wonder to see him employed in a project for making scientific 
discoveries by practical and mechanical operations. ...This work was 
repeated three or four times, and at every turn, the engine was so contrived,
the words shifted into new places, which he intended to piece
together....to give the world a complete body of all arts and sciences
Dean J. Swift
Gulliver's Travels 1726
(from Chapter III The People who were Too Clever by Half)
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Introduction 1 -  Combinatorial Chemistry
1. The Application of Combinatorial Chemistry to Drug Discovery
1.1 Drug Discovery
1.1.1 Driving Forces for Drug Discovery
Despite the advances in pharmaceutical science during the present century, a number of 
motives exist for continuing drug discovery effort (1). Medical need persists in the form 
of incurable common diseases (cancer, arthritis, Alzheimer’s), while further challenge 
arises from new diseases (AIDS, Ebola) or new variants of disease resistant to old 
therapies (antibiotic super-resistant bacteria). Even for existing, effective treatments, new 
drugs with fewer side effects or more acceptable dosage forms are demanded. On a less 
altruistic note, the short patent life of drugs, enforced price reductions and ever 
lengthening regulatory requirements (2) have led to a desperation within the 
pharmaceuticals industry for new products. R+D investment has risen from typical values 
of 13% of revenue to 18% while novel discovery technology companies have been 
acquired for orders of magnitude more than their start-up cost (3).
1.1.2 Drug Discovery Techniques 
Definitions
In the search for new drugs, a biological test system, a “screen” is devised to model the
biochemical basis of the disease state. A test sample demonstrating activity is described
as a “Hit”. After further investigation, a single chemical entity which displays potent,
selective activity in the disease model is described as a “lead compound”. A lead
compound is most unlikely to be immediately suitable for use as a drug. Many additional
qualities are required such as potency, specificity, absorption, resistance to degradation,
lack of toxicity, ease of synthesis and suitable formulation. Notably, whilst 50% of the
world’s prescription drugs are plant-derived, almost all have been modified (4). Desirable
qualities have to be engineered by the attentions of the organic chemist, a process
described as “lead optimisation”. The making of chemical analogues and retesting many
1
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times over to build a picture of structure to function relationships is time consuming and 
expensive. A chemist working by hand may only generate a few compounds a week, 
while it has been estimated that perhaps only one in 10,000 such analogues will 
eventually result in a marketed drug. Until recently, two approaches were employed to 
unearth (sometimes literally) lead compounds and engineer them into drugs:
Random Screening - Revealing Activity in Existing Molecules 
Traditionally, nature has been the source of the desired chemical diversity for new lead 
compounds (5). Huge effort has been expended on the random screening of rainforest 
plants, deep sea creatures and soil-borne micro-organisms. Another source of compounds 
are the chemical archives of the companies themselves. Compounds generated for other 
drug projects, dyes, cosmetics, agrochemicals and even pesticides are all considered 
candidates. Robotic methods have allowed screening to be achieved very quickly. A 
major company is capable of testing several hundred thousand compounds a year for a 
single drug project (6). The computerised storage and archiving of compounds by 
structure has permitted the “directed” non-random screening of collections, where 
compounds displaying a common chemical motif are selected. Similarly, compounds 
known to be active at a related receptor or enzyme active site are considered a high 
priority for screening at a new biological target. Competitor’s drugs provide such 
information, or are used as lead structures in their own right, known as the “me too” 
approach. A patent can be claimed in the event a new derivative shows significant 
structural difference and therapeutic advantage.
Rational Drug Design - TaUor Made Active Molecules
Advances in high resolution NMR and X-ray crystallographic techniques have permitted 
the characterisation of enzymes and receptors to a very useful degree of precision in terms 
of their three-dimensional structure, solvation, electronic character and flexibility (7). The 
results, when displayed using molecular modelling, can allow the theoretical “fitting” of
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suggested candidate structures to the target active site. Computer techniques have recently 
advanced to the self-generation of possible lead structures by the computer. Chemical 
structures are “grown” from a selected starting point to fit the spatial and electronic 
requirements of the active site (8). Rational drug design is far from a predictive science, 
however. Many other characteristics are required for a substance to be active in vivo. 
Solubility, ability to cross gut, cell wall or blood/brain barriers, and resistance to 
metabolism are all factors which are not part of the model. Since the structural details of 
only a few hundred biological targets are known, it is unlikely that the empirical iterative 
process of synthesising analogues will be abandoned (9). At present, such models are 
usually used to suggest series of chemical analogues to synthesise, results from the 
testing of which are correlated to provide detailed structure/activity profiles of the desired 
interaction (10). Rational drug design also includes genetic material. The hypothesis is 
that complimentary oligonucleotide sequences can be introduced into target cells to bind 
and inactivate specific genes, thus regulating the expression of target proteins (11). Whilst 
the techniques represent a whole new philosophy in drug therapy and give rise to great 
media interest, widespread success is in the distant future and is never likely to be a 
panacea, given the myriad of disease origins.
1.2 The Concept of Combinatorial Chemistry
Clearly, compound provision remains the essence of drug discovery. With rapid screening 
techniques, compound collections can be rapidly exhausted. New structures are sought 
which differ from existing natural collections or escape the structural bias inherent in 
synthetic archives. Organic synthesis of new structures has now become the rate 
determining step in the drug discovery process both for lead discovery and subsequent 
optimisation.
In 1988, A. Furka proposed a method by which many compounds could be synthesised at 
the same time by the random combination of starting materials (12). The idea was
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essentially the deliberate creation o f an impure product. The idea suffered a poor 
reception from the medicinal chemistry community which had spent the previous decades 
in pursuit o f pure, characterised single compounds.
Shortly afterward Houghten (13) and Lam (14) utilised the concept in the generation of 
the first peptide libraries. A sample of solid phase synthesis resin was divided and to each 
portion was coupled a different activated amino acid. The portions were mixed and 
divided once again for the coupling of a second set of amino acids. The process was 
continued to generate a mixture or combinatorial library of hexapeptides. The procedure 
became known as the divide-couple-recombine (DCR) or split-and-mix procedure. For a 
peptide sequence of n residues, with x amino acids at each position, the number of
possible peptides generated is xn* The number of reaction steps necessary is xn. Thus for 
an arithmetic increase in reaction steps, there is a geometric increase in the number of 
products, Figure 1.00. The hexapeptide library yielded 186, or 34 million products as all 
proteinergic amino acids bar Cys and Trp were used. The concept allows the rapid 
generation of molecular diversity from chosen building blocks, and adds countless 
potential compounds to the set available from natural sources. The combinatorial 
approach can be viewed as the exact opposite of rational drug design: where instead of 
specifically designing a single compound, many deliberately diverse building blocks are 
combined in a random way to cover many possible structural solutions. The idea of 
irrational drug discovery was bom (15). The selection of an individual with the right 
characteristics from a diverse population has parallels with nature (9). As such, the use of 
combinatorial chemistry for lead discovery has been described as accelerated evolution 
(16).
4
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Fig. 1.00 Split-and-mix combinatorial procedure
3 monomers coupled to resin in separate 
reaction vessels
31 products




The advantage that the technique offers the drug discoverer is apparent, and since 1990 
an explosion of interest in the concept has led to an estimated 25% of all drug discovery 
synthesis effort in the U.S.A. to be combinatorial (19).
1.3 Strategies for Creating Molecular Diversity
Since the first revelation that more than one useful compound could be made from a 
single synthetic event, other ways have been developed to rapidly synthesise large arrays 
of compounds (17). The strategies for simultaneous multiple compound synthesis fall into 
two categories: those which generate mixtures, and those which result in arrays of 
discrete compounds. Whereas “combinatorial chemistry” was originally coined to 
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synthesis techniques, where the combinatorial element is confined to the physical 
grouping of reaction vessels for shared synthetic events. A number of the latter techniques 
predate the split and mix procedure.
1.3.1. Mixture Reaction
Mixture synthesis is perhaps the simplest way of generating a combinatorial library. A 
solid phase synthesis resin is exposed to a mixture of activated residues. After 
deprotection and washing, the resin is once again exposed to a fresh mixture. A library of 
oligomers results where all have the same number of residues corresponding to the 
number of exposures of the resin to reactants. Figure 1.01. For n exposures of x residues, 





Fig. 1.01 Combinatorial synthesis using a mixture of monomers
The use of a mixture of reagents gives rise to the possibility of a product mixture biased 
toward those residues with faster reaction rates. Whilst oligonucleotide libraries have 
long been synthesised successfully by this method owing to similar kinetics of the natural 
nucleotides, amino acids vary considerably in reaction rate (20). One approach was to 
have all incident reactants in subequimolar amounts ensuring some nucleophilic sites 
were available after the fastest reacting amino acids were expended. Repeating the 
exposure ensured completion of reaction (21). A considerable amount of work has been 
done to slew the concentrations of amino acid mixtures to compensate for reaction rate
6
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(22). However, the approach becomes invalid after the first two amino acids because of 
the increasing influence of the growing peptide chain on the reaction rate (23).
1.3.2. Split and Mix
The split-and-mix method of library generation touched upon above (section 1.2) offers 
significant advantages of synthetic control over simple mixture coupling.
Under the split-and-mix protocol, the mixing step occurs after exposure of the resin to a 
single reagent. Consequently the mixing step is performed upon inert material and has no 
effect on the proportions of the products. Reactions can be performed to completion 
under the scrutiny of a monitoring procedure (section 1.6). The method in theory avoids 
the possibility of the disproportionate product described for simple mixture synthesis. 
However, it has to be considered that although only a single incident reagent is used in 
any one vessel, the solid substrate at any point after the first mixing step is highly 
heterogeneous and itself can give rise to variable reaction rates and incomplete couplings, 
a phenomenon widely described in peptide chemistry. Several articles describe the split 
and mix procedure as a “guarantee” against disproportionate product (13, 24), though 
mass spectroscopic analysis of two large peptide libraries synthesised under each of the 
described techniques yielded very similar products with up to tenfold disproportion 
between most and least abundant components (25).
By virtue of the successive division of solid support to achieve combinatorial effect, there 
is a maximum of one product possible per smallest divisible unit of the solid support, 
neglecting impurities. In the case of solid phase resin, the polymer beads represent this 
unit, a feature which has important implications for screening (section 1.7). Successive 
split and mix steps with a large set of residues can quickly generate millions of peptides. 
Early enthusiasm for the huge numbers theoretically possible has been tempered by a 
number of practical considerations. Care needs to be taken that the amount of the solid 
phase resin used is sufficient to support all of the theoretical products. It has for example
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been calculated that there is insufficient material in the known universe to support a 
library of all 20 natural amino acids in a 20 amino acid peptide library. An octamer 
library would require 50kg resin, for just 10 copies of each peptide (26). To ensure that 
95% of expected products are synthesised, the theoretical capacity for at least three copies 
of each compound are required (27). To circumvent the limitation, a method of 
combining DCR with mixture synthesis to give single beads containing families of related 
peptides has been patented (28). A related approach has been to limit the multiplicity of 
the library by coupling just one amino acid as representatives of a family e.g., one acidic, 
one basic etc.(29).
1.3.3 Second-Derivative Libraries
Having made a mixture library, several methods have been applied to further increase the 
diversity of the library Figure 1.02. After synthesis, a portion of a peptide library has 
been derivatised by N-methylation to produce a daughter library in a process described as 
“library of libraries” (30) Figure 1.03. Another library synthesised on a mixture of resin 
with two different linkers was used to liberate two sister libraries with amide and 
carboxyl termini. Further, libraries synthesised separately have been conjugated together, 
“parents” to produce a new library using metal ion co-ordination (31) or by an organic 
tether (32). Notice that although the synthesis is convergent, a greater number of possible 
products is produced than is present in either of the starting mixtures. The process has 
parallels in nature in the formation of antibodies. Conversely, missing a coupling step for 
a portion of resin under the DCR principle, known as “Binary Synthesis” (33) also gives 
rise to an additional set o f shorter and frame-shifted sequences (section 1.5).
8
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Library 1 derivatise
Library 1 — linker +  Library 2
Library 2
------ ► Library 3
Library 1
H□ Truncated precursor libraries 
Fig. 1.02 Libraries derived from libraries
Transformation synthesis, L1+L2 
products
Convergent synthesis, LlxL2 
products












Another method of making peptide mixtures harnesses the efforts of organisms to
perform the synthetic work. Short randomised oligonucleotides are synthesised
chemically. The sequences are inserted into the protein coat gene of filamentous phage.
Upon replication of the phage and expression of the modified gene, a random peptide is
displayed on the surface of each virus as part of the protein coat. Bacteria, eukaryotic cells
and polysomes have been used in a similar way to generate soluble protein libraries,
reviewed in (34). The technique allows the generation of very large libraries using well
established techniques of genetic manipulation. Expressed peptides can be very long, a
feature difficult to accommodate synthetically. Sequences of 60 amino acids have been
reported where short variable sequences (10 residues) were displayed as part of globulins
of known secondary structure (35). Alternatively random units have been arranged in a
repeating manner within long peptides to encourage secondary structure (36). However,
9
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the concept is limited to naturally encoded amino acids. Displayed peptides will often be 
segments of longer sequences which may adopt conformations not representative of the 
small peptide in free solution. Also, phage particles only retain structural integrity in near 
physiological solvent conditions, which limits the assay systems in which they can be 
used.
1.3.5. Single Compound Arrays
The techniques described so far all generate compound mixtures. The extraction of 
meaningful biological data from mixture libraries is not straightforward and is discussed 
in (section 1.7). For lead optimisation work where quantifiable data is required and the 
synthesis often demands a wide repertoire of organic transformations, single compound 
synthesis, possibly in solution (section 1.4) is more appropriate. Physical grouping of 
reaction vessels, substrates or reaction sites on substrates has allowed rapid parallel 
synthesis of compounds on solid (37) or in solution phase (38) without resorting to any 
pooling. With miniaturisation of vessels and robotic handling, the phenomenon amounts 
to the industrialisation of medicinal chemistry, and seems likely to have as profound an 
effect on the drug industry as the Industrial Revolution did upon manufacturing in the 18th 
century. Products are often screened in crude form, with allowance made for common 
impurities and measured abundance of the desired product (38). Several combinatorial 
methods give rise to discrete products by merit of the technology used, and are discussed 
in (section 1.4).
1.4 Technologies Enabling Combinatorial Chemistry 
Solid Phase Chemistry
The performance of combinatorial chemistry requires a sequence of reactions to be 
performed without classical isolation and purification steps. As such, work to date has 
almost entirely relied upon the principles of solid phase synthesis pioneered by Merrifield
10
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in 1963 (39), allowing the facile removal of excess soluble reagents and protecting groups 
without the isolation and purification of intermediates (40). Figure 1.04.
Fig. 1.04. Solid Phase Synthesis. Peptide sequence 
can be elaborated by removing a-amino protection 
Pf and coupling by agitating the resin bead
suspension with an excess of an activated amino 
acid. Resin washing over a glass frit permits easy 
removal of excess reagents. Cleavage at A liberates 
free or protected peptides according to the choice 
of sidechain protection P2#
Polymer bound molecules are prevented from free association with neighbours, and this 
pseudo-dilution effect permits cyclisation of oligomers without polymeric side products. 
Even phage display relies upon solid phase synthesis of the starting oligonucleotides. In 
recognition of the pivotal role solid substrates play in combinatorial chemistry, the 
following review is divided according to type of synthetic support.
1.4.1 Particulate Solid Supports
Solid phase chemistry substrate in the form of beads is easily manipulated as a powder,
cake or solvent suspension and can be divided and mixed simply for split and mix
protocols. Commercially available resins have been thoroughly reviewed by Winter (41). 
Reaction Chemistry
The original solid support used for peptide chemistry was polystyrene resin derivatised 
for peptide synthesis by the Merrifield method. A variety of linkers are now available 
which afford cleavage under different conditions. The abundance of active moieties on 
the polymer is typically in the region of 0.2-0.7 mmol/g dry resin, or 200 pmol per 
100pm bead. The linker chemistries allow the choice of cleavage conditions to be 
orthogonal to that chosen for functional group protection, or give rise to different 
functional groups upon cleavage. The polymer is chemically functional throughout and 
good penetration of solvent and reagent is essential for complete reaction. Reagent
A
ii
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penetration is achieved by swelling to gel state in solvent and agitation. A tenfold 
reduction in reaction rate has been reported for unagitated reactions (52).
Polymer Chemistry and Mechanical Properties
The chemistry of the polymer support influences the behaviour of the bead in solution and 
dictates the limits of the chemical environment to which it can be exposed. Commercial 
resin beads are typically 30-200pm in diameter. The polystyrene is usually crosslinked 
with a proportion of divinylbenzene to confer mechanical strength, typically 1% Figure
1.05. Such a resin will swell to approximately 3 times it’s dry volume when suspended in 
dichloromethane. Conversely, the volume scarcely changes at all in a polar solvent (42). 
Density changes associated with these solvation effects has been usefully exploited. The 
centrifugation of resin after solvent exchange has been utilised to allow aspiration of 
solvent when making libraries in small tubes (43). Similarly, the differentiation between 
floating and sinking resins allowed the performance of two different reactions within one 
vessel (44). Inclusion of iron within the polymer has also been used to allow manipulation 
of resin with external magnets (45). However, automatic synthesisers which rely on 
pipetting volumes of resin suspension to achieve divisions suffer inaccuracy from density 
changes. Beads consisting of polymer coated silica grains do not exhibit density changes, 
however the large chemically inert core of the bead conveys low capacity to the bulk resin 
and renders it unsuitable for large library generation as the total resin weight is 
prohibitive. Atherton and Sheppard (46) proposed that a resin whose solvation properties 
were closer to that of the peptides synthesised would allow better reagent access, and 
introduced a polyacrylamide resin Figure 1.06.
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Fig. 1.06 Polyamide resinFig. 1.05 Merrifield resin, 
polystyrene/divinylbenzene.
Hydrophobic polymers perform well under synthetic conditions where lipophilic 
protected residues are conveyed in organic solvent. However, on-bead assays (section 
1.7) require aqueous soluble biological components. Additionally, the demand for new 
chemistries to be performed on solid phase has created a need for resins amenable to
polar solvent. Tentagel™ is a proprietary resin which incorporates polyethoxy spacer 
molecules between a polystyrene bead and linker (47). The ethoxy “tentacles” solvate 
well in polar and apolar environments Figure 1.07, though loading per unit weight is 
lower than equivalent conventional resin. The interior of Tentagel beads has been shown 
to be accessible to proteins (48). PEGA resins (49) also utilise polyethylene glycol 
spacers which are cross linked to form the bead and are thought to form helices in 
solution with the oxygen atoms on the outside, Figure 1.08. A strategy entirely based 
upon polyethylene glycol as a support has been developed for liquid phase chemistry. 
The support offers similar reaction kinetics to the equivalent solution reaction (50). 
Portioning of the support under DCR protocol occurs easily by pipetting true solutions, 
while removal of unreacted chemicals is performed by washing after precipitation of the 
gel in apolar solvent, or by separation over size exclusion membrane. Additionally, the 
polymer acts as a solubilising partner to allow the solution of a library of compounds with
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widely variant solubility. Dendritic molecules have also been explored for similar 
reasons, and offer very high loading capacities (51).
°  n M l,
{
\ O
Fig. 1.07 Tentagel resin Fig 1.08 PEGA resin
Under the split and mix, one-bead-one-product protocol, each resin bead can be regarded 
as a microscopic reaction vessel, housing a single product. The concept of the 
microreactor has been widened considerably by the way in which porous beads are used. 
Rapp Polymere™ extended the philosophy and developed an outsize 800pm bead resin so 
that an individual bead can be selected in an on-bead assay, then cleaved to yield 
meaningful amounts of products for a solution assay. The beads have even been mounted 
in glass capillaries as miniature flow-through reaction vessels (52).
1.4.2 Segmented Solid Supports
In one of the earliest parallel synthesis technologies, Houghten encapsulated beads in 
porous membrane bags, described as “T-bags” such that they could be dipped in chosen 
activated amino acids or placed together in a flow-through vessel for deprotection, giving 
a one bag one compound library (53).
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seal Fig. 1.09 Houghten’s T-bag allowed the grouping
of resins for shared processes while keeping the 





The handling principles described for the T-bag approach define another series of solid 
phase substrates. Segmented substrates are used, like resin beads, in a collection for 
exposure to common chemical treatments, but are large enough to handle as individuals, 
and most importantly, to label with the reaction history.
Multipin™ pin technology employs a dense polyethene pin, resembling a matchstick, the 
head of which is derivatised on the surface only with a functional linker (54). Reactions 
are performed on a pin by dipping it into a series of wells each containing reagent. The 
pins are manipulated and identified on an 8x12 grid system commonly used for automatic 
microtitre plate manipulators, and several such robots have been converted for automatic 
synthesis. One compound per pin is generated, or mixture reaction can be used (55). 
Products are assayed on the pin, in which case they have been reused up to 60 times (56). 
If an appropriate linker has been used products are cleaved from the support and assayed 
in solution (57). If desired some immobilised compound can be preserved by the simple 
procedure of clipping off some of the pin. The principle disadvantage is the low molar 
capacity of the derivatised pin, originally around 50 nmol, since only the surface is 
involved. Recently, corrugation of a removable crown on the end of the pin has increased 
the surface area, and attempts have been reported to magnify the loading capacity by use 
of multimeric linker molecules (58). Pins are now reported with a capacity of 2pmol. 
Though a different shape, an alternative system using porous polyethene discs of around 6 
mm diameter (59) uses handling principles similar to pin technology.
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Other segmented substrate approaches include the use of derivatised paper discs, which
can be stacked in a flow-reactor, Figure 1.10 (60). Similarly, Teflon wafers have been
used to encapsulate resin beads in a manner analogous to the T-bag approach (61) or
beads have been trapped between layers of polypropylene mesh (62).
Figure 1.10 Segmented substrates such as T-bags, cotton discs or 
wafers can be grouped together for shared chemical treatments, 
such as packed in a column for flow-through deprotection.
Resin has also been contained within small tubes with liquid permeable closure, rather 
confusingly dubbed “pins”, to allow handling of discrete resin samples on a robot 
synthesiser (63). Resin containment in other discrete vessels such as multiwell plates 
(64), syringes or Eppendorf tubes (43) is also reported. Interestingly, the use of colour- 
coded beads has allowed the partial labelling of reaction history in DCR mixture libraries, 
thus blurring the distinction between beads and segmented, labelled substrates (65).
1.4.3 Planar Solid Supports
The previous examples all involve reactive substrates arranged to be sufficiently large as 
to permit direct labelling to identify compounds, or placing in specific wells with a 
known “address”. Combinatorial reaction sites can also be permanently arranged in 
discrete sites grouped together on a single substrate, yielding libraries of compounds 
identifiable by position or “spatially addressable” libraries. The technique SPOTs™ 
involves spotting activated amino acids onto particular positions on a paper sheet (66). 
The spotting can be achieved by hand or robot, while wash and deprotection steps are
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performed on the whole sheet. The technique yields nanomolar quantities of permanently
bound peptides which are identifiable by grid reference on the sheet. Limited mixture
syntheses where each spot contains a set of peptides has also been reported (67).
Sequentially subdividing the paper into two zones and treating only one zone at a time
with reagent in a binary fashion has also been used to assemble the sequences (68).
Tedious hand work or specialised spotting equipment has been rather neatly avoided by
one group who employed an inkjet printer to accurately dispense reagents to allotted
points on a sheet (69). Continuous cotton tape has also been used to make similar
spatially addressable peptide libraries. The cellulose substrate used in these methods
naturally displays functional groups for conjugation in the form of sugar hydroxyl. The
sugars can be derivatised with peptide synthesis linkers to allow products to be cleaved
into solution (70). The polymer itself is hydrophilic and amenable to synthesis using
polar solvents or requiring aqueous assay conditions. The solvent capacity of cotton is
such that one group were able to avoid the use of reaction vessels and simply soak up the
reagents (71). Cellulose is however limited in tolerance to harsh reagents, and Gao et al.
(72) have presented polyvinyldienefluoride sheets as a substitute. The surface of
microwell plates have also been derivatised to allow the anchoring of combinatorial
libraries as has polythene film. On an even smaller scale, spatially addressable libraries
have been synthesised on the surface of glass slides divided on a grid system into tiny
discreet reaction sites 100pm square, VLSIPS™ (73). Photolabile amine protecting
groups were used in conjunction with a masking strategy such that in any one cycle a
subset of the sites were exposed to light and deprotected. Treating the whole glass plate
with activated amino acids and washing results in a set of new compounds at only the
chosen sites. Rearrangement of the mask allowed a different chemical derivatisation of
other areas, in a binary synthesis protocol as described above Figure 1.11. Under the
binary protocol where half the reaction area is treated at a time, 2n compounds result from
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n reaction steps. The method utilises the highly accurate machinery available in the 
miniature electronics industry and is extremely economic of reagent, but requires 
sophisticated equipment. Reaction on selected areas of glass slides has also been 
performed in a similar manner but using a using a physical barrier resembling a painting 
stencil (74).
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Fig. 1.11 Masking half the synthesis area at a time creates a binary synthetic process
1.4.4 Liquid Phase Combinatorial Synthesis
Combinatorial synthesis has increasingly been performed in solution as the demands of 
lead optimisation studies require a range of chemistries greater than those available on 
solid phase. While one-pot mixture syntheses have been carried out to mimic the 
beginnings of life, the difficulties associated with cumulative by-products and unreacted 
starting materials have dictated that most solution synthesis be carried out as discrete 
compounds. Also, a solution mixture lacks any synthetic memory or compound labelling 
making deconvolution difficult. An exception is the synthesis of indexed mixture libraries 
where synthesis of two libraries of the same starting materials yields information about 
active components directly and is discussed under screening strategies (section 1.7).
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During lead optimisation where a single starting material is singly derivatised to form a 
set of analogues, the process cannot be abbreviated by split and mix techniques. Reliable 
chemical transformations and those where the by-products precipitate or evaporate are 
obvious choices for rapid synthesis in multiwell arrays (38). Multiplicity of functional 
groups can lead to differences in solubility of reactants (75) and unreliable results. Recent 
attention has surrounded the purification of solution synthesised arrays. Liquid/liquid 
extraction techniques have been used to purify the intermediates of a solution library 
synthesised on an iminodiacetic acid core (76) utilising acid or base washes as different 
functional groups became exposed Figure 1.12. The merits described of solid phase 
chemistry have been inverted in the use of polymer-anchored reagents to perform 
reactions on soluble building blocks in the form of coupling agents (77) or by-product 
scavengers (75). The same advantages of easy removal of unwanted material applies. 
Anion exchange resin has been used to reversibly hold nucleophiles, while reacting 
electrophiles are continuously washed through in sub equimolar amounts (78) resulting in 
no unreacted material in solution. Automated preparative HPLC using “universal” rapid 
gradient elution is an increasingly popular if rather inelegant solution to the problem 
applied in industrial laboratories.
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Fig. 1.12 Facile purification of analogues in solution, utilising the exposure of polar 
functional groups
1.5 Chemical Targets of Combinatorial Chemistry
It is apparent from the preceding sections 1.1-1.4 that a number of technologies exist for 
the rapid provision of new compounds for pharmaceutical lead discovery. Two 
fundamental questions remain before rushing to the laboratory however: exactly what 
structures to make, and how many variants are appropriate?
1.5.1 Peptide or Organic Chemistry?
Most early combinatorial techniques were proposed using peptide or oligonucleotide 
chemistry. The solid phase synthesis of these compound classes has been developed to 
excellent reliability, and the starting materials are commercially available. Successes 
quoted are primarily confined to peptide epitope mapping. Peptides are rarely directly 
useful as drugs because of enzymatic degradation and poor absorption (79). Also, the 
chemical diversity of peptides is limited by the available amino acids; 20 proteinergic, D -  
enantiomers and a small collection of artificial residues. The repetitive nature of the 
oligomer backbone linkage is also contrary to the philosophy of exploring the greatest
R3COOH/ EDCI
am ine R ^ H g/ EDCI
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possible chemical diversity. Given these constraints, recent attention has been very much 
focused upon the adaptation of other organic chemistry transformations to the 
technologies of combinatorial chemistry. Many familiar organic reactions are now quoted 
in a solid phase protocol and were reviewed recently by Jung (80). Robot synthesisers 
have been developed to feature heating, cooling and inert gas blanket required for organic 
synthesis. It is a cruel inevitability however, that the quest for the inclusion of wider 
structural diversity within a combinatorial array also gives rise to a diversity of reaction 
performance. A major challenge of organic combinatorial chemistry is to ensure that the 
intended products have been synthesised. For this reason, reported syntheses are generally 
as arrays of discrete reaction vessels, and many of the recent technological advances have 
been in the areas of automated analysis and purification, including imaginative 
applications of solid phase reagents discussed in (section 1.4.4),
Whilst the widening repertoire of chemistry available for combinatorial techniques has to 
be regarded as a benefit in terms of functional group diversity, the contribution of 
conformational diversity made by the peptide backbone should not be ignored (23). Also, 
while small molecule organic libraries have showed success as enzyme inhibitors, the 
drug discovery world is very short of molecules which inhibit protein/protein binding. 
The molecular size and delicate architecture of the peptide backbone which results in the 
very high levels of specificity of antibodies for proteins may be required here. 
Additionally, peptides have not been completely dismissed as oral drugs as research into 
dosage forms continues, and one attraction is that it is reasonable to suppose that any final 
metabolites are harmless!
On a final note, although combinatorial chemistry allows access to many structures not 
found in nature, the opposite is not true (2). Current combinatorial lead generation 
programmes would hardly have thrown up Taxol, or even the much simpler p-lactam
motif upon which many antibiotics are based (5) though it has subsequently been used as
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a combinatorial template (81). A compromise example is given by Jacobs et al. with the 
combinatorial modification of natural alkaloids (82). A similar concept, using 
combinatorial genetic modification to change enzyme expression and hence ultimately 
the nature of endogenous compounds is currently being marketed by Galilaeus OY.
1.5.2 Library Membership
Lead discovery has been likened to finding a needle in a haystack, however, whereas it 
would normally be desirable to reduce the size of a haystack to abbreviate a search, in the 
case of random combinatorial lead finding, the haystack must be of sufficient size to give 
a reasonable chance of containing a needle at all. Several attempts have been made to 
quantify chemical diversity by various structural and physicochemical parameters, though 
these inevitably involve discriminating between “small” and “large” changes, and what 
appears a small change to the eyes of a chemist may be very significant to a receptor (83). 
When nothing is known about the biological target, the range of diversity used is likely to 
be as wide as possible to find a lead. Mixture techniques capable of randomly generating 
millions of members have been used to this end and have been described above. 
Knowledge of the structural or electronic requirements of the chosen target has allowed 
the focusing of combinatorial effort to particular molecular sizes, include known 
pharmacophores or protein structure motifs. Where a lead structure is known, compounds 
are desired in good purity and sufficient quantity to compare very similar analogues over 
a number of biological parameters. Single compound arrays where a wide range of 
conventional chemistry, purification and analytical techniques can be performed are
R5
Fig. 1.13 Possible sites of variation 
identified between alkaloids of genus 
Rauwolfia by Jacobs et al. (82)
R4
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appropriate. While large arrays may not be necessary, the library size will be limited by 
the number of reactions that can be handled and cost of the starting materials. 
Computational pre-screening of “virtual libraries” has been attempted where molecular 
modelling is used to select a subset of proposed structures which have the correct 
conformation or fall into a physicochemical “band” of suitable calculated logD or pKa 
(38).
The above choices have a number of implications for screening. The screen must be 
capable of selecting compounds from a mixture if the random techniques are used. If a 
more focused library is applied, the protocol should be designed so as to reduce the 
number of compounds in any one mixture pot, or otherwise segregate closely related 
analogues between sub-libraries. Another option is to split big mixture libraries into 
small pools for this purpose.
1.5.3. Random Oligomeric Libraries
An early application of the combinatorial principle was the split and mix synthesis of 
hexapeptides. The protocol generates totally random sequences, one per bead, which can 
be sequenced after assay identifies beads displaying active peptides (14) Figure 1.14a. If 
products in solution are desired, identification of an individual active is not as 
straightforward. The protocol has been modified to omit the last mix step, yielding a set 
of “sub-libraries” where the last coupled residue, (position 6) is known (13) Figure 
1.14b. If screening identifies one sub-library as more active than the others, synthesis of a 
new set of sub-libraries is made, with the first four positions randomised, the fifth a 
selection of known amino acids in separate sub-libraries, and all terminated in the 
optimum sixth residue Figure 1.14c. The iterative process toward a single sequence is 
abbreviated if during the original synthesis, sufficient material is retained at each step for 
future iteration (section 1.7). A similar system was used by Geysen et al. for discovering
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new antibody binding epitopes, “Mimotope” strategy, here the starting point was two 
known amino acids, requiring (20x20) 400 syntheses (55) Figure 1.14f.
a) XXXXXX c) CAXXXX e) XXXXXX A,B.. = known residue
CBXXXX xxxxx x = random residue
b) AXXXXX ccxxxx xxxx
d v v v v v  _ XXX ® •  = set of known residuesBXXXXX CD «* XX
cxxxxx d) XXX@
S ' *  x x , , x
( (  i t X0XX 
•XXX
Fig. 1.14 Random oligomeric libraries
A variation of the method described as position scanning (84) has been developed which
does not build up the single sequence directly to the exclusion of others. A set of libraries
is constructed, each with a known amino acid at a different position, and the remaining
randomised by mixture synthesis. The libraries are assayed simultaneously, which results
in a matrix of information of the activities of individual amino acids at given positions in
the absence of the influence of neighbouring residues, since their effect is averaged in
each sub-library Figure 1.14d. The method relies on the premise that a residue significant
for binding to a receptor protein will convey greater activity on a mixture containing it at
the correct position than a mixture with a less influential amino acid. Considerably more
information is provided very quickly compared to the laborious recursive deconvolution
above. Positions where the residue is less important are easily visualised; an occurrence
which can cause ambiguity and much extra synthetic effort in an iterated sequence
library. Simply synthesising the sequence of all the most active residues is inadequate
however, as complexity arises when two amino acids which are most active in
randomised sequences detract from one another when together in a single peptide.
Single peptides have been derived by making all possible combinations of the more
active residues. The synthesis is not amenable to split and mix protocols, so reaction-rate
compensated slewed concentration mixtures are often used. Furka et al. (85) published a
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method of approaching such libraries in stages, where a “first order” library identifies 
likely residues as above, which are then used in much more restricted libraries with pairs 
of known amino acids staggered progressively along the sequence in different sub­
libraries. Active sub-libraries can be compared and the full active sequence read by 
“matching the dominoes” Figure 1.15.
Active Fig. 1.15
A contrasting strategy, the omission library, involves a similar mixture strategy, but at 
one defined position a known amino acid is absent from the set. The full library set yields 
residues which are irreplaceable at particular positions, and the information is 
complimentary to the position scanning system. A further very simple variant is the size 
scanning library, Figure 1.14e. A mixture library is synthesised as above without known 
residues at any position. All resin portions are cleaved and peptides assayed. The results 
immediately indicate if there is a minimum to the essential number of residues required 
for activity, providing a starting peptide length for one of the other library approaches. 
Some difficulty may exist here because mixtures with different numbers of components 
as well as molecule size are being compared in the same assay. Non-specific responses 
may be greater in the larger component mixtures. An imaginative development of the size 
scanning library has been proposed by Furka et al. (33). At every coupling step in a split 
and mix synthesis, a “no coupling” portion is reserved, so that the resulting peptide 
library potentially scans for frameshift deletions as well as truncations Figure 1.16.





Furka’s Domino Strategy: Active sublibraries identified 
from pools of peptides with known pairs of residues are 
compared to yield the full active sequence ABCDEF
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Greater diversity and potential resistance to enzymatic degradation has been conveyed by 
the inclusion of D-amino acids (86), though these cannot encoded genetically nor are they 
distinguished from L-enantiomers using on-bead sequencing. The potential antigenicity of 
random peptides has been enhanced by synthesising multiple copies of them on branched 
cores (87).
1.5.4 Directed Libraries
The combinatorial protocols above generate completely random sequences, it can be seen 
for example, that a library containing the natural amino acids will automatically contain 
all the peptides required for an alanine replacement scan, an activity common in peptide 
structure/function studies. It is often desired to more closely focus the membership of a 
library toward the biological target however, or to at least approach the diversity 
possibilities in steps. The Domino strategy by Furka et al. has already been described for 
breaking down a random search library into progressive steps (85). Lowe et al. reduced 
the multiplicity of their libraries by choosing amino acids to represent families of amino 
acids, e.g. Lysine instead of including all basic residues (29). In the optimisation of a 
dipeptide lead, Bowden et al. chose to vary only one end at a time (88). A combination of 
split and mix with mixture synthesis was used by Hadas et al. (28) to generate a library of 
one bead per family o f related peptides by using the representative principles of Lowe. 
Oligomeric libraries with a partial random component and some constant features 
important for activity have been used to probe the possibilities for variation of a known 
active peptide. A clear advantage was shown by Chen et al. (89) in including known 
structurally important proline residues in an otherwise random peptide library over the 
fully random equivalent. The principle was used again later for a non-peptide library with 
a peptide “binding handle” such that one binding area was occupied by a constant peptide 
portion, and a specificity pocket probed with novel residues (90) Figure 1.17.
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Fig. 1.17 Chen’s SH3 domain directed library. 
Proline rich peptide tail interacts with a known 
binding groove, while variable unnatural amino 
acid residues M l,2,3 and N-terminal cap are 
used to find new specificity relationships.
The original application of many of the multiple peptide synthesis techniques were the 
epitope mapping of large peptides by making large arrays of sequentially overlapping 
sequences (54). A combinatorial protocol for the mapping of a discontinuous epitope was 
also applied where two randomised positions were placed in turn along a sequence (55), 
Figure 1.14f (page 24) . In other studies, residue positions known to be important for 
activity were left in position while less determined positions were varied combinatorially, 
also using representative amino acids. The principle has been applied to the structural 
elements of DNA binding zinc finger peptides, with random positions used to find new 
sequence specificities (91). Often protein recognition requires large (200A2) contact areas, 
and large peptides are required (92), only a small part of which is varied, and encoded 
libraries have been used (35).
Small molecule libraries which feature known pharmacophores for the biological genre 
under scrutiny have also been tried, for example phosphotyrosine containing libraries for 
targeting SH2 domain receptors (93). Also, structural features common to a number of 
drugs (“universal pharmacophores”) are popular for inclusion, for example the ubiquitous 
benzodiazepine has been functionalised in a combinatorial fashion (94) Figure 1.18.
Resin
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Fig. 1.18 Library of benzodiazepine derivatives Bunin et al. (94)
Small peptides have been randomly expressed as part of an otherwise intact globulin, and 
resulting actives have been conformationally analysed to aid the design of small molecule 
mimics (95).
1.5.5 Constrained Libraries
Whilst peptides are, for reasons already stated, inherently unsuitable as drugs, the
simplicity of the chemistry and the existence of many biologically active peptide lead
compounds means that drug discovery interest persists in the area. In the process of
rationally engineering a peptide lead into a molecule suitable as a drug, the conformation
of the peptide at the active site needs to be known. The elucidation of that structure is
rarely possible as it requires the isolation of the peptide/receptor complex. A frequently
adopted strategy for lead-finding peptide library design is to engineer some form of
conformational constraint in the peptides (96). If an active compound has restricted
conformational freedom, then the active conformation is also likely to be closer to the one
displayed in solution, which can be elucidated using NMR (97). In theory, the correct
constrained peptide spends more time in the desirable conformation than does a
corresponding linear example, and should yield a stronger binding interaction, a principle
proved by several workers directly comparing linear and cyclic peptide libraries at the
same target (98, 99). Constraint by metal binding of a short bend of an active protein has
been shown to increase the potency 200 fold over the corresponding linear peptide (100).
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It can be argued that the mobility restriction simultaneously reduces the number of likely 
hits from any given library, as fewer members will be able to adopt the desirable 
conformation. The approach is thus a high-risk/high-reward strategy. In any case, in a 
random library of many millions of peptides, a plethora of weak, closely related active 
structures is undesirable.
There are many examples of constrained peptide libraries. P-bend motifs (101) and other 
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Fig. 1.19 Tethered p-bends and turn-inducing artificial residues
Cyclisation via head-to-tail amide (103), sidechain amide (104) and sidechain disulphide
(98) have all been reported. One group has trademarked a combinatorial procedure for
arranging a variety of spacer molecules across the backbone of an existing active linear
peptide in an attempt to “lock” the active conformation (105) Figure 1.20. Peptides have
also been expressed as part of naturally “rigid” globulin proteins (96).
c O m ^ Fig. 1.20 Substitution of selected
A T I NT O s  A residues in a known active peptide with
\ d i a m i n o  a c i d s  X  a l l o w e d  v a r i a b l e  O M ?  b r i d g e s  to  b e  f o r m e d  w i t h  s p a c e r
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Branched peptide libraries where a diaminoacid core allows combinatorial substitution at 
two points has been reported as an alternative to linear peptides (106). Alternatively, 
novel backbone structures including N-substituted glycines (107) and diamino acid chains
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(108) have been used for the display of potential pharmacophores. A small cyclic peptide 
of four lysines has been used as a template on which to hang other combinatorially varied 
residues (109). A similar approach is shown where variable spacer molecules were 
placed between the residues and the template Figure 1.21.
NHBoc F2 R3
N H Fm oc
Fig. 1.21 Branched diamino acids (A), a , p , y  amino linked backbone (B), N- 
substituted glycine (C) with synthetic scheme (D) and cyclo-lysine template (C)
The template concept is an interesting and widely adopted procedure for arranging amino 
acid residues closely together in space without having them as part of a linear peptide 
sequence. The library members all share a structural feature, dubbed homogeneous 
libraries by Krchnak et al. (110). As well as the cyclic peptide example above, cyclic 
organic molecules in the form of Kemp’s triacid (111), steriod (112), sugars (113) and 
bicyclics (76) have been used.
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Kemp’s Triacid library Template assembled side chain library
Fig. 1.22 Libraries directed to one face of a template
The use of a planar structure can allow derivatisation to be directed to only one face of 
the ring, prompting attempts at mimicking the surface of proteins by Mutter at al., who 
used a cyclic peptide scaffold to display residues selected from the molecular modelling 
of the surface of an antibody (109) Figure 1.22. Rather less precisely, multiple branching 
cores have been used to generate multiple copies of libraries to enhance their antigenic 
potential (87). Metal ion co-ordination has been used to direct molecules to one face of a 
ring, and also to recruit pairs of library members into a combinatorial “receptor” (114).
1.5.6 Toward Organic Libraries
An additional approach to reducing the disadvantages associated with peptide structures 
is to incorporate unnatural amino acids while taking advantage of the facile amide linking 
chemistry (37). Several companies now provide a variety of unnatural amino acids. 
Peptide libraries have been derivatised after synthesis by N-methylation, resulting in an 
unnatural backbone and also a new library, the “library of libraries” principle coined by 
Houghten (30). A number of peptide bond isosteres and peptidomimetic building blocks 
have been developed in medicinal chemistry, and the applications of these to 
combinatorial chemistry have been reviewed by Murray Goodman (115). The desire to 
perform a wider variety of organic chemistry on solid phase has led to an explosion of 
publications over the last few years and have been reviewed by Balkenhohl et al. (116).
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1.6 Quality Control of Combinatorial Synthesis
“Combinatorial Chemistry - a term that evokes amazement and joy in the hearts of many 
medicinal chemists and produces feelings of panic and anxiety for the analytical 
chemists” J.A. Loo (117).
Combinatorial chemistry owes its very origins to the requirement of making many 
compounds quickly, often without isolation and characterisation of intermediates. 
However, for biological results to be meaningful, it is necessary to know the identity and, 
for lead optimisation, purity of candidate compounds. Mixture products are of course 
already impure, and there seems little prospect of removing undesired compounds. While 
analysis of support-bound libraries occurs after an active has been identified, the question 
still arises with any DCR library as to whether the full spectrum of intended compounds 
was present for the assay. A number of reaction monitoring procedures have been used to 
verify the completion of couplings, as well as post synthetic analysis. Such analysis has 
been performed on whole library populations and on statistically representative samples. 
Combinatorial chemistry is often performed on small scale, and as such there is a heavy 
reliance on mass spectrometry as a confirmatory tool. It is perhaps sensible to plan a 
library protocol to avoid nominally isobaric compounds in the same sub-library.
1.6.1 Chemical Indicators
Chemical indicator tests borrowed from conventional peptide chemistry have seen
widespread use in combinatorial chemistry, since they can readily be applied to mixtures.
The most commonly applied are the Kaiser ninhydrin test (118) which gives a bright
purple colouration in the presence of free amine and thus a negative result is used as an
indication of completion of reaction in amide chemistry. Similarly, bromophenol blue
(119) forms a deep blue on forming an ion pair with amines. The test is reversible and
thus permits addition of dye to the bulk reaction. The quantitation, of Fmoc-piperidine
adducts by UV absorption under continuous flow conditions has also been used (120),
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and sluggish removal of the group has been suggested as an indicator of likely difficult 
coupling of the following residue. Another aspect of measuring the bulk property of a 
mixture has been provided by Sugawara et al. (121) who correlated the optical rotation of 
a peptide mixture with the sum of the rotations of the component residues.
1.6.2 Separative Techniques
HPLC has been widely used to verify the appearance of the expected number of peaks 
from a library synthesis, up to about 40 compounds (21). Capillary electrophoresis has 
also been shown to be useful for the resolution of peptide mixtures (122). The extra 
resolving power of two dimensional electrophoretic maps were used by Sebestyen et al. 
to analyse families of truncated peptides from binary synthesis (33). Amino acid analysis 
has been employed to verify synthesis of peptide mixtures, and notably to verify the 
utility of slewed mixture synthesis (22). Sequencing of pools has permitted observation of 
all the expected N-terminal residues (123) and is discussed below as it has most often 
been applied to the revealing of individual peptides after biological assay. Similarly, GC 
has made an appearance in the analysis of synthetic code molecules (see section 1.7 
below).
1.6.3 Mass Spectrometry
By far the most widely used technique in the analysis of combinatorial products is mass 
spectroscopy, and the subject has merited a review of its own by Loo (117). Although a 
destructive technique, MS is very sensitive and thus highly conservative of material. 
Electrospray MS
The gentle ionisation technique of electrospray tends to generate only simple, molecular
ion spectra. The feature, in combination with the ability to rapidly introduce many
samples in series in a fluid flow has earned ESI-MS great popularity for the analysis of
combinatorial products. Even where libraries are so large as to give unresolved clusters of
peaks, the movement of the bulk towards higher mass has been used to verify the addition
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of a residue (124). The fluid sample introduction system allows coupling of the ESI-MS 
to chromatographic techniques, and in conjunction with LC (125) or CE (126), the ability 
to resolve one compound from another is considerable. Adding MS-MS constitutes a 
three-dimensional identification system, consisting of retention behaviour, mass and 
masses of substituent parts (127). High resolution ESI-MS using FT instruments has been 
used to analyse libraries of 104 products without resorting to chromatography (128). 
MALDI-TOF MS
Matrix Assisted Laser Desorption Ionisation - Time of Flight is another recently invented 
technique which generally yields the molecular ion intact, making the observation of 
mixtures as simple as possible. Although the signals are not quantitative, samples are 
readily prepared from even single beads, and the samples can be re-examined many times 
once prepared. A convenient method for the in situ cleavage of product from a single 
bead already on a sample target using TFA vapour has been described by Bradley et al. 
(129), while Fitzgerald et al. have employed a photolabile linker which was sensitive to 
the frequency of the laser (130). Energetic fragmentation with metal ion bombardment 
(Secondary Ion Mass Spectrometry, SIMS) of compound direct from the surface of a bead 
has allowed the scrutiny of component residues of bead bound products without pre­
treatment or special linkers (131).
1.6.4 O ther Spectroscopy
The performance of organic chemistry on solid phase, perhaps in developing a new
chemistry for subsequent rapid synthesis, require that reactions be quantified, and release
from the bead followed by verification that (some) of the expected product is present is an
inadequate characterisation. Current analytical techniques adapted for solid phase have
recently been reviewed (132). Reflectance Fourier Transform Infra Red can now be
performed on single beads, and allows the monitoring of the appearance/disappearance of
particular functional groups. The inclusion of deuterated protecting groups with
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characteristic IR signatures has allowed quantitation of reactions to around +/- 2% (133). 
FT Raman spectroscopy has also been used to examine the formation of secondary 
structure of growing peptide chains (134).
The usefulness of NMR is limited by excessive signal broadening caused by the restricted 
movement of the resin, even with solvent swollen tentacle resins which in other respects 
mimic the solution state. 13C work is still practical though it requires a large sample size 
and/or long experiment times by combinatorial standards (132) and references therein). 
Magic angle spinning (MAS) technology overcomes the problem to a useful degree, and 
has recently been used by Rapp et al. (135) in the analysis of compounds on single beads, 
albeit rather large ones. The MAS technique has also permitted CH correlation 
spectroscopy in solvent swollen resin (136).
For the characterisation of combinatorial products, a consensus of techniques are usually 
required, and several industrial groups have reported HPLC-NMR systems based upon 
through-flow NMR probes (137) or robotic systems to perform MS, NMR and 
chromatography (138).
Finally, workers using pins have reported routinely synthesising compounds in duplicate, 
which can be viewed as insurance against accidental product loss rather than verification 
of correct synthesis.
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1.7 Screening and Deconvolution Strategy
The ultimate aim of the schemes above is to isolate a biologically active compound. The 
use of combinatorial techniques presents some special challenges to biological assays, 
and these are described according to the type of product as outlined in section 1.3.
1.7.1 Single Compounds in Solution
Combinatorial technologies which generate single compounds in solution are 
superficially no different from conventional medicinal chemistry products. However, 
since classical purification steps are often omitted, the biological result needs to be 
viewed in the context of the analytical verification of synthesis. Unwanted impurities can 
give rise to false positive results, while just as importantly, the absence of the expected 
compounds in a tested library can cause false negative results, where promising structures 
are erroneously deemed inactive. A recent comparison of rapid synthesis products with 
purified samples suggested the approach of weighting the biological result for found 
purity was valid (38). Mass spectrometer manufacturers now provide software for setting 
threshold criterion for automatic verification of an expected molecular ion. Considerable 
effort is being put into the development of automated purification systems to overcome 
the problem (139).
1.7.2 Phage Displayed Libraries
In biologically expressed libraries, microscopic amounts of many millions of proteins are 
produced. The entire phage collection is exposed to the immobilised receptor of interest. 
Wash steps elute the phage in reverse order of binding strength. The most strongly bound 
are amplified by infection of a bacterial broth, and when present in sufficient quantity the 
protein coat is sequenced to reveal the active (15).
1.7.3 Mixtures in Solution
Mixtures arise in solution i f :
a) A library has been made by mixture of reactants.
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b) A number of beads from a split and mix library have been cleaved into solution.
c) The cells used for a biological display technique secrete the randomised proteins.
The biological assay of mixtures in solution present a number of challenges. Undesired 
impurities as described for single compounds are very difficult to remove from the 
heterogeneous library body, though the procedure has been attempted by affinity 
chromatography using the biotin/avidin system (140). As the number of compounds in a 
mixture increases, the concentration of any single compound in assay solution decreases 
for a given total concentration of compound. Individual compounds are thus either 
present at low levels, requiring a highly sensitive assay such as antibody recognition (54), 
or a very high total compound concentration has to be used, giving rise to unwanted non­
specific effects, for example pH change has been observed on addition of high peptide 
concentrations (29). Common impurities may be at high concentrations compared to any 
single product. Also, the presence of many compounds in the biological system may 
result in co-operative or subtractive effects and the activity observed disappears when the 
library is deconvoluted. For this reason, and to enhance the number of desirable products 
in a library mixture, much effort has been expended upon the focusing of library 
membership toward compounds thought likely to succeed, leaving out extraneous 
products and reducing total membership. These approaches are discussed under (section 
1.5). Unfortunately, the focusing of libraries also tends the membership toward similar 
structures, exacerbating the possibility of co-operative activity. It follows that the number 
of compounds in any one test mixture should be reduced as the structural similarity of the 
membership increases, and that a library should be designed as far as possible to group 
the most dissimilar products in the same sub-libraries. A contrast to that is the approach 
of grouping similar compounds on one bead in a combined DCR/mixture synthesis 
strategy, where the co-operative effect is deliberately used to show activity trends (28). 
Non specific activity or other “false positive” results have been diluted by introducing
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serum albumin as a competitive non-specific binding agent, repeating the assay in an 
progressively higher dilution, or conducting several rounds of enrichment when screening 
phage or solid beads.
Assuming a valid assay can be found, the question arises as to how to identify a single 
compound, or at least subset of compounds, responsible for the observed activity. Under 
some of the mixture library protocols, such as position scanning designs or the Domino 
procedure already described, it is not necessary to identify a single compound from a 
mixture.
The process of deconvolution by resynthesis of progressively more defined libraries, the 
so called Recursive Deconvolution (141) has already been described (section 1.5). 
Resynthesis involves considerable effort and also introduces the possibility of 
synthesising something other than the exact mixture which showed initial activity. The 
recursive process has suffered a bad press because of co-operative effects, but has been 
used successfully in real lead discovery applications (142) and was subjected to 
investigation by Frier et al. (143) who concluded the method was generally able to 
identify the most potent compounds in a mixture, provided that the most potent was not 
in the company of the weakest, in which case mixtures of many weakly active compounds 
were collectively more potent.
Another method proposes synthesising the library on an orthogonal format which allows 
the single active sequences to be deduced directly from mixture activity (144). The highly 
original method proposed by Deprez et al. involves making the same library twice. A set 
o f monomers is divided into groups, and the resin is successively split and each portion 
reacted with a mixture of one group. No recombination is performed. A set of sub- 
libraries results where the sequence is denoted by a list of the mixture groups used at 
each step. The library is made again, using the same set of monomers, but the set is 
divided into coupling groups in an orthogonal manner. Thus, when the final sub-libraries
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are assayed, a single active sequence will be present in both libraries. The coupling 
groups being orthogonal, there is only one monomer at each position which is common, 
thus revealing a single active sequence.
R)-A 1A 1 
— ► (r ) —A1A2 
( r ) —A 2 ^ '''* "  ( r ) —A 1 A3 
(li) -A3
^  etc.
( r ) -------------------------► repeat with B1,B2,B3
Fig. 1.23 Orthogonal libraries. The set of monomers to be used is divided into
orthogonal groups. Two libraries are synthesised as shown. When tested, active pools 
of library A share only one monomer with those of B. E.g. If pools containing A2 and 
B3 are found to be active, the responsible monomer is deduced to be Asp.
A similar principle has been used for the synthesis of solution mixture libraries (145) 
where mixtures of dimers were created using a series of monomer Al, A2... with a 
mixture of monomers (B1,B2...) then with monomers B in series with mixtures of all A’s. 
Again, active sub-libraries compared share only one unique A and one B giving the 
single active dimer. In this case, a 2-dimensional array of activities can contribute more 
information than one active; difficult to visualise in the multimeric Deprez example. 
A.M. Bray has refined the process to be expressed in digital terms, and sets of active 
peptides are deduced from overlapping subsets of peptides present in different sub­
libraries (146).
Some recent assay techniques involve selection of the active from a mixture by the
biological target itself. One method requires immobilising a protein of interest on a
packed chromatography column, then flowing a mixture library through it. The library 
members are eluted in order of affinity, and can be identified by electrospray mass 
spectrometry (147). Another method using affinity selection/MS identification employs 
capillary electrophoresis. The target protein is present in the capillary, and the library
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introduced as sample. The migration of binding ligands is retarded by the presence of the 
protein (148). van Breeman et al. (149) have used on-line ultrafiltration to remove 
unbound ligands from the incubation of a target protein with a library, before dissociating 
with organic solvent and MS analysis. A similar technique employs size exclusion 
chromatography to isolate the protein/ligand complex prior to LC-MS analysis, the latter 
procedure also effecting the dissociation (150). Another very rapid system described 
immobilising the target antibody on a MALDI-TOF probe, thus achieving selection and 
sample preparation in one operation (151). It has been commented that in comparative 
studies, affinity selection gives less pronounced differential between ligand activity than 
the corresponding on-bead fluorescent antibody screen (93).
Some groups have also exploited the gentle ionisation system of electrospray to directly 
visualise protein/ligand complexes. Loo et al. (152) demonstrated the mass spectrometry 
of phosphopeptides non covalently bound to SH2 protein (13kDa). High resolution 
Fourier Transform-MS has been used in similar studies to select ligands for carbonic 
anhydrase (29kDa) from a library of 289 compounds (153). Several studies have shown 
binding affinity measurements by relative abundance of signals due to bound/unbound 
protein, and these compared accurately with solution studies. Importantly, the relative 
abundance of different peptide complexes are preserved when the experiments are 
conducted as a mixture.
Perhaps the most extreme case of selection of actives by the biological target is provided 
by Hue et al. (154). A number of aldehyde and amine monomers are incubated with 
carbonic anhydrase, and after some time, the solution was analysed for condensation 
products. The supposition is that the hydrolytic action of anhydrase on substrates being 
reversible, the best fitting monomers will yield the greatest abundance of products; the 
self-assembly of a library.
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1.7.4 Compounds on Solid Supports
Assay of compounds still attached to solid substrate has several advantages. A large set of 
compounds can be exposed to assay media without interacting with one-another. The 
advantage is particularly marked with the on-bead assay of one-bead-one-compound 
libraries, as millions of compounds are assayed effectively in isolation.
Compounds synthesised on planar supports or pins can be readily marked making their 
identification easy. Immobilised compounds have been reused in different assays as many 
as 60 times, making the generation of random lead discovery libraries economically very 
attractive, as well as facilitating the archiving of compounds. However, the soluble 
receptors necessary for such assay are not always available. The assay must permit the 
identification of individual beads, pins or spots. Fluorescent labelling of antibodies 
permits easy visual identification of beads allowing manual or automatic selection using 
existing automatic cell-sorting technology, followed by sequencing of the peptide or code 
(see below) . The principle formed the basis of Lam’s original Selectide™ system (14). 
Radio labelling systems are also reported where beads are mixed with radiolabelled 
receptor and spread in agarose gel over x-ray film (155) the sensitivity of the assay is 
conveniently regulated by exposure time on the film. Active bead-bound compounds have 
been isolated using receptor immobilised on magnetic beads (156). Compounds on active 
beads have also been identified by MS-MS after photolytic cleavage of compound from 
single beads (157). Pool sequencing of mixtures has allowed the identification of 
favoured residues for the subsequent synthesis of more focused libraries (93). Youngquist 
et al. used a partial capping protocol to generate a set of precursors to the sequence on 
each bead, thus leaving a synthetic trail to facilitate subsequent “sequencing” by MALDI- 
TOF MS (158).
For non-peptide libraries, several strategies for recording the reaction history, and hence
encoding the bound compound have been reported. Oligonucleotides conjugated in
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parallel with the combinatorial steps have been used because of the reliable synthesis and 
very sensitive sequencing available (159), making it useful even for peptide libraries. 
Other code molecules include halo-phenols, identified by gas chromatography (160). The 
use of macromolecular reagents to modify the outside accessible surface of beads has 
allowed Vagner et al. (161) to generate two peptide sequences on the same bead, and 
allow the coding of peptides by peptides. Importantly here, the physical separation of the 
ligands from the code molecules means that activity is not modified or confused by the 
code molecules. Reaction history has even been recorded on microchips encapsulated in 
large beads (162) or even etched by laser in microscopic barcodes on plastic synthesis 
supports (163). The extra synthetic effort involved in encoding strategy has been avoided 
by Bradley et al. (164) with the use of multi-functional linkers. Three linkers with 
different acid lability allow the stepwise release of compound from the bead, permitting 
on or off bead assay and sequencing.
A principle disadvantage of the solid phase screening approach is that the putative ligands 
are not in a natural solution state, and active species apparent in the initial assay may not 
translate to active compounds in solution. Conformations may be different to that in 
solution or crucial functional groups may be involved in resin attachment. Protein-ligand 
interactions may be affected by the proximity of solid surface and spacer molecules are 
common. Lack of access to compound within the bulk of the bead by large proteins is a 
concern and has led to the development of hydrophilic resin spacers and hydrophilic 
resins described in (section 1.4.).
Finally, combinatorial approaches have found their way into computer aided molecular 
design, where virtual libraries are pre-screened for receptor fit allowing the synthesis of 
only the most promising subset of a putative library (165). The method has been extended 
to an evolutionary approach where “actives” from a computationally “screened” set 
provides information for the design of a new set of electronic ligands (166).
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2. The Structural Utility of Metal Ions in Protein and Peptide 
Architecture
2.1 Roles of Metal Ions In-vivo (167)
Metal ions are present in all life forms, and contribute to biological function in diverse 
ways. Group 1 and 2 metals are present as bulk inorganic salts or as electrolytes in nerve 
signal transduction. Metals from the d-block are present in trace quantities but are 
nevertheless essential to life (168). Transition metal ions can perform a purely structural 
role within proteins, where the metal performs “fine tuning” and stabilisation of a pre­
ordered protein structure. Alternatively, when the metal is actively enrolled in chemical 
processes, the chelate structure and manner in which the metal is presented to the reacting 
species is crucial to function (169), and as such will be discussed here.
2.2 Structural Features of Natural Metal Complexes
A wide variety of co-ordination geometries are found in nature. Co-ordination is provided 
by anionic chelation or by lone pair donation from amino acid side chains, peptide 
backbone, water or inorganic sulphide, or even as an organometallic in the case of 
vitamin B12. A number of different metal complexes will be discussed which illustrate a 
cross section of the structures which occur in nature and provided the inspiration for the 
work in Chapter 3.
Glutathione
Glutathione is a highly ubiquitous endogenous tripeptide, y-Glu-Cys-Gly. Glutathione has 
a number of physiological functions, primarily the performance of redox reactions. The 
peptide is also widely observed in a complex with zinc, where two glutathione molecules, 
each acting as a bidentate ligand, complex one zinc ion in a tetrahedral co-ordination 
geometry. The primary source of electron donation is the cysteine thiol, with participation 
by the glutamic a-carboxyl, Figure 2.00.
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Fig. 2.00 Fig. 2.01
Metallothioneins and Phytochelatins (170)
Metallothioneins are found in the liver of mammals. The peptides are induced in mice on 
administration of cadmium, and are thought to have a role in detoxification and excretion 
of heavy metals. The polypeptides are relatively small, around 60 residues, of which 20 
are cysteine. The peptides can each bind 7 metal ions; of Cd2+, Hg2+, Cul+ or Cu 2+. The 
metal ions when bound are held in distinct clusters of three or four, Figure 2.01. Each 
metal ion is tetrahedrally co-ordinated by terminal and bridging cysteine residues in a six- 
membered ring. The ring is distorted from the ideal chair. The phytochelatins are a similar 
cysteine rich peptides that exists in plants, a heterogeneous family of peptides, consisting 
of repeating units of y-Glu-Cys, interspersed with the occasional glycine. The peptides 
can thus be viewed as repeating sequences of glutathione. Complexation of cadmium 
consists of two neighbouring glutathione units co-ordinating tetrahedrally with a single 
ion, in a manner analogous to glutathione in free solution. Larger clusters are also known 
with eight units holding six ions with the contribution of one inorganic sulphide. 
Transferrin
Higher animals employ large tailored proteins to maintain iron in a soluble form for 
transport. Human lactoferrin is a monomeric protein of 80kDa incorporating one binding 
site for Fe2+. An octahedral environment is created by the co-ordination by two tyrosine
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anions, an aspartate, a histidine and a free bidentate carbonate anion Figure 2.02. The 
iron is bound tightly with a binding constant of 10 M' , and release is thought to be 
effected by a change in protein folding depriving the ion of some of the ligands. 
Siderophores
Siderophores occur in prokaryotic cells and perform a similar role to transferrins. They 
are far simpler organic molecules which use either hydroxamic or catecholate bidentate 
ligands arranged around linear or cyclic molecules such that three can act in concert to 
bind a single Fe3+ in octahedral format. In Ferrioxamines, a peptide-like backbone 
provides the appropriate spacing between ligands. Figure 2.03.
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A metalloenzyme is an enzyme in which the incorporated metal ion serves as the 
chemically active centre. In the bacterial superoxide dismutases (SOD), a Mn ion is four 
co-ordinated by three histidine residues and one aspartic acid. The structure is effectively 
a trigonal bipyramid with one apex left empty. In some SOD enzymes, the site is filled 
transiently by water, but in others, solvent is excluded and the site is empty. The 
mechanism of action is believed to be the binding of an oxygen anion to the vacant site, 
followed by reduction of the metal and release of molecular oxygen Figure 2.04. In
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eukaryotes, the SOD enzymes are more complex, incorporating an additional metal ion. 
The active centre is a Cu2+ ion, co-ordinated in a square pyramid of four histidines and a 
water molecule. One of the histidines is shared with a neighbouring Zn ion, which is 
itself tetrahedrally co-ordinated by another two histidines and an aspartate Figure 2.05. 
Other enzymes incorporate zinc in a structural role. Alcohol dehydrogenase possesses a 
non-catalytic Zn2+ which is tetrahedrally co-ordinated by four cysteine sulphur atoms, 
contributed by residues sequentially distant in the primary sequence, thus stabilising the 
formation of a loop. The structural motif occurs in several DNA binding enzymes and has 
become characterised as a Zinc Finger (172). Zinc finger motifs have the general structure 
of Cys-X2 -4 -Cys-Xi2 -His-X3_5 -His, where X are other amino acids. More complicated 
variants exist in the form of two proximal zinc ions co-ordinated by two patches of 
cysteine residues on the same sequence, with a large twisted sequence in between (173). 
Looped structures consisting of a cluster of two zincs sharing a pair of cysteine thiols 
have been found in yeast transcription factor Figure 2.06.
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2.3 Protein Engineering
Metal binding sites have been engineered into proteins to convey novel structure or 
catalytic activity. Alternatively, existing metalloprotein sites have been modelled to create 
simpler functional mimics to explore the role of the metal in the natural structure.
Natural proteins are inherently unstable to temperature, oxidation and endogenous 
enzymes, limiting their use as drugs or in process chemistry. Since both thermal 
inactivation and enzymatic degradation involve protein unfolding, one approach to the 
stabilisation of proteins has been the addition of multidentate metal binding sites across 
sections of the folded protein, anchoring the folds via dative bonds to an introduced metal 
ion. Metal chelating motifs within natural proteins are well known and described above. 
Several workers have successfully transplanted these natural motifs into proteins and 
reported gains in conformational stability. In a general methodology reviewed by Regan 
(174), conformational studies were performed to find existing regions of the proteins 
which correspond spatially to one of the known binding motifs. Selected residues within 
the site are substituted for His, Cys or Asp, to form the authentic binding motif.
For example, Kellis et al. (175) modified the iso-1 cytochrome C globular protein to
 ^i • • • • •contain a Cu binding site by a single substitution of His at position 58. A bidentate 




A zinc binding site consisting of three histidine residues has been engineered in the 
artificial 3a-helix bundle protein alpha-4 (176). The protein had previously been designed 
to illustrate the role of hydrophobic residues in the association of helices into bundles
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(177). Two surface His residues on one helix in His-X3 -His format form a tridentate site 
with another His on a second helix Figure 2.08. A similar site has been engineered into 
an antibody, an idea developed as a scaffold for combinatorial protein synthesis (see 
below). A tetradentate site has also been substituted into the same alpha-4 protein (178). 
A Cys-X3-His motif was substituted into each of two helices Figure 2.09.
Fig. 2.08
The stabilisation of protein structure by native chelate site is perhaps most dramatically 
illustrated by the synthesis of a minimalist zinc finger by Michael et al. (179). A zinc 
finger sequence was re-synthesised with all residues substituted by alanine, except the 
chelating Cys2 His2 and some structurally essential hydrophobic amino acids. The ability 
of the derived peptide to bind Co 2+ was very similar to the native sequence, but the 
structure significantly changed when any of this small subset of the parent sequence was 
altered.
The concept of preferential binding of a metal ion to a pre-organised multidentate site has 
become sufficiently accepted for metal ion binding events to be quoted as evidence of the 
structural integrity of designed proteins. Pierret et al. (180) engineered a tridentate 3- 
histidine metal binding site, analogous to the carbonic anhydrase copper site, across a p- 
bend of scorpion toxin. Experiments by CD and NMR indicated that the ap motif of the
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native toxin was highly conserved, suggesting that the motif was tolerant of the 
modification, and a suitable stable scaffold for protein engineering.
In a fascinating reversal of the previous strategies of using metal binding to stabilise a 
defined secondary structure, Struthers et al. (181) used the pre-organised structure of the 
metal binding pocket of a zinc finger to design an organic structural motif which forms 
and remains independently of the metal. The sequences include a type II turn motif, 
Pro4D-Ser5, as well as the hydrophobic residues reported as important for organising the 
parent zinc finger. Evidence was presented for the structure of the peptides being almost 
identical with or without bound metal. The result is very important as the peptides are 
unusually small to have well defined secondary structure and the procedure illustrates the 
utility of metal complexation resulting in a relatively fixed conformation which permits 
the design of artificial mimics. The authors were more interested in the removal of the 
metal as tantamount to a spare binding pocket, leading to the possibility of designed 
functional proteins. Similarly, Berg et al. (182) have deleted a single chelating residue 
from the zinc finger CD1, to yield an artificial zinc finger with retained metal binding 
affinity, but with a "spare" ligand site, occupied in the example peptide by solvent. The 
spare accepting site is proposed as a possible catalyst, by analogy with alcohol 
dehydrogenase.
2.4 Metal Ion Mediated Conformational Control of Polypeptides
The preceding examples of protein sculpting using natural sequences rely heavily upon a 
co-operative of hydrophobic interactions and H-bonding to organise protein structure into 
a shape suitable for metal co-ordination, with the metal subsequently contributing to the 
stability of the folded state. One of the goals of artificial protein design is to reduce the 
highly complex natural form of a protein structure to an essential functional unit which 
could be used as an industrial or therapeutic agent. Alternatively, the minimisation of
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structure could aid the elucidation of a mechanism. The slimmed-down target structure 
may lack the finely tuned secondary structure of the parent protein which gives the pre­
organisation necessary for the soft ligand/ labile ion binding interactions previously 
described. To this end, more strongly electronegative artificial ligands in combination 
with slowly exchanging cations have been used for the induction of new conformations 
by metal ion binding. Bipyridyl amino acids are a common choice in conjunction with 
R u3+ and Co3+ (183) Figure 2.10. Recently, Torrado et al. (184) have modified the 
bipyridyl structure to feature fluorescence which is modulated upon metal binding, 
allowing the ligand to act as a reporter molecule in binding studies, Figure 2.11. Other 
artificial amino acids cited as ligands are aminodiacetic acids.
These acids, Figure 2.12, act essentially as half an EDTA molecule, and two placed in a 
peptide sequence have been used to bind a single metal ion and facilitate a bend (185) or 
coil of an a-helix (186). Rana et al. (187) have unusually employed full EDTA 
derivatised lysine residues to bind iron. The slow-exchanging metal chelation principle 
has been used to impose many topological forms upon synthetic peptides.
The a-helix has been a chosen target for metal mediated formation. Although 40% of 
natural proteins exist as a-helix, the form is not entropically favoured, and requires 
exogenous stabilising factors for formation (186),(188). The formation is easily followed 
by characteristic changes in CD spectra (189).
0  h2n o
Fig. 2.10 Fig. 2.11 Fig. 2.12
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The contrast between the fast and slow exchanging methods is clearly illustrated by two 
papers by Ghadri et al. (190). A peptide with regularly repeated (i, i+4) His residues is 
induced to form a stable a-helix on complexation with Ru . The result is clearly 
contrasted with earlier work where the same task is attempted with exchange-labile zinc 
and copper, where only partial coiling occurs (191) Figure 2.13.
Ru3+
-  / vRu;
Fig. 2.13 Fig. 2.14
The shorter the peptide, the fewer the additional stabilising factors such as H-bonds are 
available. Ruan et al. (186) used two aminodiacetic acid residues inserted into a peptide at 
chosen spacing (X-Ala3 -X) to partially induce and stabilise a helix turn on addition of 
Cd2+. One peptide was described as 80% helical for an 11 -residue peptide, despite 
negligible helix content in the absence of metal. A peptide with only one ligand was used 
as a comparitor to check that the helicity was derived from the 1:1 intramolecular 
complex. The induction of a helix by metal binding has also been shown to be a 
nucleation event by Ghadri et al. (192). The formation of a complete repeating a-helix 
could be induced by the chelation of just two ligands in the manner described above 
Figure 2.14. The result lead to the conclusion that the helix formation was very 
dependent upon hydrophobic interactions for the formation of the whole structure. To 
further illustrate the point, example synthetic peptides were described which were 
unordered in pure solution, but both formed stable a-helices when present as a mixture. 
In this case, the helix was nucleated by intermolecular interactions.
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As well as modifying the secondary structure of a single peptide chain (186) the strong 
interaction of Ru 3+/ Bipyridyl amino acids has permitted the tailoring of intermolecular 
associations. Lieberman et al. (193) tagged a bipyridyl moiety onto the end of a 15 amino 
acid a-helix. Upon addition of Fe 3+, trimers were formed. It was observed that not only 
did the metal ion induce aggregation in a fixed stoichiometry, but that the association also 
dramatically increased the helicity of the peptides Figure 2.15. The finding supports the 
previous theory of the importance of hydrophobic packing to the stability of these 
structures. An additional comment was made in the work regarding the chiral nature of 
the complex. The complex was theoretically capable of stereoisomerism about the iron, 
but only forms one isomer due to the packing preference of the attached coils. Sasaki et 
al. (194) performed very similar experiments where four closely related bundle structures 
were formed by random usage of the possible isomers. Ghadri et al. (195) further 
developed the bundle formation principle by adding a second ligand (His) to the opposite 
end of the bipyridyl derivatised peptide chains. In this way, when aggregation occurred on 
complexation with Ru3+, a second tridentate binding site was created by the proximity of 
the three histidine residues after aggregation and coiling Figure 2.16.
,5 + F e3+ aa _ _ a
-L i /
C u2+





\  1 /  
R u3+
Fig. 2.15 Fig. 2.16
The second site was shown to have a high affinity for copper. The bundle thus contained 
one labile and one inert metal binding site. With two ligands per peptide, the potential 
existed for multiple products on aggregation with metal. However, the desired product
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was exclusively formed. The regiospecificity observed was attributed to the affinity of the 
bipyridyl groups for Ru , the kinetic stability of the complex with respect to 
lmidazoyl/Ru and the geometrical constraints imposed by the stacking of the helical 
coils in alternative structures. The lack of significant structural change upon binding of 
Cu 2+ to the L3RU complex suggested a highly pre-organised site, as observed with 
examples of near-native proteins (178). The product is a step toward designed functional 
proteins and is an illuminating example of the interplay between labile/inert complexation 
and the role of hydrophobic interations in determining the final structure of a protein. 
Whilst most examples of the stabilising of protein structure by metal ion co-ordination 
feature the well characterised a-helix, other protein motifs have received attention, such 
as the p-sheet structure. Unlike the a-helix, p-sheet structures are believed to require 
extensive long-range tertiary interactions, given that small segments of P-sheet proteins 
do not adopt the conformation in isolation. The interactions which would pay the entropic 
price for folding are apparently distant (196). Kelly et al. (197) have substituted bipyridyl 
groups into the backbone of peptides, such that co-ordination of Cu by the bipyndyl-N 
and immediately adjacent amide carbonyl groups forced a p-type bend. The square planar 
geometry of the copper co-ordination enforced a reverse turn conformation, and nucleated 
a P-sheet form in peptides chosen from sequences known to occur frequently in p-sheet 
structures Figure 2.17.
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The geometry of the turn is distinct from that obtained by natural p-tum motifs, and is 
believed to be additionally enhanced by hydrophobic interactions of the peptide 
sidechains with the pyridine rings.
2.5 Conformational Constraint of Small Peptides by Metal Ion Binding
Several workers have studied the extent to which the conformation of small peptides 
could be influenced by metal ion co-ordination. In most of the previous examples of 
metal binding the presence of hydrophobic interations predisposes the proteins to recruit a 
number of chelating residues into a binding site. Peptides with less than 20 residues 
however rarely exhibit distinct solution conformation, as the small number of 
intramolecular interactions are insufficient to bias the peptides toward any of the possible 
conformers (192).
Imperiali et al. (198) explored the potential of metal binding to form p-bends. Model 
peptides were synthesised with (5)-a-amino-2,2 -bipyridine 6 propionic acid (5-Bpa) 
either side of a set of the P-tum motifs of the form Pro-DX. Complexation with Cu2+ 
resulted in 1:1 cyclic products. Copper was found to be 5 orders of magnitude more 
strongly bound than zinc, though all divalent transition metals effected a secondary
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structure in the peptides. Comparison of peptides with 5-Bpa substituted for Phe showed 
no such effect, providing evidence for the role of the metal binding in forcing the 
conformation. Yamamoto et al. (199) investigated the role of the interstitial sequence in 
similar cyclisation of short peptides via 5-Bpa. Several model peptides of the general
contained glycine, strong negative ellipticity was observed by CD, indicating the 
formation of the desired cyclic structure. If glycine was substituted for alanine, a 
decrease in the effect was observed, attributed to the increase in backbone flexibility. 
Observation was also made that the complexes were chiral, with the chiral peptide 
backbone influencing the orientation of the bipyridyl about the metal. A peptide with a 
four residue spacer exhibited positive ellipticity on complexation. The result contrasted 
with other work showing complex chirality determined by the preferred geometry of the 
metal ion (200). Yamamura et al. (201) synthesised short peptides derived from the 
Rubredoxin metal binding fold containing the ubiquitous sequence Cys-X2-Cys-A-B. The 
interstitial sequence contained Pro-Leu or Pro-Val, suggesting a disposition toward a p- 
tum. The authors describe the subsequent cyclic complexes with Hg2+ as a new turn motif 
with features of both p and y turn motifs. The conformational control exerted by the 
geometric preference of the Hg ion permitted the formation of an H-bond additional to 
that present in the native protein. Figure 2.18.
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In contrast, elsewhere Cys-Pro-Leu-Cys short peptides are described as forming 2:1 
complexes with divalent metals (202). Another group working on the sequence A-Cys- 
Pro-Leu-Cys-B (203) observed two isomers from the complex, forming one preferred 
isomer when combined into one peptide as a tetradentate ligand. Figure 2.19.
Fig. 2.19 A spacer molecule provides stereoselectivity
The role of hydrophobic residues in determining complex formation in even small 
peptides is also illustrated in a patented series of sequences based upon Cys-X-Cys, (47) 
where chelation of metals occurs if the sequence is flanked by certain hydrophobic 
residues. A specific example of p-tum replacement by a metal assisted turn was described 
by Tian et al. (100). Protein inhibitor tendamistat contains the p-bend -Trp-Arg-Tyr-. The 
short sequence of the protein Trp-Arg-Tyr-Gly was only weakly active against a-amylase. 
However, the activity of the tetrapeptide was enhanced 200 times when complexed with 
copper Figure 2.20a. The authors believed that the metal chelation templates the 
peptides and increases the proportion which are in the bioactive P-tum conformation 
found in the whole protein. Figure 2.20b.
spacer
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Oa Metal binding preserves a P- 
the absence of the parent protein
Fig. 2.20b
Conformationally stabilised 
peptide exhibits stronger 
binding
The work is a potent example of the utility of metal mediated conformational constraint 
replacing the topological contribution of a large protein environment.
Not all ligation patterns of short sequences abstracted from proteins have been 
straightforward. A model peptide based upon Plastocyanin formed only 60% of the 
complexation witnessed in the authentic protein, the authors suggesting that some 
conformations of the peptide were unfavourable to metal binding (205). Vahrenkamp et 
al. (206) reported the synthesis and Zn2+ complexation of several peptides of the general 
sequence His-Xn-His. The peptides formed 1:1 complexes as experienced in the cyclic 
examples above, Figure 2.21a, however most were polymeric in nature, forming an 
insoluble chain of cyclic dimers. Evidence was also shown for 1 and 2 dimensional linear 
polymers, with TFA occupying the remaining tetrahedral co-ordination sites Figure 
2.2lb,c. The authors suggested that the monomeric rings may be too small and the loss of 
entropy too high for formation. Although one spacer chosen was Pro-Gly, selected for the 
predisposition toward p-tums, the authors concluded this was insufficient to give rise to 
the cyclic product. Reference was made to greater success achieved with a bicysteinyl 
version of the peptide.
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Fig. 2.21a Fig. 2.21b Fig. 2.21c
Imperiali et al. presented a definitive investigation into the level of influence the P-tum 
motifs have on the successful generation of monomeric cyclic complexes peptides with 
metals (196). A peptide containing metal ligands and a spacer sequence featuring the turn 
motif Pro-D-Ser was successfully complexed to metal in a monomeric cyclic structure, 
the metal nucleating a type II p-tum from the disordered solution peptide. Without the 
motif, a comparable peptide lacked high affinity metal binding and when bound with 
excess zinc, did not exhibit ordered secondary structure. The authors concluded that metal 
co-ordination alone was insufficient driving force to generate a bend.
Perhaps the ultimate pre-ordered bend is a peptide which is already cyclic by merit of a 
covalent bond. Several workers have investigated the effect of metal binding on the 
mobility of cyclic peptide structures. Palmer et al. (207) designed a small cyclic peptide to 
mimic the ion binding site of SOD. The loss of the stabilising influence of the whole 
protein was anticipated and replaced by the anchoring of the ends of sequentially 
disparate protein segments into a single cyclic peptide. The 14-membered peptide 
contained the 4 His and 1 Asp residues active in the chelation of copper by SOD. The 
model peptide bound copper strongly and good structural correlation was demonstrated 
between the complex and the parent protein. Similarly, Roques et al. (208) synthesised 
model zinc finger peptides by taking the zinc binding loop sequence from HIV1 DNA 
recognition protein, and forming a small cyclic peptide. A linkage was specifically
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positioned to retain the conformation of the native loop Figure 2.22. The peptides were 
effective at binding Zn2+ and were used to generate antibodies against the parent protein. 
Zanotti et al. (209) have also observed ion binding properties in a small cyclic peptide, 
CVPPFFC. In this case, the binding of calcium was remarkably specific. NMR and CD 
evidence showed substantial stabilising of the structure by the ion binding arresting 
rotation about the V-P bond despite the expectation that such a small cyclic peptide might 
be already quite restricted in conformation. Garcia-Escheveria et al. (210) have designed a 
symmetrical cyclic dimer based upon valinomycin. The monomer peptide possessed the 
P-tum promoting sequence Pro-D-Val. Disulphide dimerisation of the peptide resulted in 
a cyclic peptide with two p-tums, and bound Ba with considerable selectivity, using 
backbone amide carbonyl groups as ligands, stabilising the p-tums. The authors have also 
attempted to exploit the concept of ring size to dictate metal ion selectivity by linking the 
peptide to resin for ionophore chromatography (211). Equilibria studies indicated 
complexes of both 1:1 and 2:1 peptide to metal, indicating a "sandwich" complex also 
exists. Arena et al. (212) observed similar complexes during studies of the chelation of 
Zn2+ by cyclo His2 .
Fig. 2.22 Preservation of a metal 
binding bend in a small peptide 
using a covalent tether
2.6 Metal Complexes in Combinatorial Chemistry
Combinatorial peptide libraries have been reported which feature metal ligands. The 
libraries fall into two general categories, those which search random sequences for new
59
Introduction 2 - Structural Role o f  M etal Ions
metal ligands and those where a fixed metal ligation sequence performs some structural 
role for the display of random residues elsewhere on the molecule.
In the pursuit of novel metal binding ligands, Kramer et al. (21) synthesised random 
hexapeptides on cellulose sheet and discovered sequences capable of gleaning Ag+ ions 
from an aqueous wash. Brown et al. (36) isolated peptides capable of binding to the 
surface of colloidal gold from a bacterially expressed library in solution. In the latter case, 
a short randomised peptide sequence was repeated within a larger polypeptide expressed 
on the phage surface. The repeating units were aimed to give the peptides a degree of 
secondary structure and a greater concentration of possible binding sites. Several 
enrichment screening cycles yielded peptides active when isolated from the cell surface. 
Another approach to novel ligands has involved the generation of a peptide library with 
randomised residues either side of a known p-tum motif. Jacobsen et al. (102) synthesised 
a library on solid phase using randomised amino acid positions flanking an artificial turn- 
inducing residue Figure 2.23. The work was described as a library of potential ligands 
without predefined binding sites but with a diverse collection of functional groups and 
conformational restrictions. New ligands were discovered by sequencing the beads 
displaying strong coloured response after incubation of the mixture in a solution of Ni .
In a complete reversal of the above principle, Wood et al. (213) synthesised a peptide 
library where two known natural product derived chelating peptide sequences were 
spaced apart by set of combinatorially variable sequences. The interstitial sequence was 
varied both in residues and in length Figure 2,24. Some strong binding with transition 
metal ions was visible by colour change, though elucidation of active sequences was 
prevented by the original choice to block the N-termini with acetyl.
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End cap- Position 2
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His seq
Fig. 2.23 Combinatorial search for 2.24 Search for new turn elements 
new chelating sequences
Combinatorial techniques have also been used to tune the metal affinity and specificity of 
an existing ionophore. Still et al. (214) anchored cyclen to a solid phase resin, and 
derivatised the remaining three nitrogen atoms with peptides in a combinatorial manner. 
No chemical selectivity of the nitrogens was attempted, so all available groups reacted
with a given incoming amino acid Figure 2.25a. A series of libraries was made with
2+  •between 1 and 4 amino acids coupled in sequence. After incubation with Cu , selection 
by colour and sequence decoding, a set of preferred amino acids at each position was 
deduced. Interestingly, the most influential amino acid position was found to be the most 
distant from the ionophore. It was suggested that the longest amino acid chain can bend 
around, and if the terminal amino acid was suitable, act as a fifth ligand displacing weakly 
bound solvent Figure 2.25b.
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Fig. 2.25a R = H or 1,2,3 or 4 couplings Fig. 2.25b The most distant ligand was
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The potential advantages of conferring a level of constraint or defined secondary 
structure on a randomised library of peptides has been discussed previously. The ability of 
metal binding to stabilise the secondary structure of peptides has recently been exploited 
in the generation of macromolecular combinatorial libraries. Rebar et al. (91) used the 
zinc finger motif of transcription factor Ilia as a framework for constructing a library of 
proteins with novel DNA binding characteristics. A zinc finger consists of hydrophobic 
and chelating residues responsible for forming the structure, and six "contact" residues 
thought to be responsible for DNA sequence recognition. The contact residues are highly 
variable between different endogenous zinc fingers whilst the structural elements are 
closely conserved. The observation of natural variation was expanded by generating a 
library of peptides where the contact residues were randomised whilst retaining the 
essential zinc-binding structural features. The library was expressed on bacteriophage, 
using degenerate DNA codons within the zinc finger code to randomise the chosen 
residues. Affinity purification of the products against target DNA sequences permitted the 
elucidation of zinc finger proteins with novel DNA binding selectivities.
Pessi et al. (35) chose the heavy chain of immunoglobulin as a scaffold of defined 
secondary structure for the display of randomised "minibodies". The approach again 
involved randomisation only of sequences not important for secondary structure, the 
hypervariable loops of the parent antibody. In this case, additionally a new metal binding 
site was engineered across two of the proximal loops of the putatively conserved area of 
structure, Figure 2.26. The library members were found to bind zinc strongly, thus 
indicating that the region was indeed of conserved secondary structure. The example is of 
special note because the metal binding is proposed as evidence of a conserved secondary 
structure, contributing little change to the desired shape. The library is also an example of
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the display of discontinuous combinatorial epitopes which are proximal, and hence 
potentially co-operative, by merit of the chosen scaffold.
The concept of bringing randomised subunits together to form a library of collaborative 
molecules has origins in nature. Antibodies achieve binding site diversity by the 
recruitment into one macromolecule of different light and heavy chains in the FAB 
fragment. Each has a constant domain and a variable region. The constant domains are 
responsible for association, while the variable regions acting in concert provide the 
tailored binding site. The concept has been utilised by Scott-Goodman et al. (31). Metal 
binding was used to recruit randomised subunits into a tertiary structure, likened to an 
artificial receptor. Variable functional groups were substituted onto the 5 position of 
terpyridine. Addition of Ru3+ to the mixture in solution caused the formation of dimers, 
where a pair of molecules with single point variability formed a diverse co-operative of 
functionality and spatial orientation, Figure 2.27. Examples of such convergent 
combinatorial strategy are rare in the literature, though Boger et al. recently announced a 
library of dimers joined by combinatorially varied bridges (215).
Fig. 2.26 Engineered metal binding site in a 
combinatorially varied immunoglobulin by 
Pessi et al. (35)
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RuCI.
X Ru
Fig. 2.27 Variable molecules X,Y with half- 
chelating pyridyl tags are brought together 
to form a convergent library or artificial 
receptor by metal ion binding
.Ru
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2.7 Analytical Techniques in the Investigation of Metal Complexes
The work cited previously draws upon a variety of analytical techniques to investigate the 
nature of peptide/metal complexes. Whilst the detailed nature of each proof is not 
discussed above, presented here is a summary of the techniques employed. Different 
techniques scrutinise either the metal ion, the ligand, or the new properties of the complex 
itself.
X-ray Absorption Fine Structure (XAFS) is an x-ray technique which does not require 
a regular crystal structure and allows the visualisation of the co-ordination geometry of a 
metal ion in solution (201).
Atomic Absorption Spectroscopy (AAS) enables the quantitation of a metal ion in a 
sample. The technique has been used to determine the overall stoichiometry of stable 
complexes after gel filtration to remove excess metal in solution (180).
NMR of Paramagnetic Metals can yield information as to the co-ordination 
environment, whether complexed or in free solution, while multiplicity of signals has
1 1 Tbeen used to suggest a number of isomeric complexes of Cd (216).
NMR Signal Shape. Qualitative comparisons of peak shape between complexed and 
uncomplexed ligands has provided indication of formation and ligand mobility about 
complex conformational mobility. Broad spectra of ligands which are suggested to slowly 
interchange between several conformers have been observed to sharpen upon metal 
complexation, or even reduce split peaks of isomers to a single sharp peak of the 
conformer preferred by a stable complex (176). Conversely, relatively sharp peaks of 
highly mobile ligands have been observed to broaden on addition of metal ions, attributed 
to the metal stabilising a structure and increasing the dwell time of the molecule in that 
particular conformation (209).
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Loss of NMR Signals. Perhaps the simplest quantitative NMR observation of a 
complexation event is loss of particular signals from the NMR spectrum of the ligand. 
Comparative 1H NMR spectra has revealed absence of participating thiol protons in the 
formation of metal/thiol anion complexes (217).
NMR Signals of Reporter Nuclei. Other nuclei have been used as reporter groups for 
ligand conformation. For example, 19F NMR of Fluoro-Phe substituted near the site of 
complexation has been used to investigate the chiral form of a complex (203).
Chemical shift. Upon complexation, specific participating ligands donate electron 
density to the metal cation. The phenomenon results in inductive deshielding of
1 i ' i
immediately neighbouring nuclei. Downfield shift of Cysp H and C signals have been 
recorded for glutathione on complexation with zinc (218). Steady shift of the 5 value of 
the naked ligand to a new fixed value under titration with metal has been used to measure 
complex stoichiometry (219). J coupling constants have been used to deduce 
conformational changes on peptide complex formation, particularly of the backbone; 5Jaa 
(220) and ^ n h  (221)
2D NMR. The Nuclear Overhauser effect has been used to reveal the proximity of 
protons which are far apart in the primary protein sequence. In several examples, 
sequentially disparate residues giving no NOE signals in free solution have been shown to 
have been brought into close proximity by metal complexation (199). ROESY 
measurement has been applied in cases where the tumbling rate of relatively mobile 
structures has diminished NOE signals below a useful level.
Variable Temperature NMR. In solution, the protons of the amide backbone of a 
peptide undergo a shift when freely exposed to aqueous solvent, which increases with 
temperature. The shift of amide protons shielded from solvent exchange by H-bonding or 
restriction within a fixed secondary structure undergo less dramatic shifts. Quantitation
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of the change of aNH as a function of temperature provides information about the solvent 
environment of protons, magnitudes > - 4ppb/K being indicative of free structures. (97). 
Physical form. Simple observation of a change in physical form has been reported as the 
first indication of a new chemical entity formed on exposure of a metal to a ligand. 
Precipitation of oligomeric complex from a monomeric ligand (206) has been reported. 
Dialysis of metal cation in solution across a membrane impermeable to ligand has 
allowed the equilibrium of a complex to be measured directly, using a cation specific 
potentiometric electrode (174).
Chromatography. Stable protein/metal complexes have displayed different selectivity on 
reverse phase HPLC to parent ligand, allowing purification and quantitation (190). Gel 
filtration has allowed the separation of complex from excess free metal salt and the 
subsequent quantitation of the amount remaining bound to the protein by counting of 
metal radioisotope activity (35).
Capillary electrophoresis (CE). Complexation of a metal has been shown to change the 
overall charge and effective radius of proteins and result in altered migration times under 
electrophoresis (222).
Mass Spectrometry. The recently developed soft ionisation technique Electrospray 
Ionisation (ESI) has been used to visualise solution complexes transferred rapidly to the 
gas phase. The techniques permit the observation of ionic complex species and the loss of 
protons from the eletronegative ligands (223)
Fluorescence Quenching. Fluorescent marker residues have been placed close to sites of 
metal binding in proteins. Fluorescence quenching from the electron withdrawing effect 
of the nearby binding of a metal cation is observed (184).
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Infra-red Spectroscopy. The anchoring effect of metal ion co-ordination has been 
observed to alter the stretch frequencies of ligand backbone amides as solvent access is 
modified (224).
UV/Visible Spectroscopy has been very widely applied to the analysis of complexation. 
Upon binding of a metal, the UV absorption spectrum of the ligand displays a charge 
transfer band in the region 400-550nm. The band is characteristic of the ligand atom 
involved, the bonds formed, and also the type of co-ordination geometry (225). By 
titration an extinction coefficient (Eo) for the complex can be deduced. Knowledge of the 
Eo for the complex permits the direct calculation of an equilibrium constant (226). 
Denaturants. The sensitivity of protein secondary and tertiary structure to denaturants 
such as urea and guanidine-HCl has been assessed by NOE and UV absorption. 
Comparative stability values allow quantitation of the contribution metal complexation 
makes to the overall stability of the structure (176).
Circular Dichroism (CD) is a spectroscopic technique which gives information about 
characteristic types of ordered structure, for example the presence of a-helices or p-sheet 
in peptides. The formation of such ordered structure of a ligand by a metal under titration 
has yielded stoichiometry values (191) and dissociation constants (178).
Potentiometric Titrations. The use of a potentiometric electrode specific to a particular 
cation allows a measure of the amount of cation in free solution. The application of the 
electrode to a titration of a ligand with a metal cation allows the equilibrium constant of 
the complexation to be calculated (227). Titration profiles have been used to spot the 
formation of complexes of different stoichiometry according to the concentration of metal 
ion present. pH-metry is a specific type of potentiometry, where the titration of a metal 
complex by acid allows the basicity of the ligand to be measured compared to the 
uncomplexed form, yielding stability information.
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Calorimetry allows direct measurement of enthalpy changes during complex formation 
(212).
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3. Conformational Constraint of Peptide Libraries by Metal Ion
Complexation
3.1 Aims
Many biologically functional molecules are peptides or proteins and consequently 
considerable drug discovery effort has concerned the manipulation of peptide sequences. 
Recently, the potential biological properties and ease of synthesis of peptides has 
prompted the use of peptide libraries of many millions of members in the search for new 
pharmaceuticals. Translation or mimic of a peptide into a synthetic drug molecule is 
usually required to gain resistance to endogenous enzymes and allow for oral 
administration. However, there is well documented difficulty in translating observed 
biological activity from peptide leads into drug candidates (79). Peptide sequences are 
typically highly flexible with many possible conformations, only a small set of which 
may be active. Determination of the active conformation is crucial for the design of 
organic molecules which accurately mimic the important spatial and electronic character 
of the active peptide (97). A conformational determination is highly challenging, the 
peptide may adopt a different conformation in free solution than when bound to the 
target receptor, and the characterisation of an entire complex has only rarely been 
achieved. In the absence of such data, trial and error stepwise synthesis of analogues of 
an active peptide have been performed, or more recently, parallel synthesis of arrays of 
analogues.
An alternative approach, when using combinatorial libraries for lead discovery, is to 
begin with libraries which are either already organic molecules or peptides which are in 
some way conformationally restricted (83). Thus, should any member of a library prove 
biologically active, the subsequent optimisation process could be simplified by the 
reduced number of conformational possibilities.
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At the time of the project, a number of ways of conferring conformational constraint on 
peptide libraries had been published, by far the most ubiquitous of which was the making 
of cyclopeptides, either by disulphide formation between terminal cysteines; amide 
formation across the termini; or between residue sidechains. Other techniques involved 
the inclusion of artificial turn-mimic residues, or the anchoring of combinatorially varied 
amino acids on fixed planar templates such as Kemp’s triacid (see Chapter 1 and 
references therein).
The aim of the work described in this chapter was to exploit the naturally occurring 
phenomenon of peptide structural stabilisation by metal chelation. It was hoped to 
establish a general method which could be applied to combinatorial libraries.
In the structural stabilisation of zinc finger proteins, pairs of chelating residues far apart in 
the primary sequence but in close proximity to one another collectively bind a single 
metal ion, resulting in structural stability of the region. It was supposed that if a peptide 
sequence was synthesised with a half-chelating sequence at each end, then it might be 
induced to form a cyclic peptide in the presence of a metal ion. Such a cyclic peptide 
would probably differ in conformation from an equivalent covalently cyclic peptide. The 
difference could arise not only from the spatial and orientation requirements of the 
chelating moieties, but also from the possibility of chiral species arising from alternative 
co-ordination modes of the peptide around the ion. In Figure 3.00, structures A and B 
are enantiomers by merit of the directional nature of the peptide sequence, and two 
possible orientations of the chelating termini.
B
Fig. 3.00 Optical isomers arising from metal co-ordination
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The differences would lend a new set of diversity possibilities to a combinatorial library 
compared to a set cyclised via the oxidation of terminal cysteine residues. Or, if suitable 
terminal sequences were selected, both cyclisation options could be available from one 
library synthesis, allowing the introduction of increased diversity to a peptide library. 
The principal post synthetic modification of peptide libraries has already been described, 
the so-called library of libraries (30). Metal cyclised peptides may also be resistant to the 
proteolytic and reductive environment of cells to which disulphide cyclic peptides are 
vulnerable.
The stabilisation system was intended for employment in large peptide libraries for the 
exploration of the binding requirements of protein surfaces. Such libraries are most 
easily generated by phage expression. Consequently, metal-ion chelating sequences 
would need to be composed from endogenous amino acids. The intention to eventually 
employ the libraries in biochemical systems necessitates the use of metal binding agents 
which are not so strong as to deplete necessary metal co-factors, such as calcium, from 
the system under investigation. A chelating sequence must however be strong enough to 
effect the desired cyclisation. A combination of high metal affinity combined with high 
specificity for a metal ion not otherwise significant in the biological test system was 
sought. For the discussed reasons, the chelating sequence selected for the cyclisation 
experiments was yGluCys, present in the ubiquitous biological agent glutathione. 
Glutathione naturally binds zinc ions in a ratio of 2:1, other divalent transition metals are 
bound with less affinity, while group I and II metals are largely unaffected. The repeated 
sequence Glu-Cys is also present in the excretory proteins metallothioneins where two of 
the repeats tightly bind one divalent transition metal ion (Chapter 2). It was proposed 
that if a glutathione-like sequence were placed at each termini of a synthetic peptide, the
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stoichiometry of the interaction with zinc would be correct for the formation of a cyclic 
molecule.
3.2 Experimental Plan
The intended library scheme is shown in Figure 3.01
Randomised interstitial sequence
C ys ji Gill
Fig. 3.01 Metal induced formation of a cyclic peptide
For application of the proposed procedure to a combinatorial library, the cyclisation event 
necessarily must be generally applicable to a variety of interstitial sequences, since this 
region was to be combinatorially varied with all the endogenous amino acids. The concept 
of cyclisation of peptides by metal chelation has been investigated by others using 
unnatural (bipyridyl) amino acids (199) or by excision of metalloprotein loops (201), but 
the application of the procedure to GluCys sequences and most importantly, to variable 
interstitial sequences with no predisposition to form a bend, was unproved.
A series of progressive experimental objectives was established to attempt verify the 
existence and utility of the proposed procedure.
1. Characterise the reported binding of glutathione to zinc and establish analytical 
indicators for the chelation event which could be applied to the peptide model.
2. Apply the analytical indicators to some example peptides in the presence of zinc ions to 
confirm the existence of similar metal complex.
3. Establish the stoichiometry of the chelation with the test peptide.
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4. Assuming the expected 1:1 ratio is found in (3) prove that the test peptide was indeed 
a cyclic structure in the presence of zinc ions.
5. Explore the tolerance of the system to different interstitial sequences; residue character 
and number. Establish that cyclic structures could occur in the absence of a predisposed 
bend.
3.3 Synthesis of Example Peptides
A set of example peptides were synthesised, each containing the sequence GluCys - X - 
GluCys, where X = 4 to 6 selected amino acids. The synthesis was performed using Fmoc 
protected amino acids and DCC/HOBT activation on an automatic synthesiser according 
to standard protocols (Chapter 9). Preparative HPLC was performed in all cases, and 
peptides were assayed for free thiol content using the Aldrithiol assay (Chapter 9). 
Additional characterisation was provided by gradient HPLC and MALDI-TOF MS. 
Peptides were recycled from experiments by exposure to 10 eq. DTT overnight followed 
by preparative HPLC and re-analysis. Glutathione, reduced form (GSH), y-GluCysGly 
was purchased from Sigma.
The peptides were synthesised in successive groups as different aspects of the system 
were explored Figure 3.02. For brevity, the following discussion is in terms of the 
investigative technique used, rather than a chronological account of the treatment of each 
set of peptides
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6 GluCysLysLysPheLysLysPheGluCys 3
7 GluCysLysLysPheLysLysPheGluCys












Description of the Peptide Groups:
1 The first peptide 1 synthesised was chosen to include alternate Phe residues as 'H 
NMR probes, interposed with Ser to promote hydrophilicity. The peptide was very 
insoluble in crude form and was abandoned in favour of the revised sequence 2 
which was purified twice by HPLC, finally yielding a material insoluble in water.
2 A set of peptides varying only in interstitial sequence length for the purpose of 
exploring the effect of ring size on the chelation event. Lysine was employed to 
enhance water solubility
3 Two sequences with corresponding disulphide cyclic versions for comparison of 
NMR signals from linear, metal complexed and conventionally cyclised peptides. 
Inclusion of Phe was varied for possible identification of mobility changes or 
sidechain/sidechain interactions.
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4 One sequence in linear, thiol-protected and disulphide cyclised forms. Residues 
were chosen to avoid overlap in NMR and for simplicity of signals from residues 
immediately adjacent to the GluCys sequences; Gly and Ala.
5 As set 4, but with y- linked Glu, reflecting the form found in native glutathione.
3.4 Characterisation of Glutathione-Zn2+Complex.
3.4.1 ‘H and 13C NMR
Glutathione 0.13M (40mg/ml) was analysed in D2 O at pD 6.0 (with NaOD). A similar 
sample was also titrated with Zn(CH3C00)2.2H20 from addition of solid, 0 . 1-1 Oeq. A
third sample was treated with 1, 5, and 50 eq. NaCl. pD was corrected for the salt 
additions to 6.0 +/- 0.2. Samples were referenced to the water signal at ‘H 4.80 ppm or 
Gly-Ca at 13C 45.8 ppm.
Fig. 3.03 lH NMR assignment and chemical shift values for glutathione with and 
without 0.5 eq. Zn 2+
In D20 With lOec . Zn2+
Assignment Appearance 5 / ppm Appearance 8 / ppm A8 / ppm Integral
*Gly a-H 2 s(br) 3.75 s(br) 3.75 0 (2)
Gly NH -
Cys a-H t 4.53 s(br) 4.50 -0.03 1





Glu y-H2 m 2.52 m (br) 2.52 0 2
Glu p-H2 dd 2.14 m (br) 2.14 0 2
*G1u a-H s(br) 3.75 s(br) 3.76 +0.01 (1)
* merged
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Glu, GlyCys a
A
Coincident signals from two 
Cys|3 (2x2H) become non­
equivalent upon formation of 
the zinc complex.
Fig. 3.04 NMR spectrum of glutathione (top) and in the presence of 0.5 eq. Zn 
(bottom) showing the dramatic effect on Cysp protons
It can be seen that the presence of Zn2+ caused general broadening of the spectra, with the 
most dramatic effect on Cys a  and Cys p protons. In particular, Cys p signals became 
non-equivalent at 2.9 and 3.1 ppm. The effect appeared to a small degree with 0.1 eq. 
Zn2+ and increased with rising metal concentration to a constant effect after 0.6 eq. 
Addition of TFA reversed the effect below pH 4. Addition of NaCl to a sample of 
glutathione produced only slight signal base broadening above 10 eq.
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4 - Cys amide; 5 - Glu carboxyl 1 - Cysp; 2 - Glup; 3 - Cysa
Fig. 3.06 13C NMR spectrum of glutathione (top) and in the presence of excess Zn
(bottom)
2+
Effects of Zn2+ on the peptide viewed by 13C NMR are clearly confined to the Cys 
carbons and Glu carboxyl. The Cys signals have shifted downfield to a degree 
proportional to the proximity of the thiol (CON < C-a < C-p). Cys-p signals are once 
again broadened by the bond formation with zinc.
78
Results 3 - Peptide /M eta l Complexes
Fig. 3.05 13C NMR assignment and chemical shift values for glutathione with and 
without excess Zn 2+
In D20 With lOeq.
Assignment 5 / ppm 5 / ppm A5 / ppm
Gly COO 178.8 178.7 -0.1
Gly a-C 45.8 set reference -
Cys CON 174.2 174.4 br + 0.2
Cys a-C 58.2 58.9 br + 0.7
Cys 3-C 28.0 30.8 vbr + 2.8
Glu CON 177.4 177.2 - 0.2
Glu y-C 33.8 33.8 0
Glu P-C 28.6 28.8 br + 0.2
Glu a-C 56.5 56.3 - 0.2
Glu COO 176.6 183.8 + 7.2
3 0 .5
2 9 .5
S  28 .5
2 7 .5
2 6 .5
o CM CO 










Figure 3.07 13C NMR titration of glutathione with Zn2+. The chemical shift moved 
downfield to a new fixed value after 0.5 eq. metal
The effects of zinc on the spectra suggest that only the Cys thiol and Glu carboxyl are 
involved in chelation with zinc. NMR provides a primarily qualitative view of 
stabilisation of the structure of the peptide through signal broadening and non­
equivalence of Cys p protons, though Podanyi et al. (228) have used coupling constants 
to quantify conformer populations of glutathione. I3C NMR shows a quantifiable shift in 
Cys p and again exhibits marked signal broadening. The downfield signal shift is 
indicative of deshielding by formation of the dative bond by the neighbouring S atom. 
The absence of a similar behaviour in the presence of Na+ suggests a specific chelation
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effect and not simple salt formation. The observed changes are reversible below pH 4,
1 ^while an isolated experiment at pH 9 showed some broadening of amide carbonyl C 
signals suggesting participation by the deprotonated amide. The gradual movement of the
1 'X 1signals to a new, fixed value in both C and H NMR suggest an equilibrium exchange 
between free and complexed forms occurring faster than the experimental NMR 
relaxation time. The value of 0.5 - 0.6 eq. metal ion for the completion of signal 
transitions appeared to confirm the expected 2 peptide : 1 metal ion complex. The effects 
observed in both spectra conform to the literature expectation of Fur et al. (218), though 
in our experiments signal effects were somewhat more pronounced and confined to Cys-P 
and Glu-COO, probably a reflection of the lower pH of our experiments excluding amide 
participation. It was concluded that NMR shift of Glu-COO and Cys-P nuclei would be 
useful as both qualitative and quantitative indicators for glutathione-like complex 
formation in the test peptides.
3.4.2 Mass Spectrometry of Zinc/Glutathione Complex
Late in the project, electrospray MS became available, and the complexes were analysed 
by flow-injection of samples diluted with water to 0.01 mg/ml. Zinc chloride, nitrate and 
acetate were used at molar ratios of 0.5, 1 and 10 to glutathione. Results are quoted using 
65Zn isotope.
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Fig. 3.08 Positive ion electrospray of glutathione in the presence and absence of 
Zn2+1 eq.
Observed m/z Relative abundance / % Assignment Calculated
m/z
Glutathione
308.0 100 [GSH + H r 308.08
615.2 5 |(GSH)2 + H+]+ 615.14
637.2 1 |(GSH)2 + N a T 637.20
653.3 1 |(GSH)2 + K T 653.2
Glutathione + leq. Zn(CH3COO)2
308.0 100 |GSH + H T 308.08
339.5 <1 [(GSH)2 + Zn1*]2* 339.57
371.2 20 |GS' + Zn1*]* 371.1
403.3 5 [GS‘ + MeOH +Zn2*\* 403.1
615.1 <1 [(GSH)2 + H*]* 615.14
647.1 <1 [(GSH)2 + M eO H +H T 647.18
677.4 <1 |(GS")2 + Zn2t+ H V 678.1




Relative abundance / % Assignment Calculated
m/z
Glutathione
306.0 100 [GST 306.1
613.0 0.5 [GSH+GST 613.1
Glutathione + leq . Zn(Ch3COO)2
306.0 (1) 100 [GST 306.1
370.0 (2) 8 [GS2- + Zn2+ - H T 370.1
613.0 (3) 0.5 [GSH+GST 613.1
675.5 (4) 1 |(GS12 + Zn2*- H T 676.1
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Fig. 3.10 Electrospray (negative) spectrum of glutathione/zinc 1:1
Although higher ratios of zinc were tolerated without precipitation at these low 
concentrations, the signals became swamped with complexes of Zn , counter ion and 
carrier solvent. The results indicate formation of the neutral complexes of 1:1 and 2:1 
with loss of protons from the glutathione balancing the charge of the zinc, with a further 
+/- proton to give MS ions. The abundancies compared to uncomplexed peptide are very 
low, especially as the zinc complex signals are spread between 63, 65 and 67 isotopes. 
Acetate, chloride and nitrate counter ions made no observable difference to the spectra.
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3.5 and 13C NMR of Peptide-Zn2+ Complexes
NMR experiments were performed on example peptides to confirm the existence of 
glutathione-like zinc binding, primarily using the Cys-P shifts identified above. Titrations 
were performed between 0.1 and 10 eq. Zn2+. The experiments were performed at pD 6.5 
(with NaOD), while precipitation occurred at pD 7.0.
3.5.1 ‘H NMR
Proton NMR were inevitably confused, given the number of similar protons in the 
component amino acids. On the addition of Zn (1 eq.) to solutions of the example 
peptides in D2O and correction to pD 6.5, several changes were observed to the proton 
NMR spectrum. A general broadening occurred, which was not repeated if  the zinc was 
substituted for sodium. The signals from both Cys-P pairs were shifted downfield, 
merging with the signals from Lys-e as shown in the example below, Figure 3.11. The 
event parallels that observed in glutathione, and produced a similar effect under titration
a 1
to steady state after 0.5eq Zn . Acetamidomethyl protected linear peptides did not 
exhibit the changes to the Cys-p signal, confirming the specific role of the thiol in the 
chelation event.
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GluCyg p
GlupCys Glu
J. i ).s<.c J . s J. • I. 5(>?■
Fig. 3.11 Peptide 4 (top) and with 0.6 eq. Zn2+ (bottom). Cysp protons have shifted 
downfield and are coincident with Lyss. Peptides of Group 2 exhibited general 
broadening to a greater degree than other series, presumably because of 
participation by multiple Lys residues in chelation.
Peptides of group 3 were synthesised to allow a comparison of the effect of peptide 
cyclisation on the signals of the sidechains of the spacer sequence. Phe residues were 
substituted at various points along the sequence, and a disulphide cyclic version of each 
peptide was compared with the reduced form with and without zinc ions. The signals 
from the pair of aromatic sidechains produced a multiplet in the region 7.0 - 7.2. ppm 
(Figure 3.12A). In the cyclic disulphide, the spread of the signals increased, reflecting 
more restricted movement of the sidechains within the cyclic structure and lesser degree 
of signal equivalence. (Figure 3.12B). The zinc treated peptide exhibited a total signal 
width identical to the untreated reduced form, while the general broadening of the 
individual signals from the zinc complexation caused the signals to appear as a pair of 
adjacent singlets, presumably one from each Phe residue (Figure 3.12C).
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7
Fig. 3.12 !H NMR of the Phe sidechains, peptide 6. Linear (A) and Zn2+ treated 
(0.6eq.) peptide (C) exhibit identical total signal widths. Cyclic (disulphide) version 7 
(B) shows total signal broadening as the movement of the peptide is restricted.
The results suggest that the peptides are participating in complexation of the zinc and 
employing the Cys thiol. However the complexation event does not give rise to effects of 
reduced sidechain mobility characteristic of a known cyclic analogue, and thus the 
conformation of the chelated peptide may be something other than cyclic.
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3.5.2 l3C NMR
1 -J
C spectra were only obtained in good quality for a limited number of the example 
peptides which were available in sufficient quantity. In the examples examined, the 
signals assigned to the Cys-Cp in the untreated peptides disappeared completely into the
 ^i
Lys 8 signal (A = 3ppm) upon exposure to 1 eq. Zn . The event is analogous to the 
suppression and broadening of the similar signal in glutathione, though the high 
background noise and proximity of Lys signals largely masks the chelated signal in the 
example peptides. Figure 3.13.
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Acetate
Downfield shift of Cysp 
on formation of zinc 
complex, broadened 
signal overlaps Lys5 and 
GluB
66 46 26
Fig. 3.13 13C NMR of peptide 4 showing downfield shift of Cys[3 signal with Zn2+
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3.5.3 Variable Temperature !H NMR
'H VT NMR was performed on the peptides of group 5 using a 500MHz instrument. 
Peptides were dissolved in D2 O and the temperature was varied between 5°C and 50°C in 
5°C increments. Figure 3.14 shows the progressive shift of the amide region of the 
spectrum under variable temperature conditions. The shift of 6 - 7 ppb per 1CC rise in 
temperature is the same for both native and uncomplexed peptides, indicating the peptide 
backbone is equally accessible to proton exchange in either case. The values of the shifts 




Fig. 3.14 Amide protons of peptide 13 (A) and with leq. Zn2+ (B) at 5,10, 20 and 
30°C. The temperature coefficient of -6ppb/K is indicative of freely mobile, solvent 
accessible peptides according to Kessler’s rules.
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3.5.4 Two - Dimensional Nuclear Overhauser Effect Spectroscopy (NOESY).
Peptides in group 5 were analysed for NOE signals, with particular attention paid to the 
possibility of through-space effects between Ala-a protons and the a  or P protons of 
Gly, at the opposite ends of the spacer sequence. The residues would be expected to be in 
close proximity if the peptides were formed into a bend by bidentate chelation of zinc by 
the terminal sequences. No signals were observed at 100, 250 or 500ms mixing time, 
suggesting no vicinal effects were occurring and that the termini of the peptides were 
distant.
3.6 Mass Spectrometry of Peptide-Zn2+ Complexes
Laser desorption time-of-flight mass spectroscopy was used to examine the example 
peptides in the presence and absence of zinc. The peptides (lmg/ml, 0.8mM) were mixed 
with 1 eq. of Zn(CH3COO)2 in water, pH adjusted to 6.0 using NaOH and applied to the 
laser target. Zinc free samples were also analysed. In all examples, the most abundant ion 
was attributed to the addition of a single zinc ion, A m/z 64.6, (average mass after 
isotopic weighting 65.4, difference from protonated molecular ion expected 64.4). Minor 
signals of around 20% base peak abundance were attributed to protonated molecular ion 
and addition of two zinc ions Figure 3.15. The result is consistent with the 1:1 complex 
expected. Removal of background sodiated signals by washing with dilute ammonia 
suggested that the ions observed originate from the authentic complex rather than non­
specific salt association. However, at elevated pH backbone amide involvement has 
already been implicated by NMR experiments, which may explain the presence of 1:2 
complexes.
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2+Peptide 8 Peptide 8 + leq. Zif
Fig 3.15. TOF-MS of peptides 8 with and without Zn2+. Increase in mass from 
protonated molecular ion is +64.6, + 129.2, attributed to 1 and 2 zinc ions.
Latterly, ESI-MS analysis was performed on the example peptides in dilute solution with 
Zn2+. No signals attributable to complexes were observed.
3.7 Circular Dichroism of Peptide-Zn2+ Complexes
CD analysis was used to detect changes in secondary structure of the example peptides on 
exposure to zinc ions. ZnC^ was used to avoid interference of the UV absorbency by 
acetate. Samples were prepared at 3.2mM (1:1) in water, pH corrected to 6.0 and 
lyophilised. The samples were reconstituted to 0.4mM and analysed by Dr. A. Drake 
(Birkbeck College, London) between UV 185nm and 260nm. No significant changes in 
molar ellipticity were observed on addition of metal, suggesting no stable secondary 
structure was formed by the chelate.
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Fig. 3.16 CD spectrum of peptide 8 in the presence and absence of 1 eq. ZnCh aq. 
No significant differences in secondary structure are observed on addition of Zn2+
3.8 Chromatography of Peptide-Zn2+ Complexes
A criterion for the utility of metal stabilised peptide libraries was that the products should 
be isolable from the metal ion in free solution, since many biological interactions are 
influenced by divalent transition metals.
3.8.1 Size-Exclusion Chromatography
Example peptides (lOmg) in concentrated solution ( 4mM) with 4 eq. Zn(CH3 COO) 2  
were applied to a 1cm x 60cm column of size-exclusion gel, nominal m.w. exclusion 
300Da (LH20 Pharmacia) equilibrated with methanol. The column was pumped at 1 
ml/min, slightly in excess of the gravitational flow. Fractions were collected at 2 minute 
intervals and the eluent monitored at UV2 2 0 - Acetic acid was used as a small-molecule 
elution marker in a trial run, eluting 39-43 min. Peptide was detected in the first eluted 
peak (25-32 min) by HPLC, evaporated and reconstituted in D2 O for NMR analysis as
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previously. No difference in the spectrum compared to untreated peptide was observed, 
indicating the desalting process had removed the associated zinc.
3.8.2 HPLC
Glutathione yielded a single peak under gradient HPLC conditions, monitoring at UV220, 
when running typical peptide analysis conditions of 0-50% acetonitrile (0.05%TFA) in 
water (0.1%TFA) on a Cl 8 derivatised silica column. For analysis of complexes, various 
buffer systems were employed; ammonium acetate lOmM pH 6.0/acetonitrile; 
K2HPO4/KH2PO4 20mM pH 7.0 / acetonitrile, since the complex was known to dissociate 
below pH 3. Glutathione, when run under these conditions gave poor chromatographic 
performance, with broad and heavily tailed peaks, matching experience with other 
peptides. Analysis of peptide and peptide/zinc actetate mixtures under these conditions 
yielded identical peaks, with the addition of a large spread peak at the solvent front 
attributed to acetate. Since the formation of the proposed cyclic complex would involve 
substantial changes in arrangement of the functional groups of the peptide involved in 
interaction with the stationary phase, a change in column retention would be expected for 
the complexed material. It was concluded that either the chromatography was removing 
zinc ions from the bound/unbound equilibrium, or the interaction with the stationary 
phase was causing disruption of the complex conformation and releasing the metal ion .
3.8.3 Metal Affinity Chromatography
A polystyrene resin derivatised with methyl iminodiacetic acid sodium salt (Sigma 
C7901), capacity 0.4 mmol divalent metal ions per ml) was packed into a 1 cm x 10 cm 
column and washed with water at 2 ml/min. Peptides of set 2, 8 pmol (10 mg) were 
applied to the column and eluent monitored at UV220- Samples eluted immediately after 
the void volume (5ml) and were identified as the peptide by HPLC. A fresh column was 
equilibrated for 2 hours with Zn(CH3COO)2 20mM, then 1 hour with water to convert the
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column to the zinc form. Peptides applied to the column began to elute after the void 
volume and continued for 20 minutes (5 void volumes). Collected fractions showed no 
characteristic chelation effects by *H NMR. The result suggests a transient binding to the 
column through an affinity for Zn , with selectivity over sodium.
3.9 Reactivity of Peptide-Zn2+ Complexes
The Aldrithiol™ assay for free thiol used for quality control during peptide synthesis 
provided a convenient method of assessing the availability of the thiol group of zinc 
complexes to act as a nucleophile. Example peptides in the presence of 10 eq. ZnCb were 
subjected to the thiol assay, and the appearance of 2-thiopyridone monitored at UV 
343nm. Rate of reaction was found identical to that of uncomplexed peptides (first time 
point 0.2 min following mixing).
3.10 Conclusions
Peptides have been synthesised to validate the bidentate ligand model described in 3.1 
and a variety of analytical techniques have been used to establish the nature of the 
interaction of the peptides with zinc ions. The peptides feature interstitial sequences from 
4 to 6 amino acids, while residues were chosen either to facilitate NMR analysis or to 
encourage water solubility.
By comparison with glutathione NMR spectra, all the example peptides exhibit an 
interaction with zinc ion via the Cys thiol as proposed in the model. The stoichiometry 
was difficult to quantify by NMR under titration because of the weak 13C spectra and
1 9+overlap with other signals in H spectra, though effects appeared constant after 1 eq. Zn 
suggesting the expected 1:1 complex. Negative controls for the binding in the form of 
comparison with the effect of Na+ and thiol-protected (Acm) peptides also suggest the 
effect is specific to the thiol. TOF mass spectroscopy indicated a predominantly 1:1 
association between the peptides and zinc. The result was obtained directly from solid
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material after lyophilisation of a peptide/Zn solution, and the relevance of the result to 
the true solution status of the complexes is unproved, though the basic wash step 
removed associated sodium, suggesting that the zinc was retained in a selective manner. 
Electrospray MS analysis produced no evidence of the expected complex, in contrast to 
the clear, if rather weak [(GS')2 + Zn2+- H*]* and [(GS‘)2 + Zn2++ H+]+ complexes seen 
when scrutinising glutathione. Recent papers have cited the electrospray of zinc 
complexes of N and C terminal bipyridylalanine peptides yielding the 1:1 species as the 
most abundant molecular ion, while other workers have shown glutathione-Hg complexes 
in much higher abundance relative to the free peptide (233). The stability of known 
monomeric peptide-metal complexes to electrospray conditions and the absence of 
expected molecular ions for complexes of the test peptides suggest that the proposed 
monomeric cyclic product was not formed.
Attempts to isolate the complexes using chromatographic separation of the peptide- 
complex from unassociated zinc salts yielded only the free peptides (by NMR), indicating 
a rapid equilibrium between the peptide and the zinc ions. Though perhaps the least 
sophisticated experiment performed, the result means that the complexes, whatever their 
geometry, would have no utility outside of a zinc solution, and hence would not be useful 
for our intended purpose. The metal affinity chromatography and the thiol assay also 
support the existence of a merely transient association between Zn and the peptides. 
Experiments to disclose the geometry of the peptide-metal complexes gave no positive 
indications of formation of secondary structure (CD, VT ^-N M R  or 2D-NOESY). 
Comparison of Phe sidechains with those of known cyclic analogues (disulphide) 
suggested the structure of the complexes more closely resembled that of the linear 
peptides. No differences in behaviour were observed when equivalent peptides with y - 
linked Glu were used.
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The results indicate that, independent of the number of interstitial residues (4, 5 or 6) the 
example peptides form only weak, rapidly exchanging complexes with zinc, using 
electron donation from the Cys thiol and with some participation from the Glu a- 
carboxyl. It seems highly unlikely that under the conditions used, the peptides are 
forming the desired secondary structure. A number of forms for the complexes are 
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Fig. 3.17 Of the possible 
modes of association of 
the peptides with Zn2+, 
several offer 1:1 
stoichiometry.
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Vahrenkamp et al. (206) have inferred a polymeric structure from observation of 
precipitation at neutral pH of cysteine containing peptide - zinc complexes. A similar 
result was observed in our study. In the formation of cyclic disulphide peptides by 
oxidation in solution, high dilution is required to discourage the formation of oligomeric 
products and by analogy some of the NMR and ESI-MS experiments were repeated on 
complexes formed at low concentration (0.1 mg/ml peptide) and lyophilised. No 
difference in results was observed.
At the time of the work, some mixed opinions existed in the literature regarding the 
necessity for a peptide to have a sequence predisposed to form a bend before bidentate 
metal ion binding could occur. Much of the literature survey in Chapter 2 is a post-hoc 
discussion of work which enables understanding of the results here. Imperiali et al. (196)
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performed comparative experiments between a random spacer sequence and one with a 
known P-bend motif, and concluded the bend was necessary to bring both chelating 
moieties close enough for the monomeric complex to form between terminal His residues 
and Co3+. Conversely, Yamamoto et al. (199) observed secondary structure in peptide 
sequences induced by metal binding by (N,C) terminal bipyridylalanines. Ghadri et al. 
(190) have commented that interactions such as Cys —> Zn are rapidly exchanging 
whereas bipyridyl -> Co is much closer to a covalent bond, since exchange occurs at a 
slower rate than protein unfolding. Cheng et al. (229) clearly demonstrated the 
requirement for a turn element in a peptide to perform the metal binding cyclisation, and 
even for covalent cyclics, reaction rate and yield are enhanced by the presence of a turn 
element (230).
The original inspiration for the work, the report of very high affinity binding of zinc by 
multidentate phytochelatins has not been mirrored by the example bidentate peptides. The 
binding observed has been shown to be much closer to that of glutathione which, while 
occurring specifically at the intended residues, is a rapid equilibrium. The high affinity of 
the phytochelatin binding may be due to a multiple folding process involving many 
metal-thiol and hydrophobic interactions and is not reproducible in a small peptide. 
Recently Pessi et al. (35) published a combinatorial approach where metal-ion binding is 
successfully used as a method of stabilising the secondary structure of the members. The 
crucial difference is that the library is based upon a segment of a known protein 
structure, where pre-organisation exists for a metal binding site. Combinatorial variation 
is carefully confined to those regions not involved in the formation of the site.
Whilst some sophisticated techniques were applied to single, pure peptides in an attempt 
to verify the utility of the procedure for a future combinatorial library, it is the gel 
filtration experiment that proved pivotal to disproving the utility for a library. Ironically,
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a verdict could perhaps have been obtained more easily by making a library first, with a 
variety of interstitial sequences and applying a bulk analytical technique, such as gel 
desalting followed by Zn metal quantitation, to assess the extent to which the proposed 
bidentate binding could be regarded as a general case. The answer would presumably be 
confined to that proportion of random sequences corresponding to P-bends or similar. 
Very recently, some remarkably similar library structures have been published, though for 
a different purpose. In one example, a variable region is arranged between two half 
chelating units as in our proposal, but the library is intended to screen for metal binding 
and thus show new turn motifs (213). The example employs the colour response of 
chelated transition metals as an on-bead assay.
The use of metal ions to stabilise small molecule combinatorial products may still have 
some use in the restriction of rotation of sidechains about a cyclic peptide. A general case 
is far more likely to occur as the ring size could be fixed appropriately, and the chelation 
performed using constant amide functions. A similar principle has recently been proposed 
for face-selective ligation of coiled proteins to a ring (231).
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4. Protein Structure Directed Cyclic Peptide Libraries 1 and 2
4.1 Aims and Objectives
As part of the antithrombotic research effort at CIBA Pharmaceuticals, compounds were 
sought which would slow the formation of blood clots in patients after surgery. The 
haemostatic process involves an activation cascade whereby an inactive molecule 
(zymogen) is cleaved to an active form by another enzyme, which can then go on to 
activate an enzyme further down the series, often with an amplification effect. An 
initiator in the blood coagulation pathway is the contact between Factor VII, a circulating 
serine protease zymogen, and Tissue Factor on the surface of cells exposed following 
tissue damage. Following binding and enzymic (predominantly autocatalytic) conversion 
to two-chain activated FVIIa, the active proteolytic complex commences the activation 
cascade by converting factor X to Xa, Figure 4.00. It was decided to search for molecules 
which would inhibit the formation of the active complex by binding to FVIIa, thus 
reducing the amount of active complex available in advance of surgery. At this stage, no 
binding inhibitor existed for the interaction save polyclonal antibodies raised to the 
proteins concerned or the endogenous protein inhibitor TFPI (232); and a random 
screening programme had produced no active compounds.
Contact Factor Pathway Tissue Factor Pathway
(Intrinsic Pathway) (Extrinsic Pathway)
KaBikrein
Tissue
Zl lla THROMBIN 
| Fibrinogen \ I )  ^  P'lipid
Monomeric Fibrin
Fibrin Clot| Fibrin Polymer |
Fig. 4.00 TF/FVIIa in the coagulation cascade (D. Head)
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4.2 Random Combinatorial Peptide Library
A combinatorial approach was adopted to generate random sets of small peptides. An 
adaptation of the equimolar mixture of reactants synthesis protocol was used to generate a 
library of pentapeptides of the general sequence CysYXXCys; where X represents the 19 
endogenous amino acids (excluding cysteine) and Y a single known amino acid, resulting 
in 19 sub-libraries denoted by residue Y. The protocol theoretically generated (19x19) 
361 peptides per set. Synthesis was performed on an automatic synthesiser using 
Fmoc/HOBT/DCC chemistry on a scale of 0.2mmol per sub-library beginning with 
Fmoc-Cys(Trt)Wang resin (200-400 mesh 1% DVB) Two exposures of a mixture of the 
19 amino acids (lmmol total) was used at each coupling step. After cleavage using 
standard protocols and precipitation from ether, the peptide mixtures were subjected to air 
oxidation at 0.2mg/ml pH 8.5 for 4 days to effect cyclisation via the disulphide. After 
lyophilisation the recovered samples (40mg +/- 8mg, 36% yield) were assayed at 1 mg/ml 
(4pM per compound) against the rate of cleavage of a chromogenic substrate by the 
TF/FVIIa complex in vitro (Direct assay, Appendix). The libraries caused between 30% 
and 70% attenuation of the rate of substrate cleavage. Deconvolution of sub-library 
GluXX was performed by re-synthesis of a set of 19 libraries of the sequence 
CysGluYXCys (19 compounds each). All libraries were inactive at 1 mg/ml (80pM per 
compound). It was concluded that the previous activity was due to non-specific effects of 
high peptide concentration and no high affinity ligands had been generated. It was judged 
that a more focused approach to the synthesis of binding ligands was required.
4.3 The Interaction of Tissue Factor and Factor FVIIa
In 1994, two papers were published describing the features of TF which were responsible 
for binding FVIIa. Ruf et al. (233) reported an exhaustive alanine scanning mutagenesis 
study which identified a number of external loop regions and individual residues
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significant for the interaction, notably Lys20, Ile22, Asp58, Argl35 and Phel40. Shortly 
afterward, Harlos et al. (234) published the results of a crystal structure investigation into 
the complex, though the co-ordinates were not released until the following year. The 
crystal structures showed that some of the significant residues found in the previous study 
were grouped closely together in two patches on the surface of the protein, though distant 
in the primary sequence. In Figure 4.01, it can be seen that the important binding residues 
Asp58, Ile22, Lys20, lie closely together across a bend, with their sidechains pointing 
toward the exterior. Some distance away, the residues Argl35 and Leu 140 are also close 
together.
Fig. 4.01 The structure of Tissue Factor (Harlos et al.) highlighting residues shown 
by Ruf et al. to be significant in binding FVIIa.
4.4 Design of Library 1
It was proposed that the elements of TF structure known to be responsible for binding 
could perhaps be combined within a small molecule and preserve the desired effects, 
yielding a competitive binding inhibitor. Concentrating upon the three residues of the first
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binding patch, Asp58, Ile22, Lys20, it was decided to attempt to mimic the disposition of 
the three residues as they appear in the protein by arranging them in a peptide. It was 
hoped that a small molecule with the right geometry could preserve the binding qualities 
of the three residues. Furthermore, it was proposed that any molecules made should have 
a level of conformational constraint such that useful information for further design could 
be gathered from the solution geometry of any active molecule. Since only photographs 
were available of the crystal structure data, a combinatorial approach was taken to 
encompass a range of possibilities for display of the three putative binding residues. 
Viewing Figure 4.01, the drawing of imaginary bonds across the chains between 
positions 23—»57 and 59—>19 would result in Aspss, Ile2 2 , Lys2o being captured in a small 
cyclic peptide, Figure 4.02. A similar approach has been reported before by Roques et al. 
(208) when fixing a zinc binding loop by covalent bridge to preserve secondary structure 
and function in the much smaller peptide.
2-3
Fig. 4.02 Imaginary small cyclic structure Fig. 4.03 a-Amino acid backbone
from bridging protein P-strands length equivalents
By rough measurement of the published pictures and equating to multiples of residues in 
p-strands, it was estimated that the imaginary cyclic peptide would contain 7-8 residues, 
Figure 4.03. A combinatorial approach was designed to generate a set of cyclic peptides 
encompassing the imaginary peptide and including a spread of ring size and residue
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occurrence possibilities. A split-and-mix protocol was devised where between each 
coupling of a random choice of the three residues, there was inserted one of a set of 
variable length spacer molecules. Further, the concept of binary synthesis, or a “no­
coupling step” described by Furka et al. (33) was included within the monomer set such 
that there was a possibility of “no spacer”, that of two significant residues being adjacent 
to one another in the final products, Figure 4.04a.
Schematic representation of the library 
members
X = either L-Lys, L-Ile, L-Asp or absent 
S = Spacer molecule 1,2,3»4,5 0r absent
Fig. 4.04a Fig. 4.04b
The set of spacer molecules were chosen to cover from zero (no coupling) to 
approximately 3 peptide backbone lengths, giving an effective size range of the cyclic 
peptides of 0 to 12 residues. The spacers were also selected for low sidechain 
functionality. The final spacer 5, 8-amino-3,6-diethoxyoctanoic acid, was chosen for 
hydrophilicity, as it was believed that an aliphatic amino acid of this length would detract 
from the aqueous solubility of the products. Ethylene glycol based spacer molecules have 
been used for this purpose as amino acid replacements in atrial naturetic factor (235), and 
have already been discussed as hydrophilic solvation tentacles in resins, (section 1.4). 
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Fig. 4.05 Spacer molecules used in Library 1
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The inclusion of aspartic acid amongst the residues of interest suggested the potential for 
the synthesis to be conducted by anchoring of the a-carboxyl protected aspartic acid 
sidechain to a solid phase resin, followed by chain extension using Fmoc chemistry, 
deprotection of the Asp a-carboxyl, and intramolecular amide formation with the 
terminal amine. The feature meant that aspartic acid would be present in all library 
members, revising the scheme to Figure 4.04b. Orthogonal protection of the acid 
functions of aspartic acid was required. McMurray et al. (236) have described the 
synthesis of cyclic peptides in this manner by the use of Fmoc-Asp(OH)2,4- 
dimethoxybenzyl ester. The a-carboxyl protection was labile to weak acid (1%TFA) 
allowing the removal to be conducted in the presence of Wang resin linker and Boc/Bu1 
protected amino acid side chains, Figure 4.06. It was particularly desired to use an on- 
resin cyclisation technique, as the reaction could be completed using excess reagent. The 
variation in solubility likely to be encountered in the library products would make 
consistent treatment and recovery of all members from a solution method unlikely.
O
1 %  TFA
20%  P iperid ine
F m oc O H r  RESIN
NH
Boc 95%  TFA
95%  TFA95%  TFA
Fig. 4.06. Protection strategy for Library 1
Since the compounds were intended to be screened in solution in an existing ELISA 
assay, an iterative deconvolution was planned requiring conservation of some resin at
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each synthetic step. A program was written in Microsoft Excel™ to estimate the quantity 
of resin to retain at each step given a desired amount of final product and the other 
parameters of the synthesis, (Appendix IV).
4.5 Synthesis of Fmoc-Asp(OH)ODmb (18)
Fig. 4.07.
The synthesis of both the L- and D- Fmoc-Asp(OH)ODmb was attempted by the methods 
described by McMurray et al. (236), Figure 4.07. Fmoc-DAsp(OH)OH 16 was obtained 
by dissolving Fmoc-Asp(OBut)OH in a minimum volume of DCM, then treating with 
80% TFA (aq.) 1 hour, before adding five volumes of water and lyophilising. The product 
was treated with acetic anhydride to yield the aspartic anhydride 17, though the anhydride 
was very moisture sensitive, and was quickly used without further characterisation. 
Earlier attempts to characterise the product suffered from reversion to starting material, 
though the expected molecular ion was visible by ESI-MS, along with a majority signal 
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carrier solvent. Reacting the fresh anhydride with 2,4-dimethoxybenzyl alcohol finally 
yielded a small amount of product 18 that appeared as an evenly split peak on HPLC and 
a single spot on TLC. As only the one molecular ion corresponding to the expected 
product was evident for the HPLC peaks on LC-MS, a near-equal mixture of the 
structural isomers a -  and (3- esters was suspected, contrary to the literature value of 
2.7% p-impurity. After several additional attempts to rigorously exclude water from the 
reaction, reversion to starting material was still the predominant result. The product 
became commercially available in the L-form from Bachem AG, allowing the synthesis of 
Library 1.
4.6 Synthesis of Test Peptides 20, 21 and 22
Three sample peptides representing a subset of the intended library were synthesised to 
assess the reliability of the chemistry and verify the utility of the loaded resin batch.
A lOg batch of Wang resin (polystyrene/1% DVB 200-400 mesh 0.64 mmol/g) was 
loaded with the Fmoc-LAsp(OH)ODmb in the manner described by Sieber (237). A 
procedure for capping unreacted sites using acetic anhydride was also used. Loading was 
assessed by quantifying Fmoc-fulvene release by UV absorbency (120). The resulting 
0.307 mmol/g (50%) load 19 from a twofold excess of amino acid followed the literature 
expectation. Loading was fixed at this level as some reports suggested that sparse 
loadings (below 0.4mmol/g) discourage the formation of oligomeric products, but this 
assertion was not explored in our study. Aliquots of the resin were used to assemble the 
test peptides in an automatic synthesiser. Samples of the linear protected peptide-resin 
were removed for analytical purposes. After Fmoc removal, the remaining resins were 
briskly treated with aliquots of 1% TFA in DCM. After the last aliquot, the resin cakes 
were immediately washed with 10% Hunig’s base in DCM, before washing with other 
solvents. During the acid treatment, the periphery of the resin was observed to pinken
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slightly, possibly indicating the premature cleavage of peptide from the support as 
evaporation concentrated the TFA on the surface of the resin. Peptides were cyclised on- 
resin in the described manner using 6 equivalents of HBTU/HOBT with 12 equivalents of 
DIEA for 3h monitoring occasionally by ninhydrin. The peptides were cleaved in 
90%TFA (aq.) without additional scavenger and lyophilised directly. Precipitation steps 
were omitted to reflect the intended library work-up. Peptides were found to have 
converted completely from linear form by HPLC and lost the expected m/z 18 by ESI-MS. 
No products of higher molecular weight were observed, indicating the removal of 
protecting groups and absence of oligomers, Figure 4.08.
It was notable that formation of the cyclic amide did not always give later eluting 
products on reverse phase. Lack of positive ninhydrin response from the cyclopeptide- 
resins suggested aspartimide formation had been avoided. Despite the colour monitoring, 
appearance of significant linear product remaining in the longest example peptide led to 
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Fig. 4.09 Example ESI-MS Spectrum of cyc/0 -KIAD
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120 KIAD (446.5) 446.4 (428.5) 428.2 2.50 2.20
121 AKAIAD (588.7) 588.4 (570.7) 570.4 2.55 2.65
122 AAKAIAAD (730.8) 730.6 (712.8) 712.5 2.70 2.60
4.7 Synthesis of Library 1
8g (2.5 mmol active groups) of the above resin was divided into six portions by weight, 
and five placed in sinter funnels on a specially designed solid phase synthesis manifold 
(Section 9.1). The resins were swollen with NMP, then Fmoc deprotected using 20% 
piperidine/NMP for two treatments. N-deprotections were carried out after the splitting 
steps because of the tendency of the free amino peptide-resin to stick to the glass. After 
washing, the five spacer molecules were coupled using 3 fold excess with 
HBTU/HOBT/DEEA in NMP/25% DMSO. Spacer 4 was generated by treating one flask 
with alanine twice to generate the dipeptide. The DMSO had been adopted into our 
peptide synthesis protocols after reports of its utility in causing the disruption of 
secondary structure in the growing peptide chains with consequent improvement in access 
by incoming reagent (238). After coupling, a ninhydrin test was performed before an 
analytical sample and lOOmg protected peptide resin were removed, dried in vacuo and 
stored. Later these samples were removed using the practical measure of wet volume, but 
proved remarkably accurate. All six resin samples were combined in a large flask, 
agitated in NMP for 30 min. After solvent removal, the wet resin cake was divided into 
four portions, using division marks on the circumference of the round vessel, one saved 
and three distributed to reaction vessels for Fmoc-deprotection and coupling of the three 
residues Lys Asp and lie, Figure 4.10. The procedure was repeated to complete the
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scheme, culminating in 6 sub-libraries denoted by the identity of the final spacer 
molecule.
r n  n  sa v e  analytical anda U n deconvolution samf ■ \
d ep rotect and  
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1-5
sa m p le s
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1, cy c lise  
2, c le a v e  +lyophiiise
x 2
(6x4x6x4) = 576 
compounds in 6 flasks
Fig. 4.10 Synthesis of Library 1
The final peptide resins were deprotected as described for the test peptides, then exposed 
for three treatments of coupling reagent over 5 hours. Cleavage in 90%TFA (aq.) and 
lyophilisation gave off-white gelatinous products. Repeated solution in IN HC1 and 
lyophilisation improved the colour and gave flaky/powder products of around 120mg, 
55% of the theoretical yield based on an average molecular weight of 700 Da.
4.8 Assessment of Synthetic Success
During the synthesis of the test peptides and Library 1, it became clear that because 
mixtures of compounds were being synthesised (or trial single compounds made without 
purification) conventional characterisation techniques such as NMR or IR had limited 
value. Chemical tests to verify completeness of coupling may be able to confirm that the 
bulk of a reaction has gone to plan but for a mixture synthesis the small part that is 
unconfirmed might represent the entire population of some of the members. An 
investigative technique which was capable of handling very small quantities and able to
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confirm the presence of mixture components was sought. To this end, the application of 
mass spectrometry was explored extensively during these studies.
Direct Injection Atmospheric Pressure Mass Spectrometry
A program was written in Microsoft Excel™ to calculate all the expected molecular 
masses generated during the progress of the synthesis, and to count repeated mass values 
(Appendix). Confirmation of expected molecular ions in library mixtures was performed 
by flow injection electrospray mass spectroscopy in positive ion mode. Small amounts of 
resin were exposed to aqueous TFA, and the vials shaken vigorously on a vibrating table. 
Ultrasonic treatment was found merely to compact the beads at the apex of the conical 
vial. After the addition of water, the samples were lyophilised in situ. The samples were 
re-dissolved in methanol, and the bulk of the sample removed with a fibre plugged 
pipette, leaving the beads behind. It was found that 2-5mg beads in 30pl acid was the 
smallest convenient sample size for handling by this method. After re-dissolving in 100- 
500pl methanol, lOjul samples were introduced in a solvent stream of lOOpl/min 50% 
aqueous methanol, though later revised to acetonitrile/methanol/water 2:2:1 to reduce 
carry-over between injections. Several scans of 100-1000 m/z were collected at 300 
Da/sec during the appearance of the sample slug and an equivalent period of background 
subtracted from the summed spectra. A Gilson autosampler was modified to perform 
wash steps after injection in parallel with the MS acquisition, such that sample turnover 
could be increased to 1.5 minutes on automated runs where the acquisition was begun by 
remote contact closure. After some disappointing signal intensities during early work, 
samples were Fmoc deprotected prior to cleavage and analysis. It is possible that with 
Fmoc in place, re-dissolution was poor, or that the hydrophobic molecules clung to the 
spent polystyrene beads. Additionally, the presence of primary amine has been observed
109
Results 4  -  Protein Structure D irected  Libraries
to promote ionisation in positive mode electrospray during previous work. Free-amine 
peptide samples were dissolved in 50% aqueous methanol.
For the first three steps of the synthesis, discrete mass ions were observed, Figure 4.11.
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Fig. 4.11a Example single compound, coupling first spacer
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Fig. 4.11b Coupling second residue, 6 products, 5 expected masses
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For the final products, virtually all (92-95%) of the 127 expected signals from each of the 
576 library members in each sub-library were identified, however the result has to be 
viewed in the context of the high number of isobaric compounds. Even for non-identical 
masses, a number appear in sets separated by only 1 Da. Since the data was collected as 
centroid summaries of raw signals resolved to IDa, with an accuracy of +/-0.2Da and that 
the expected mass tables are calculated to within 0.3Da windows it seems unlikely that 
mass ions with only 1 or 2 Da difference can be differentiated. An example final sub­
library (terminating in spacer 5) is shown along with the theoretical product distribution 
Figure 4.12a,b. The signal sizes at the lower masses are proportionately higher than 
predicted. The result could be because the smaller peptides are more readily ionised, or 
that the smaller expected masses arise from both intentional “skipped steps” and 
unintentional failed couplings, which would yield the same masses after occurring at 
different times during the synthesis. The possibility of doubly-charged ions was not 
investigated. Other workers have plotted the movement of the apex of an unresolved 
cluster of ions to higher mass after coupling a new residue (124). In the case of L ibrary 1 
where residue inclusion is not completely random, a truly Poisson type distribution does 
not arise. Nevertheless a general shift in mass of certain dominant peaks could be 
quantified directly Figure 413a,b, where 15 selected mass ions are picked out, with their 
p-alanyl derivatives shown in the following coupling step. Both cyclic and linear samples 
of the final libraries were generated with the intention of validating the cyclisation step, 
however examination for signals which had failed the condensation reaction was 
frustrated by the high number of expected peptides which were at or near Am/z 18 
anyway. 10 selected masses from each sub-library (where M+18 signals were unique) 
showed corresponding linear expected ions of below 15% of the cyclic expected signal 
intensity.
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Fig. 4.13b Library 1 final sub-library 2, peaks numbered 1 thro’ 15 show a consistent 
shift of 71Da, from the addition of the final spacer molecule P-Ala
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HPLC Analysis
Reverse-phase HPLC was also performed at each stage of the synthesis. At the second 
coupling, individual peaks were visible in the middle of the gradient, though thereafter 
the peaks were not resolved Figure 4.14.
a
Fig. 4.14 Gradient HPLC of Library 1: GABA-(residues)-(spacers)-Asp 24 
compounds. Very late running peaks probably represent retained protecting groups. 
The final peak at 9.7 min. appeared in all runs.
Constant artefact peaks were observed at the solvent front and at the end of the gradient, 
the later peaks absorbing particularly strongly at 254nm. The HPLC contributes little 
information after the first mixture other than confirming a proliferation of compounds as 
the sequence progresses. Fmoc protected library samples viewed at 254nm gave peak 
counts closer to the theoretical value, presumably because of the contrast in absorbency at 
this wavelength between Fmoc groups and peptidic impurities. The approximate area 
under the unresolved peak cluster was used to gauge the sample concentration for mass 
spectroscopy (0.005mg/ml per theoretical single compound calculated on the basis of 2Au 
at UV2 2 0  = 1 mg/ml).
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4.9 Biological assay of Library 1
The products were tested under competitive ELISA conditions at 1 mg/ml (1.67mM 
nominal, 3pM per compound)) with successive dilutions to 0.01 mg/ml. All sub-libraries 
were approximately equal in activity across the dose range, and activity disappeared 
below 0.2mg/ml Figure 4.15. The levels of activity were similar to the random library as 
a function of total peptide mass and judged insufficient to attempt a deconvolution.
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Fig. 4.15 Biological response to the six final sub-libraries of Library 1
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4.10 Conclusions
As well as disappointing level of activity, Library 1 showed no differential of activity 
between sub-libraries. The result suggested that either the activity was artifactual due to 
common synthesis by-products, to non-specific peptide binding interference or that co­
operative effect of many weakly active library members averaged to a similar value in 
each subset. At the concentrations used, some non-specific inhibition of protein-protein 
interaction is probably to be expected, and the first random library provided some 
measure of that. Considerable discussion regarding the co-operative effect has led many 
workers to synthesise only very small libraries for solution assay, or to assay on the solid 
phase. However, even with this approach, subdivision into pools containing only a few 
beads each has been adopted. Houghten (239) states that as the size of a mixture library 
increases, so the difference in the nature of the molecules in each sub-library must 
increase to show sufficient activity difference to deconvolute. Clearly, with the deliberate 
repetition of three residues in the library members, there is considerable functional group 
similarity between the library members. It is notable that the Library 1 protocol 
generated more compounds per sub-library than did the entirely random first library, 
which, in combination with the low residue diversity has to be viewed as a major flaw 
under the above principle.
It appears that no sufficiently active molecules were generated and that the activity of any 
modestly active compound was hidden by the high background activity caused by the 
plethora of closely related molecules in the assay. The library is an attempt to step directly 
from protein structure to small constrained peptides on the assumption that the protein 
merely provides the correct orientation of three amino acids to bind another protein. 
Whilst there is some precedent for excising part of a protein structure and retaining 
functionality by covalently joining the ends of the original sequence with designed
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bridging molecules using known orientation requirements (208) it has to be concluded 
that either the chosen set of bridging structures was incorrect, that the assay is 
insufficiently selective, or that replication of the binding site is simply not possible with 
molecules o f this size.
4.11 Design of L ibrary  2
Further scrutiny of the synthesis protocol of Library 1 revealed several questionable 
features in addition to potentially co-operative similar members.
Employing a choice of all three significant residues at two coupling positions allows the 
possibility that library members lack one or more of the “essential” amino acids. All 
members contain Asp, so the possible residue inclusions for Library 1 in synthesis order 
are:
Asp Lys lie Asp Asp He Asp He He Asp Zero He
Asp Lys Lys Asp Asp Lys Asp He Lys Asp Zero Lys
Asp Lys Asp Asp Asp Asp Asp He Asp Asp Zero Asp
Asp Lys Zero Asp Asp Zero Asp He Zero Asp Zero Zero
It is evident that:
1) Only two of the 16 possible combinations contain all three desired amino acids.
2) Because the library members are head-to-tail cyclic peptides, they lack the “origin” 
shown when viewed according to linear synthetic sequence. Consequently a number of 
different order combinations are actually equivalent. In the set above, there are only 11 
unique structures, as the following are equivalent pairs: DKD/DDK, DKZ/DZK, 
DDLDID, DDZ/DZD, DIZ/DZI.
The diversity conveyed by the spacer molecules superimposes the effects above, and thus 
the proportions shown apply to the whole library.
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3) An additional complication arises because of possibilities offered by the omission 
steps, where two adjacent alanine spacers give the same structure as an omission step 
followed by a di-alanine spacer.
4) There is a significant proportion (1/8) of the library which contains three or less of the 
monomers.
The overall effect is that the diversity of the library is lower than superficially calculated, 
contains some undesired compounds, and most importantly, generates some identical 
structures in different sub-libraries, despite the unique order of assembly of the parent 
peptide sequence.
From this analysis, it appears that the library was deficient in desired members, there were 
too many molecules per sub-library and the presence of identical molecules in different 
sub-libraries severely curtailed the possibility of differentiating activity between pools. 
The latter effect would apply to any cyclic-backbone peptide library assembled by 
classical split-and-mix protocol, and while the presence of extra duplicates is no barrier to 
bead-bound or affinity assays, it is a major drawback when using solution assay.
A second library was designed to correct the deficiencies of Library 1. Co-ordinates for 
the TF binding site became available from the work of Harlos (234) Figure 4.16, and 
modelling was performed to gain a better estimate of the required inter-residue distances. 
Figure 4.17.
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Fig. 4.16 Three residues of interest (Cambridge crystallographic database)
Fig. 4.17 C a to C a distances for three binding residues of Tissue Factor
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Though using the same starting materials, the protocol was modified to produce a smaller 
library with a much higher proportion of desirable members. The effect was achieved by:
1) All three significant residues present in all members.
2) No duplication of the three significant residues within any one peptide.
3) No duplication of peptides between sub-libraries due to equivalent cyclic sequences.
4) Full chiral variation of residues, increasing the diversity of side-chain orientation.
5) Size variation to more closely match the residue spacings shown by the model.
6) Superior orthogonal protection strategy.
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7) More convenient synthesis by pre-synthesis of di-alanine spacer. 
































Fig. 4.18 New split and mix protocol showing Library 2L
Two separate libraries were synthesised starting from L- and D- Asp respectively, denoted 
Library 2L and Library 2D. The conventional linear split and mix protocol was 
replaced with a branching structure. In this manner, any resin pool which had previously 
been exposed to one of the chosen residues was not exposed again, thus no residues were 
repeated in any sequence and consequently all three residues appear in all sequences. By 
having a pair of branches with Lys and lie coupled in opposing order, all the possible 
rotational order variants are included, Figure 4.19. 
bond direction
Resin Resin
Fig. 4.19 All order variants generated from the exchange of two residues
A choice of chiral form was introduced at each residue position. To cut out very small 
molecules and to reflect the spacing data from the crystal model, the skipped-spacer 
option was removed from the protocol except for the last coupling, suggesting products of
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cyclic peptides from 5 to 12 residue equivalents. Following one of the four possible 
synthesis branches, the number of compounds synthesised becomes 1 (Asp) x 5 (Spacers) 
x 2 (L or D Lys) x 5 (Spacers) x 2 (L or D lie) x 6 (separate) spacers; making six sub­
libraries of 100 compounds each. The whole scheme thus generated 4 sets of six sub­
libraries at 100 compounds each = 2400 compounds.
During the cleavage of dimethoxybenzylester protection of Library 1 using dilute acid, 
pinkening of the resin periphery was observed. The colouration was attributed to the 
appearance of locally concentrated acid due to evaporation, as observed during synthesis 
of the test sequences. However, whilst some loss of product through resin cleavage may 
be acceptable in the synthesis of single sequences, it was thought undesirable in a mixture 
synthesis, because the loss could be sequence specific and bias the ratio of products in the 
final library, a-carboxyl protection was revised to allyl ester. The protection system is 
more truly orthogonal to the resin anchorage/sidechain protection and has been described 
for the synthesis of cyclic peptides (240) and for the generation of cyclic peptide libraries 
(241). The new protection strategy is shown in Figure 4.20.
Pd(0)
20%  Piperidine
Fm oc I'V'A'— A/w^A/VV'—A/nA^ —AAA'— A/Av O - k  RESINVW'—
95%  TFA 95%  TFA
4.12 Synthesis of L- and D- Fmoc-Asp(OH)0All, Compounds 25, 26.
The synthesis of Fmoc-LAsp(OH)OAll, 25 was attempted using the protocol described 
by Trzeciak et al. (748) Fmoc-LAsp(Bul)OH was treated with allylbromide/DBU in DMF 
under nitrogen at R.T. according to Scheme 4.21.
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DBU/DMF
Fmoc-Asp(But)OAII
(L - 23, D - 24)
90%TFA(aq)
Fig. 4.21 Attempted synthesis of Fmoc-LAsp(OH)OAll
Fmoc-Asp(OH)OAII
(L - 25, D - 26)
None of the required product Fmoc-LAsp(But)OAll 23 resulted, and a mixture of low- 
running ninhydrin positive spots appeared on TLC, along with a high running spot 
strongly fluorescent at 254nm. TLC-MS analysis suggested the presence of aspartic acid 
and aspartic acid allyl ester. The high-running spot gave no molecular ion under ESI-MS 
conditions. Flash column chromatography was used to isolate the high running spot as a 
bright yellow oil. The oil was identified by proton NMR as the product of Na- 
deprotection of the starting material by the DBU base. Fresh reactions were performed, 
using the above scheme with diisopropylethylamine and with N-methylmorpholine. 
Products were isolated at 75% and 45% respectively. The DIEA protocol was adopted 
and used to produce 25 and 26 in 93% cumulative yield from acidolysis of 23 and 24 after 
purification by flash chromatography. The optical rotation of 23 and 24 were compared 
and specific rotations were approximately opposite at +19.4 and -15.43.
4.13 Synthesis of Test Peptides 31,32,33
As previously, a trial synthesis of a number of single cyclic peptides, of sizes covering 
the approximate range of the planned library members was conducted using the new 
chemistry. 3g batches of Wang resin (polystyrene/1%DVB 0.74 mmol/g) were loaded 
with 25 (giving resin 27) and 26 (giving resin 28) using Sieber’s method (237) using 1 
equivalent of amino acid. The resins were capped with acetic anhydride, and loading
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confirmed by the previous method at 0.152 mmol/g 27 and 0.169 mmol/g 28. A repeat 
using 5g resin yielded 29(L-) (0.10 mmol/g) and 30(D-) (0.065 mmol/g). The expected 
yield of <25% of potential conjugation sites was deliberately lower than previously, as it 
had been observed that a greater resin bulk facilitated manual handling of the library 
synthesis. lOOmg aliquots of the resins were used to synthesise the peptides on an 
automated synthesiser. After completion, the allyl ester protection was removed using two 
30 minute treatments of Pd(0) 0.05 eq. suspended in DMF. Fmoc removal and cyclisation 
was performed in the previous manner. An analytical scale sample was preserved in linear 
form. The syntheses yielded no significant linear monomer (by MS or LC) or dimeric 
products (MS) and the procedure was deemed suitable for general application to a library 
synthesis.
Fig. 4.22 Test peptides for allvl-ester protection strategy
Peptide Sequence [M+H]+
(expected) found
Purity / % 
HPLC
UV220
HPLC / k ’ Yield /
%
131 KIAD (446.5) 446.4 68 2.50 trace*
cyclo-KIAD (428.5) 428.2 72 2.20 78
132 AKAIAD (588.7) 588.4 83 2.55 trace
cyc/0-AKAIAD (570.7) 570.4 86 2.65 60
133 AAIAKAAD-D (730.8) 730.6 66 2.70 trace
cyclo-
AAIAKAAD-D
(712.8) 712.5 78 2.60 65
*linear samples were generated on an analytical scale and no yield is quoted
4.14 Synthesis of Library 2
The synthesis was conducted in a similar manner to Library 1. The spacer molecule 
Spacer 4 was synthesised in advance as Fmoc-LAla-LAla, 34, from proprietary di-alanine 
using a method modified from Lapatsanis et al. (243). The manoeuvre allowed all steps of 
Libraries 2L and 2D to be conducted using the same number of reagent exposures,
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considerably simplifying the procedure. The synthesis was conducted on 3g of resin for 
each L and D arm of the library, with lOOmg deconvolution samples and lOmg analytical 
samples reserved at each step. After the first three steps, the remaining resin proved too 
small to process in sinter funnels, and the synthesis was continued in 4ml glass vials. 50% 
methanol/NMP wash steps caused shrinkage and sinking of the resin, permitting 
aspiration of solvent in a manner reminiscent of Ruvo et al. (43), though not requiring 
centrifugation. The final division into 2 x (2 x 6) sub-libraries of each branch resulted in 
resin samples of approx. 80mg. After coupling the final spacer molecules, the resins were 
exposed to 0.05 eq. Pd(0) for 3.5h. Following very thorough washing, Fmoc deprotection 
was performed in the previously described manner. The deprotected peptide resins were 
exposed to coupling agent for 6hrs. After cleavage in 0.7ml aqueous TFA, the products 
were recovered by evaporation, re-dissolved in IN HC1 and lyophilised to yield an 
average 8mg (106%) of flaky white product per sub-library.
4.15 LC-MS Analysis
During the earlier synthesis of Library 1, the observation of discrete mass ions to confirm 
the expected products at each synthetic step was only possible within the limitations of a) 
beyond the first two synthetic steps, the collections exhibited many isobaric compounds 
and b) the resolution of the system to discriminate between compounds very close in mass 
or c) with such large discrepancy in expected abundance that lower intensity masses were 
close to background compared to the largest. Additionally, associated small molecules, 
such as TFA from cleavage, clutter the spectra. TFA has been observed to suppress 
sample ionisation in electrospray during other work. While the expansion of mass spectral 
“hedgehogs” over the expected range is some indication of synthetic progress, it 
contributes no more than the ninhydrin indication of coupling success and can scarcely be 
described as a characterisation, especially in work which generates a large proportion of
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isobaric peptides. A single sub-library from Library 2 generates 100 compounds but only 
10 discrete masses, with 4 to 16 compounds having the same nominal mass, whereas 
Library 1 showed abundance ranges from 1 to 12. The problems of isobaric compounds 
are thus exaggerated over the case with Library 1, and an improved method of scrutiny 
was sought.
Since the isobaric peptides arise from different order of assembly of the same residues, 
even accurate mass analysis would offer no improvement. In HPLC analysis of Library 
1, the number of observed peaks had some correlation to the number expected for 
mixtures below 24 compounds. However, peaks coalesce into a single hump very rapidly. 
If a chromatography system running over 30min resolves sample peaks to 0.25 min width, 
it follows that only (30/0.25) 120 peaks can be fully resolved. Peak capacity theory 
suggests that since any random selection of compounds is very unlikely to contain a full 
and equal spread of retention characteristics, the real resolvable number of peaks will be 
only 18% of the theoretical maximum, suggesting 22 peaks in our case. Since a collection 
of closely related peptides are likely to occupy an even narrower range of retention, 22 
resolvable peaks would represent a optimistic value and suggests that a number of the 
later peaks observed even at these modest numbers are attributable to lipophilic 
impurities, such as retained protecting groups.
To circumvent these difficulties and give a more valid indication for the presence of the 
desired compounds in Library 2, an LC-MS technique was developed using example 
peptides. Gradient reversed-phase HPLC was used, using lOmM ammonium acetate (pH 
3.0) to methanol over 15 min. Columns of highly base-deactivated ODS, Prodigy ODS3 
and Hypersil Elite were used to maximise the resolution of the system. Initially 4.6 x 
150mm columns were used, and the 1 ml/min flow was split 1 OOpl/min to the MS 
electrospray source after the UV detector using a T-piece and appropriately adjusted
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lengths of restriction tubing. Later, columns of 2 x 100mm run at 200pl/min allowed 
more rapid runs and a greater proportion of the sample to enter the mass spectrometer. To 
avoid contamination of the source by TFA, a pneumatic diverting valve was used to 




It was hoped that the two-dimensional nature of the LC-MS would allow far greater 
scrutiny of the synthetic mixtures, since overlapping UV-LC peaks would be 
differentiated by selected single-ion monitoring chromatograms, while isobaric 
compounds might be eluted at different times. A drawback of the system lies in the 
amount of data generated. Summation of the spectra collected during the entire run for 
any mixture gave a result inferior to a corresponding flow-injection analysis, presumably 
due to the additive effects of background noise. For the purposes of characterising the 
mixtures of Libraries 2L and 2D, each expected ion was displayed as a single-ion 
chromatogram, and the number of discrete LC peaks shown at greater than 3:1 
signal/noise was compared to the theoretical number. The technique allowed visualisation 
of plural peaks for single expected masses, Figure 4.24 however even these selected 
chromatograms were not properly resolved from one another after more than 2 - 4  
isobaric compounds - peptides of the same amino acid composition might perhaps be 
expected to have similar elution times. Also, by comparison with single standard
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compounds, the MS transfer tubing was found to cause significant peak spreading 
compared to UV signal. The LC-MS system did allow the separation of compounds such 
that, scrolling scan-by-scan through the chromatogram, individual masses could be clearly 
viewed in isolation of signals close in value, thus circumventing the problem of 
differentiating ions only 1 or 2 Da apart, Figure 4.25.
a) expecting single compound 
in: Asp(spacers) monitoring 
m/z 316.2
b) expecting single compound 
in: Asp(spacers) monitoring 
m/z 319.2
c) expecting duplicate masses 
in Asp(spacers)D/LLys 
monitoring m/z 447.3




Fig. 4.24 Gradient LC-MS: selected ion chromatograms to differentiate isobaric 
compounds. Practical value limited by LC resolution after 4 isobaric compounds
Fig. 4.25 Mixtures sampled after coupling steps of Library 2D -Lys-X-Ue- branch 










Number of correct 
masses found
%  Confirmed
1 5 4 4 100
2 10 4 4 100
3 50 10 9 90
4 100 10 10 100
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For the final products, representative m/z values for all of the expected values in each case 
(10) were found, perhaps unsurprisingly given the number of duplicates. Display of the 
single-ion chromatograms for each expected ion against the corresponding values 
expected for the linear species (+18m/z) were expressed as a ratio of signal intensities, 
and gave values between 0 and 15%, measuring above background of 5% (a randomly 
selected single ion chromatogram).
A version of the system which combined some of the advantages of both FIA and LC-MS 
analysis was tried. Mixture samples were injected onto 3x 50mm Prodigy ODS3 column 
run at 0.5ml/min aqueous ammonium acetate. After allowing one minute for elution of 
the solvent front, including associated TFA, the solvent was swapped abruptly to 80% 
methanol eluting the library components as an unresolved slug lasting 0.7 min. The 
solvent flow during the eluting period was split such that 70pl/min went to the mass 
spectrometer. Scanning MS data acquired was summed to provide a result similar to FIA 
analysis but with lower background and absence of TFA. The process is essentially on­
line solid phase extraction. The low background evident from the method is probably a 
result o f the concentrating effect of the chromatography, along with the removal of TFA 
and salts at the solvent front. The quality of the resulting spectra demonstrated a closer 
relationship with the theoretical quantitative output than previously, and signals were 
compared with the theoretical abundance of the expected ions. An approximate 
correlation was observed in most cases. For the final products, m/z values corresponding 
to the linear peptides were also searched for comparison. Results may be distorted here 
because LC-MS of the first few couplings showed considerable evidence of MS induced 
water loss, hence a linear peptide would perhaps give a “cyclic” signal anyway.
129
Results 4 - Protein Structure Directed Libraries
Fig. 4.26 Summary data from sub-library Asp-X-Ile-X-Lys-Spacer 3

















585.5 16 13 603.5 0
599.5 16 6 617.5 0
613.5 4 2 631.5 0
656.5 16 10 674.5 3
659.5 16 6 677.5 0
670.5 8 4 688.5 0
673.5 8 4 691.5 0
727.5 4 13 745.5 0.5
730.5 8 5 748.5 0
733.5 4 2 751.5 0.5
The majority of impurities in the final libraries were easily attributable to deletion 
sequences by comparison with the MS result from the preceding step. Signals from 
addition of alanine or Bu* were also evident in most spectra Figure 4.27.
7 8 8  5 5
7 1 4 .0 7
5 8 6 .1 4
7 2 7 .9 6
6 5 7 .8 0
5 7 2 .3 6
6 4 3  1 8
8 4 7 .0 7
8 0 2 .5 25 0 1 .2 8
6 0 0 .0 8
8 5 8 .9 4
8 2 5 .9 1
7 4 1 .5 7
6 7 1 .7 4
6 9 6 .3 0
6 1 2 .9 8
5 5 3 .9 8 8 9 7 .2
8 8 1 .7 5
Fig. 4.27 Summed scans of DAsp-X-Ile-X-Lys-Spacer 3 deletions of Alanine -”D”; 
additional /n/z:788 +Ala; 859 + Bu*; 714 frameshift +2Ala of deletion m/z 572
130
Results 4 - Protein Structure Directed Libraries
In summary, the great majority of expected ions were present, with major impurities 
being retained protecting groups and deletions. Signal intensities had some correlation to 
expected values by inspection, but no statistical analysis was performed. The very high 
proportion of isobaric compounds made assessment of the library difficult. Whilst the use 
of a two-dimensional technique, LC-MS, allowed individual m/z signals to be viewed in 
isolation, the similarity of the elution times on HPLC prevented the counting of 
individual single-ion chromatography peaks in later stages of synthesis. A useful rapid 
method for viewing bulk mixture m/z signals in the absence of cleavage reagent has been 
found.
4.16 Biological Assay and Deconvolution of Libraries 2L and 2D
The sub-libraries were dissolved to 10 mg/ml in 50% DMSO (aq.), diluted in assay 
buffer to 303pM total peptide (using an average molecular weight of 648) and tested in 
the ELISA assay. Results are shown below, Figure 4.28.
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Fig. 4.28
The library 2D gave a considerably greater spread of activity than the L-version, and on 
that basis was judged to offer a better likelihood of displaying real rather than co-
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operative or artifactual activity. The sub-library DK4, [DAsp-X-(L,Dlle)-X-(L,DLys)- 
Spacer4] was deconvoluted by taking the saved resin portions Resin-DAsp-X-(L,Dlle)-X- 
(LLys) and Resin-bAsp-X-(L,Dlle)-X-(DLys), coupling Spacer 4 to each and forming the 
cyclic peptides as previously. The peptide mixtures, each containing 50 compounds were 
tested in the ELISA assay at 58 pM and gave 3% inhibition, and required 580pM to give 
just 9% inhibition. There was no significant difference between the second-iteration sub­
libraries. Lack of activity on deconvolution suggests that the activity shown initially was 
not due to a single peptide, or even a small set. That the assay could tolerate such high 
concentrations of mixed peptide without inhibition of binding suggests that the activity 
witnessed in the first round of screening was co-operative binding activity rather than non 
specific interference by sheer weight of material.
4.17 Conclusions
Cyclic peptide libraries have been widely reported in recent years, and the allyl ester 
orthogonal protection strategy has proved particularly popular (241), though other 
strategies using TMSE protection (67) or oxime resin to achieve head to tail cyclic 
products have also been reported (244). The generality of formation of cyclic peptides 
has also been investigated, symptomatic of the interest for combinatorial techniques and 
5-6 residues were found to be optimal (230).
Loo et al. (117) review MS analysis of libraries and suggest that a 2 dimensional analysis 
by LCMS is required over 500 compounds. The value would appear rather optimistic 
from our results, and an increase in resolution would be required to differentiate between 
library members to that degree.
The concept of a library where the principal variation lies in the scaffold rather than in the 
displayed residues is in marked contrast to the approaches of Mutter et al. (109) and 
other workers, where the dominant feature of speculative libraries for the mimic of
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protein-protein binding surfaces is the initial adoption of a synthetically convenient 
scaffold as a template for the display of variable residues. The libraries of derivatised 
ct,p,y linked diamino acids represent one of the few examples of a variable template for 
the display of fixed pharmacophores (108). However, considering either approach, 
whether it is legitimate to draw such fixed boundaries between the function of the 
different building blocks as “scaffold” or “functional” of a lead-finding library is a 
question certainly open to debate and unfortunately not verified experimentally on this 
occasion. A practical way of combinatorially varying a constrained structural feature to 
alter the display of potential pharmacophores has been introduced by the library schemes 
above (245, Appendix). In a related approach, Kessler et al. have recently reviewed their 
work where the systematic replacement of D amino acids around a cyclic peptide was 
used to vary the conformation of the rings (83). Geysen also utilised a mix of L and D 
amino acids to mimic discontinuous epitopes, the switch to D residues within a sequence 
resembling parallel chains (55); an approach which could be viewed as primarily a 
structural variation.
The libraries 1 and 2 introduce the concept of variable spacer inclusion to vary the 
separation of pharmacophores. Kessler discusses the issue of selecting a correctly sized 
template before attempting combinatorial optimisation of a lead (83). The variation of 
spacing as a primary issue has appeared in several papers in 1998, including the 
introduction of variable linker molecules to create novel variable ring-sized polyazaphane 
rings from established pharmacophores (246). Other existing variable-ring size strategies 
include the Cycloscan™ approach, where a functional peptide is constrained by a 
covalent bridge imposed at combinatorially varied points along the backbone. Both 
strategies involve using the variable spacing concept to make only structural changes to 
an existing active molecule. In our strategy, the variable spacer concept is mixed with the
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Furka binary strategy to introduce the possibility of no spacer at all. The Furka skipped- 
step principle has so far only otherwise been applied to deletion/frameshift analogues of 
linear peptides (33). Library 2 combines the variable spacer idea with a system for 
juggling the order of appearance of the same residues, providing a considerably enhanced 
set of structural possibilities over simple space variation between fixed chemical groups. 
Our revision of the Library 1 protocol to Library 2 seeks to increase the proportion of 
desired members in the library and reduce the “background” effect of molecules which 
would normally arise from the conventional split and mix protocol. The branching DCR 
protocol used to achieve this has parallels with Furka’s domino strategy (85), though in 
that case the restricted set of monomers at particular residue positions was derived from 
earlier random libraries. The removal of duplicity of residues within any one peptide (and 
hence also the assured presence of all three) generates a far higher number of desired 
molecules compared to the simple DCR protocol of L ibrary 1. Also, the removal of 
duplication of structures between sub-libraries is a special consideration for head-to-tail 
cyclic amide libraries and represents a key contribution of the publication (245). The 
introduction of chiral variation also serves to increase diversity in the required sense, that 
of sidechain positioning, without departing from the original hypothesis of particular 
sidechains being responsible for binding. The contribution made by D-amino acids to the 
orientation of sidechains in cyclic peptides has been illustrated by Kessler et al. (83).
Our libraries 1 and 2 are rather small by speculative lead-finding standards, and the 
conserved residues could be viewed as limiting the diversity of the library. Both these 
features conspire to reduce the chances of success from such a speculative approach. 
There have been several attempts to quantify the degree of diversity using chemical 
character (hydrophobicity, pKa) and arbitrary distance intervals or flexibility between 
functional groups (247, 248). It is an inescapable fact however that very small changes to
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a molecule as they may appear to the eyes of the chemist have resulted in huge changes in 
biological activity. Nevertheless, it appears to be established practice that lead-finding 
libraries consist of large numbers of molecules comprising a wide spectrum of chemical 
character, whereas lead optimisation libraries offer smaller changes around a central 
theme and low membership number to permit the differentiation of activity between 
similar members. Our ventures with library 1 progressing to 2 may offer techniques 
useful in the lead optimisation arena, where the establishment of the minimum active 
sequence is often a first requirement. Our supposition however that the significant 
residues from the TF mutagenesis study could function when part of a small molecule 
was too large an assumption on which to base a relatively focused library approach. Most 
focused libraries appearing in the literature (and therefore presumably successful ones) 
focus combinatorial variation about a known activity motif rather than protein structure 
(89, 90). Combinatorial approaches have been proposed where small molecules with 
appropriate linkages are derived from protein structure on a computer screen, though not 
yet in reality. The modification of the split and mix protocol to eliminate accidental 
duplicates in cyclic amide libraries may have utility in other solution assay based 
strategies, though not in bead-bound assays where duplicates are present anyway to 
ensure full membership. The modified protocol is more labour intensive than standard, 
but provides sub-libraries with a higher proportion of desired compounds and a greater 
level of reaction history, making the approach closer to that of the orthogonal synthesis 
strategy (144).
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5. Protein Fragment Synthesis and Lead Structure Minimising 
Library 3
5.1 Aims
In parallel with the speculative lead-finding combinatorial approaches described in 
Chapter 4, a more conventional route to binding inhibitors of TF/FVIIa was taken in the 
form of synthesis of parts of TF thought to participate in the binding of FVIIa.
By raising antibodies to selected regions of TF, it had been reported that sequences 1-34 
(249) and 40-71, 94-121 (250) were important for the binding of FVIIa. Further, regions 
3-95 and 106-174 have also been shown to be involved in ligand recognition by cross 
linking studies (250). Ronning et al. (251) have shown that the first and second repeated 
sequences WKS; which are involved in binding, are also contained within the 
independently cited 1-34 and 40-71. The X-ray structure by Harlos et al. (234) showed the 
binding regions described to be across the two domains and primarily performed by 
residues on the surface of the cleft between the domains. The proposal was supported by 
the mutational mapping work of Ruf (233) showing that binding o f FVIIa to TF has 
considerable similarity to that between GH and GH receptor, which also involves a fit 
into an analogous cleft. Based on the information, a set of sequences of TF were 
synthesised comprising the regions described above. It was hoped that an active peptide 
thus derived could serve as a lead structure for the design of smaller or non-peptide 
inhibitors.
5.2 Synthesis of Tissue Factor Fragments.
The sequences of TF synthesised were : 10-35, (37) 13-33, (39) 39-68 (36), 125-150 (38) 
and 154-174 (35). In addition, the junction region between the two domains 94-121 (41) 
was synthesised and a set of C-terminal daughter sequences from one synthesis of the 
region 40-71 (40) were produced; 62-71 (40/1), 58-71(40/2), 54-71(40/3), 50-71(40/4),
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46-71(40/5), 43-71(40/6). The disulphide bridges naturally present in the parent protein 
were preserved. The segments of the TF sequence synthesised are shown below, Figure 
5.00, and constitute 57% of the extracellular portion of TF.
The peptides were all obtained in purities greater than 90% by gradient HPLC UV220,280 
after, in most cases, exhaustive preparative HPLC. The peptides were tested in the direct 
assay and the ELISA assay at 83 pM, and were found to only very weakly active under 
ELISA conditions. Shortly afterward, Paborsky et al. (252) published an account of a 
similar approach. The information provided by Ruf and Harlos had been used as a 
starting point for a replacement-mutagenesis experiment where loop regions of the TF 
sequence around the first DWK motif were replaced by segments from the closely related 
y-interferon receptor. Regions identified as important for binding were synthesised, and a 
21 residue peptide, TF 33-53, gave 50% inhibition at l.lm M  in an ELISA assay. The 
peptide featured residue 49 (Cys) substituted for Ser to prevent oligomerisation. To 
optimise the sequence, Cys49 was restored and residues from the N terminus 
systematically replaced with Cys and oxidised to generate a set of cyclic peptides of 
progressively smaller ring-size. The smallest active peptide was trimmed of exocyclic 
residues, and remained active, yielding the sequence CTKSGDWKSKC as a cyclic 
disulphide (essentially cyc/oTF 39-49) and found to give 50% inhibition at 1.6mM. The 
peptide preserved the second WKS region quoted as crucial for FVIIa recognition. The 
result was surprising in the light of our lack of success with quite large segments of that 
region of TF, including peptide 36, 39-68. However, the region worked on to derive the 
unnatural cyclic peptide spanned the region 33-53, which was severed in our fragment 
study, and our assay had not been conducted at such high concentrations. The peptide was 
synthesised to verify the reported activity.
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Fig. 5.00 Structure of Tissue Factor from Broze et al (253) showing regions 
synthesised as single peptides (red) and peptide 42 derived from the work of 
Paborsky et al. (252) (blue)
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5.3 Synthesis of Peptide 42 CTKSGDWKSKC
I  I
The smallest active peptide described by Paborsky et al. was synthesised by standard 
Fmoc/HBTU procedures. Preliminary HPLC showed an apparently homogeneous product 
which was poorly soluble as noted by Paborsky et al. However, ESI-MS showed 
significant additional signals as well as the expected molecular ion and these were 
attributed to the retention of 1 and 2 Bul protecting groups, despite a 4h exposure to 90% 
TFA (aq.). A change of HPLC column revealed a series of additional peaks appearing in 
the chromatogram after the major product Figures 5.01, 5.02. The crude peptide was 
subjected to air oxidation under high dilution conditions to favour the formation of the 
cyclic monomeric disulphide, which proceeded relatively briskly (2 days) under HPLC 
monitoring, Figure 5.03. A series of preparative HPLC separations was performed to 
isolate the desired material Figure 5.04. Collected impurities were also analysed by ESI- 
MS and the major signal was attributed to the Bu* protected cyclic monomer. Treating the 
crop with 90%TFA (aq.) at r.t. for 3h yielded only a modest appearance of the desired 
material, which was isolated by preparative HPLC. The resulting product (99% by HPLC 
UV220, Figures 5.05, 5.06) was found to be freely soluble in water, in notable contrast to 
the report. The product was subjected to our ELISA assay in a dose dependent fashion 
and found to cause 50% inhibition at 30 - 50 pM, a significant improvement over the 
originators. The result was also substantially superior to any of our other compounds to 
date, including those from random screening. It was believed that peptide 42 represented 
a significant lead toward non-protein inhibitors of the formation of the TF/FVIIa 
complex. Also, the difficult synthesis of the peptide and the marked improvement in 
solubility between the pure material and the butylated first product suggested that perhaps 
the activity of the pure product was better than Paborsky et al. had
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Fig. 5.01 Peptide 42 crude on gradient HPLC








Fig. 5.03 Linear (A) and Cyclic 
products compared by HPLC
5  - O O
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4 0 . 0 0 5 0 . 0 01 0 . 0 0 2 0 . 0 0 3 0 . 0 00 . 0 0
Fig. 5.04 Preparative HPLC of peptide 42, collecting the first peak, recycling peak 2 
(-Bu‘)
on
0 .0 0 5 . 0 0 10 .00 1 5 . 0 0 2 0 . 0 0 2 5 . 0 0
Fig 5.05 Purified peptide 42 UV220 Fig. 5.06 ESI-MS of peptide 42
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appreciated; though it has to be recognised that the ELISA protocol quoted was the 
reverse of our own, employing immobilised TF and soluble FVIIa.
5.4 Design of Lead Structure Minimising L ibrary 3
Two priorities were identified for the engineering of 42 into a lead compound for the 
eventual development of non-peptidic drugs:
1. The reduction of molecular size to the minimum required for function 
and
2. The disclosure of the functional groups actively participating in binding.
Conventional peptide optimisation approaches have involved the synthesis of a series of 
truncated or frame-shifted peptides, and the systematic substitution of alanine for each 
residue in the target sequence. A combinatorial strategy was devised to incorporate 
truncated, residue deleted and alanine replacement sequences, while preserving the DWK 
sequence thought important for binding. A cysteine at the N and C termini was included 
to allow the facile generation of cyclic peptides by oxidation. The core of L ibrary 3 was 
the construction of sequence 42 on solid phase, but at each coupling step the resin was 
divided into three portions to allow the alternative possibilities of either a) the native 
amino acid b) an alanine replacement or c) no coupling and the resin carried forward to 
the next stage, resulting in a deletion of that residue position. The residues at positions 
4(Lys), 5(Trp) and 6(Asp) were coupled without variation. Residues subsequent to the 
DWK conserved region were combinatorially varied as before, but with a fourth portion 
abstracted from the synthesis altogether and capped with Cys, to yield a series of 
foreshortened sequences. The library quantity calculator (Appendix IV) was used to 
estimate resin quantity and permissible abstraction amounts for deconvolution; a 
particular consideration over so many synthetic steps. The overall scheme is shown below 
as Figure 5.07.
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8 7 6  S
Sublibraries...
Fig. 5.07, Schematic diagram of Library 3.
5.5 Synthesis of Library 3
The synthesis was performed manually using the sinter-fimnel manifold and 4g (2.2 
mmol) of commercially loaded Fmoc-Cys(Trt)-Wang-polystyrene resin (100-200 mesh). 
Couplings were performed in the previously described manner using 3 equivalents of 
Fmoc amino acids and PyBOP/HOBT/DIEA 1:1:2 eq. in NMP/20%DMSO for up to 1.5h 
each. Ninhydrin colour indicator test (118) was used after coupling and washing to 
establish the absence of free amine. No second exposures of activated amino acids were 
found necessary. Deconvolution samples of 200mg (latterly 1 OOmg for steps 7,8,9) were 
saved along with a small portion of resin for retrospective analysis by MS. Additionally, 
after each mixing step, another analytical sample was removed. The final two steps of the 
synthesis were performed in 4ml glass vials, using alternate shrink/swell wash protocols 
of NMP followed by methanol/NMP and vacuum aspiration. On completion of the 
synthesis, all sub-libraries were exposed to 10 eq. iodine dissolved in DMF for 2h to 
effect the simultaneous removal of trityl protecting group and disulphide formation after 
the established manner (254). The on-resin cyclisation chemistry was not specifically 
trialled for the synthesis of Library 3 since other peptides had been made in excellent 
cyclic yield (>90%) by us and widely reported elsewhere. The resins were exhaustively
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washed until the supernatant appeared clear of iodine, before Fmoc deprotection and 
cleavage in 90% TFA (aq.) for 4h. A small analytical sample was removed directly from 
the cleavage liquor and added to 50% methanol (aq.) for LC-MS analysis. After repeated 
lyophilisation from dilute HC1, off-white flaky products resulted, sub-library #6 78mg 
(41%, assuming an average molecular weight of 770 Da) sub-libraries #7 - #9T 29-50mg 
(38%, av. 850 to 1100 Da). The peptide mixtures were found to be freely soluble in water.
5.6 Analysis of Library 3
In addition to the ninhydrin indicator of coupling success, all coupling steps and resin 
mixture events of the library were sampled to allow the scrutiny of products by LC-MS. 
Expected monoprotonated m/z values were calculated for each synthetic stage using the 
library calculator (Appendix IV). 4mg resin samples were cleaved in 50pl 90% TFA 
(aq.) for 4 hours, the acid liquor abstracted and diluted to 1ml with water/30% methanol 
followed by lyophilisation from IN HC1. Samples were run on 8 min. gradient of 10- 
100% methanol/ammonium acetate lOmM pH 3, collecting MS data from 2 min to 10 
min scanning at 300Da/sec. Expected masses were entered as single ion chromatograms 
after scanning analysis. HPLC peaks were counted if  above 10% of the largest peak 
intensity. Signals identified from peaks were recorded below if a single scan selected 
from the top of the peak showed signal/noise ratio >3. From mixture stage 6 and onward, 
ions were searched by scrolling through the total ion chromatogram and checking against 
the expected mass list. For the final cyclic products all scans were examined and a 
corresponding list of m/z expected +2 was also searched to detect corresponding linear 
products, though no attempt was made to compare the signals quantitatively.
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Number of HPLC 
peaks at UV220
1 3 3 100-600 3 4
2 9 8 100-700 8 11
3 9 8 constant region not analysed
4 9 8
5 9 8 300-900 8 > 13
6 27 18 400-1100 14 unresolved
7 81 31 400-1100 24 unresolved
8 243 53 500-1300 40 unresolved
Fig. 5.09 LC-MS Analysis - Final Sub-libraries of Library 3
mass ions counted if signal/noise > 2
243 products, 53 different expected mass ions, scanning m/z 500-1300
Last Number of % Found of number of % Found Linear Number of
Coupling: correct masses 
found




Zero 42 79 9 17 25
Thr 38 72 16 30 28
Ala 39 74 14 26 32
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Fig. 5.10a Sample scan from sublibrary 6, (calculated value). Earlier in the synthesis 
LCMS was able to resolve single or pairs of compounds (shown) to excellent signal 














925 950 975 1000 1025 1050 1075 1100 1125 1150 1175 1200 1225 1250 1275
Fig. 5.10b Sample scan from Sublibrary 9A. Later in the synthesis, high background
1300
noise was observed as well as a high number of unexpected peaks, a symptom of a 
lengthy combinatorial synthesis without purification.
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Fig. 5.11 Sample scan from sub-library 9A, showing a number of mass ions, 
suggesting at least four coeluting peptides. Two display expected mass values, while 
two are Am/z +2Da over calculated mass suggesting uncyclised products
The deliberate inclusion of deletion sequences in the library made the identification of 
incomplete couplings impractical, though also renders the potential error of less 
importance since the products were desired anyway, in contrast to Library 2. The feature 
lent itself to another quality control procedure however. In order to differentiate between 
the absence of product and the failure to identify a signal, a set of 10 selected ions from 
coupling step 7 were searched after step 8, since the presence of these ions should occur 
through simple transfer during the skipped coupling step and not be a function of 
synthetic success at step 8. Since only 8 of the 10 chosen m/z were located in step 8, it 
seems reasonable to assume that a significant proportion of the unidentified ions at later
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levels were due to lack of detection rather than absence from the mixture. The quality of 
the spectra as the synthesis progressed beyond 7 residues deteriorated markedly with a 
high background. With such a long sequence and no purification procedure, the possible 
combinations of small impurities are so multitudinous as to presumably give rise to a 
raised background ion count. Similarly, a number of unexpected ions of significant size 
were apparent across the chromatogram. The high incidence of uncyclised material was 
similarly to be expected from long sequences, as it has been reported that sequences either 
side of 5-6 residues are often sluggish to form intramolecular disulphides for kinetic 
reasons (230).
5.7 Biological Assay of Library 3
Library 3 was submitted to ELISA assay at 910 pM, on the basis of nominal masses of 
#6-600 Da; #7-800 Da; 8-900Da; #9-1000Da; #9A,9T 1 lOODa.
Fig. 5.12 ELISA Screening of Library 3 at 1 mM total peptide concentration.
Libra ry  3 ELISA
S u b lib ra ry  #
On first inspection, the results appeared encouraging, as sub-libraries of peptides much 
shorter than the parent sequence appeared active. Consequently, sub-library 7 was 
deconvoluted by terminating the conserved resin portions from Layer 6 with Cys, 
resulting in three peptide-resin mixture products ending with CysAla, CysGly and Cys
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respectively. After cyclisation and cleavage, the libraries were tested at varying 
concentrations in the ELISA assay, with the original library for comparison.
Figure 5.13 ELISA results from second iteration of Library 3 - sub-library 6
% Inhibition at total peptide concentration:
Sub-library lOmM ImM O.lmM
6A 45 9 5
6G 46 10 5
6Z 43 3 4
Simultaneous repeat of first screening round for comparison:
7 50 5 6
9A 59 43 6
9T 68 52 -4
The results suggest that at 1 OmM, inhibition occurs as a simple function of the total mass 
of peptide in the assay vessel, with no differential possible between the sub-libraries 
synthesised from the conserved resin of step 6. At ImM, any activity attributable to sub­
library 7 in the first round of screening disappeared when distributed between 6A, 6G, 
6Z, despite the fact that at the second round of screening, only 9 compounds are present 
per sub-library instead of 27 in sub-library 7, raising the individual concentration 
threefold. Our initial suggestion was that the activity observed in the first screen was due 
to the co-operative effect of a number of weakly active peptides, which disappeared when 
the population of different peptides became sparser during the deconvolution process. The 
hypothesis could perhaps have been proved by mixing the second round of products to 
essentially re-create the sub-library pool 7 to see if the original activity was restored. 
However, on closer scrutiny of the results, it became apparent that such an internal check 
already existed. Of the three sub-libraries generated from the deconvolution of sub-library 
7, one, Layer 6 + Zero, is the same as the sub-library 6 in the first screen, though activity 
was not observed in this theoretically identical product in the second round of screening. 
Also, sub-library 7 itself was far less active when re-tested. The screening process thus
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failed two important internal checks. It appeared that either the assay was unreliable, 
perhaps ImM peptide being on the borderline of the assay tolerance of peptide mass 
interference, or insufficiently sensitive for detecting activities of the level of peptide 42 in 
the presence of interfering peptide background. As the concentration of 42 in the original 
sub-library 9T was theoretically 4pM, a compound of 1 order of magnitude greater 
inhibitory effect would have been required to show 50% inhibition if solely due to the one 
compound, since IC50 for the original peptide was ~40pM. To explore the latter 
possibility, it was decided to assay the activity of fractionated sub-library 9T against pure 
peptide 42, since peptide 42 should be isolatable from that sub-library, sub-library 9T 
(20mg) was fractionated by preparative HPLC over a gradient of 30-80% acetonitrile / 
ammonium acetate lOmM pH 3 over 40 minutes on a 9 x 150mm C l8 Hypersil Elite 
column. Fractions were collected at 2 minute intervals into weighed tubes, dried down 
and reconstituted in 10% DMSO (aq.) to 5mg/ml. The fractions were tested at 2mg/ml, 
nominally 17pM assuming 12 compounds/tube and 1000 Da molecular weight. No 
activity above 7% was observed, effectively zero within the error of the assay (+/- 10%). 
Pure peptide 42 assayed in parallel as a control was found to be inactive at 1 pM.
5.8 Discussion
The reduction of a large peptide with biological activity to a small organic molecule as a 
potential oral drug is a difficult though frequently trodden path (88) which has given rise 
to a multitude of peptidomimetic chemistries and molecular modelling approaches 
(Chapter 1). The approach exhibited in Library 3 is essentially one of size and structural 
minimisation of peptide 42 about the central theme of the conserved sequence DWK.
The construction of a mixture peptide library where residues are combinatorially varied 
surrounding a known active motif has been variously reported, for example in the 
generation of new DNA recognition domains where established structural features were
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conserved while recognition residues were varied (91). Diversity has been built around 
known functional residues of SH3 domain binding peptides (89). Size scanning libraries 
produced by mixture synthesis of peptides where all positions were fully varied and 
portions removed prematurely to generate sets of known sequence length were suggested 
by Houghten very early in the history of combinatorial chemistry. As discussed in Chapter 
4, Furka also pioneered the “skipped step” strategy to introduce residue deletions. The 
introduction of a disulphide bridge to reduce conformational mobility has been applied to 
combinatorial libraries (255), and was an early developmental step in the generation of 
peptide 42 itself by Paborsky et al. The strategy adopted in the design of Library 3 uses 
all four approaches to generate a sequence minimisation library. The only diversity in 
terms of residue variation is limited to alanine substitution, which itself is intended as 
sidechain functionality minimisation. The library examines all possibilities of trimming 
the sequence 42 from the parent sequence toward cyc/oCDWKC.
Although the library was constructed with conserved resin at each step for a classical 
recursive deconvolution to discover optimum residue identity, a key feature of the design 
over the preceding efforts was that information about minimum molecular size for activity 
is in theory provided before any re-synthesis. Because of the “zero-coupling” resin carry­
over step possibility each successive sub-library contains a complete replica of the 
preceding ones (hence accidental deletions are no detriment). After the conserved region, 
resin is prematurely abstracted to yield the growing peptide family as a hierarchy of sub- 
libraries Figure 5.14.
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Sublibrary 7 ------------- ^
Sublibraiy8 
Sublibraries 9
Fig. 5.14 Each sub-library of Library 3 contains the members of the preceding sub­
libraries
In this way, it was hoped that the testing of the sub-libraries would reveal, when read 
from sub-library 6 to sub-libraries 9, the threshold molecular size required for activity, 
while residue specificity would become apparent upon deconvolution. In this sense, 
Library 3 shares a common principle with the size scanning libraries described by Furka 
et al., though that library protocol scrutinises for size only since all other residues are 
randomised. In such circumstance, a threshold activity corresponding to minimum 
functional size should become apparent on assay. However, a very significant caveat for 
the principle is that either protocol generates a different number of members in the sub­
libraries, and so the bulk activity of a pool must somehow be adjusted for the 
concentration of a single member in any pool, or the concentration itself slewed. It is hard 
to see how effects due to peptide multiplicity can be corrected for to allow a truly 
uncluttered view of the size requirement of the ligands. However, if the results from the 
first screen of Library 3 are adjusted for the concentration of a single individual peptide 
in each respective pool, a new activity map emerges:
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Figure 5.15 Activity normalised for mixture population.
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The result seems to imply a minimum size requirement for activity beginning at step 8 (9 
residues including Cys2 ), and conforms to the expectation that the library should provide 
size requirement information in the form of a threshold value which is preserved in later 
sub-libraries. Unfortunately, the erratic performance of the lead compound in the assay 
made pursuit of the principle impossible. Also, this treatment ignores the possibility that 
co-operative effects may enhance the inhibitive capacity of the mixtures in direct 
proportion to their complexity.
The creation of combinatorial mixtures on solid phase is an essentially divergent process, 
where choices of residues are introduced along a sequence to create a geometric 
progression of molecular diversity. Conversely, in Library 3, the sub-library 9T 
containing the parent sequence perhaps represents the “top value of diversity”; the longest 
sequence and the greatest heterogeneity of residues. The library protocol allows access to 
less diverse possibilities along the synthetic route. Whilst the potential reward of that 
approach is the rapid identification of a lower molecular weight active molecule, it also 
carries the likelihood that no member of the library would have activity exceeding that of 
the crowning sequence, since no novel functionality is introduced, merely new geometry
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in the form of increasingly constrained rings. In that case, the library must be assayed at a 
concentration where the activity of the crowning sequence could be detected alone. It is 
apparent from our experiments that the very modest activity of peptide 42 makes that 
impossible for a mixture library of even 9 compounds. The presence of the disulphide 
constraint on the mobility of the peptides means that at the lower sequence lengths, ring 
sizes are small and the conformational possibilities are severely curtailed. In combination 
with a very limited residue variation, a very low number of diversity choices is presented 
by the earlier sub-libraries limiting the chance of finding new activity. It may be that the 
increasing constraint feature also interferes with the ability to use the library as a purely 
size scanning tool. It should be noted that the addition of constraint alone by cyclisation 
has enhanced the activity of peptide sequences (Chapter 1) whilst it has been commented 
that in doing so the chances of gaining an active molecule from a random library are 
reduced (83).
5.9 Conclusions on L ibrary 3
The activity of peptide 42 ceased in the assay and was not repeatable, leaving the validity 
of the minimising library scheme unproved. It is likely however that no compounds of 
significantly greater activity ( perhaps 1 order of magnitude) than peptide 42 were 
generated. The library protocol described above may well provide a blueprint for the rapid 
molecular size minimisation of a peptide active, and importantly provides the possibility 
of gathering information on active molecules from just the collective response of a 
mixture pool; a requirement identified from the exploits with Libraries 1 and 2. 
However, the activity of the starting sequence would need to be 1 or probably 2 orders of 
magnitude greater to allow the practical application of the approach with more than a few 
compounds per pool since there is clearly an upper limit to the tolerance of the assay to 
total peptide. Alternatively, an assay format resistant to non-specific effects of very high
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incident peptide concentration would be required. Our attempts at fractionation of a 
library pool to reduce the number of compounds in an assay well were frustrated by the 
disappearance of activity of even the purified parent compound. Interestingly, the concept 
of HPLC fractionation for just that purpose has very recently been published by Griffey et 
al. (256) of Isis Pharmaceuticals. Similarly, many researchers divide beads from large 
libraries into very small collections even for on-bead assay. Curiously, the advent of LC- 
MS-MS has permitted pharmacokinetic studies to be performed on several compounds 
mixed and dosed simultaneously to the same animal. The contrast starkly illustrates the 
requirement for a selective assay system when examining the behaviour of mixtures 
(257).
The deletion/ truncation element of the L ibrary 3 protocol is the one which would 
perhaps yield the most valuable information. The simultaneous change in the number of 
library members that occurs with such a move is a serious drawback in solution assay and 
is a common feature of both Library 3 and random size scanning libraries. The variation 
of size by the incorporation of variable linkers, as in Library 2, does not suffer from the 
feature. The deletion of side chain functionality while conserving residue position, using 
the substitution of alanine has parallels with residue omission libraries. Omission libraries 
have been designed to systematically leave a residue out of a reaction mix in order to scan 
the sequence for the importance of that residue. The procedure can be considered as 
complimentary to the position scanning libraries of Houghten et al. (84).
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6. SH2 Directed Unnatural Amino Acid Library
6.1 Aims
In the previous library synthesis efforts, we believed there were three principal barriers to 
success in discovering active compounds:
1) The lack of a sensitive, selective assay system capable of detecting the presence of an 
active molecule in the company of a plethora of other molecules.
2) Weak or possibly even non-existent binding by the only known peptide ligand.
3) The protein/protein interaction chosen as a target for inhibition appeared dependent 
upon multiple interactions over a large contact area and was, in the final analysis, 
unsuitable for mimic by small molecules (see Chapter 8).
We wanted to try some of the library design principles explored in the preceding work 
using a biological target where ligand selectivity requirements were concentrated in a 
much smaller area, and where a high specificity assay existed which would be resistant to 
non-specific binding or bulk mixture effects. A requirement to inhibit a protein/protein 
binding event was identified within an asthma/allergy project.
A major feature of asthma disease is bronchial hyper-sensitivity to antigens, leading to 
restrictive swelling and excess mucous secretions. A key event in the allergic stimulation 
pathway is the intracellular activation of Stat-6 by IL-4, resulting in the secretion of IgE. 
IL-4 activates the membrane bound receptor IL-4R-a causing it to dimerise and bringing 
the attached Jak3 kinase close enough to phosphorylate specific tyrosine residues. Stat-6 
recognises the region around the phospho-tyrosine and binds the IL-4 receptor, where it 
itself is phosphorylated at a site away from the binding area. Once phosphorylated, the 
Stat-6 can then dimerise permitting transport across the nuclear membrane to the site of 
action. Inhibition of the Stat-6 binding SH2 domain should have anti-inflammatory 
effects through loss of IgE (274,275) Figure 6.00
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Fig. 6.00 The activation of Stat-6 by IL-4 and the inhibition rationale
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The recognition motifs on IL-4 contain a phospho-tyrosine, and the interaction with Stat-6 
is very specific for this residue in combination with some of those immediately adjacent 
in the protein sequence (258). A 15-member peptide (43) representing a short sequence 
from the recognition motif of EL-4 was reported to bind strongly to Stat-6 (259). A 
competitive binding assay had been developed by Mrs. D. Head at Novartis using surface 
plasmon resonance (SPR) (260). The system employs the peptide 43 immobilised on a 
gold-coated silica chip. Stat-6 is incubated with potential competitor ligands and then 
passed over the immobilised peptide as a pulse of sample under continuous flow 
conditions. Protein remaining unbound by the candidate ligands is free to bind with the 
immobilised peptide. The binding changes the effective molecular weight of the 
molecules on the chip, which is detected as a difference in the angle of polarised light 
reflected from the chip surface. Kinetic information is derived from the rate of decay of 
the signal as the sample is washed away by fresh buffer. We believed that the 
combination of a high affinity natural ligand interaction, the specificity afforded by the 
requirement for phospho-tyrosine, and the uncluttered nature of the assay would provide 
an improved environment in which to assess the usefulness of a variable ring-size 
mixture library approach. The very local nature of the other residues required for binding 
also suggested the interaction could possibly be preserved in molecules smaller than 43.
6.2 Synthesis of Stat-6 Ligand Peptide 43
A natural ligand for Stat-6 was reported to be the N-terminal section of IL-4, comprising 
the sequence ASSGEEGY(P03H2)KPFQDLI. The peptide was synthesised using the 
standard methods. Fmoc-tyrosine(P03H2) was used without side-chain protection to 
generate the phosphorylated peptide after the method of Ottinger et al. (261). The peptide 
was characterised by negative ion mass spectrometry and HPLC, with no impurities
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visible at greater than 1% by UV2 2 0  . The peptide was tested in the SPR assay and found 
to have a dissociation equilibrium constant ( K d )  of 1 pM.
6.3 Design of Library 4
Literature reports of mutagenesis studies on the SH2 domains (262) suggested that the 
residues immediately subsequent to the phospho-tyrosine in the sequence were most 
important in binding to the indicated signal protein. The lysine at +1 is unique to ST AT 
proteins, while the Phe at +3 is in common with hydrophobic residues in other SH2 
substrates and is thought to occupy a second hydrophobic binding pocket (263). The 
specificities were confirmed by Songyang et al. (264) with combinatorial amino acid 
replacement approach. Based upon the information available, a combinatorial library was 
designed in order to present a variety of small constrained peptides, all containing 
phospho-tyrosine. At residue positions either side, the protocol offered a choice of either 
the naturally occurring residue for the position, or an unnatural amino acid, or a deletion. 
The unnatural residues were from commercial sources which existed within our 
compound collection. As in the previous Library 3, N and C terminal cysteines were 
added to permit cyclisation of the library via on-resin oxidation. The library was an 
attempt to jump from partially known protein structure requirements to low molecular 
weight unnatural peptides with novel sidechain functionality. Figure 6.01.
Fig. 6.01 Library 4 Schematic
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Library 4 was intended as a conventional split and mix library to include the essential
phospho-tyrosine residue and a further bias toward known residue requirements of the
Stat-6 protein. Variable ring size was included as before by omission possibilities at two
steps, resulting in a library of cyclic peptides between 5 and 7 residues, though some of
the unnatural constituents exhibited NH->CO spans greater than that found in a-amino
acids. The skip step also results in variation of the position at which the tyrosine appears
in the sequence; i.e. it could be residue number 3 or 4 in a 6 residue peptide Figure 6.02.
Fig. 6.02 Binary synthesis option at 
coupling steps 1 and 5 produced the effect 
of shifting the phospho-tyrosine along the 
sequence in some members
PO,H2
Fig. 6.03 Residue Choices at Coupling Steps of Library 4
Coupling step:
6 5 4 3 2 1 0
Fmoc amino acids coupled :
Cys(Trt) a,p,S,K,p,cj, A,B,C or Tyr(P03H2) 1,2,3,4,5, 1,2,3,4,5 or Cys(Trt)
2or no Gly or no
coupling Lys(Boc) coupling
Variation at step:
8 4 1 6 6 1
Peptides at completion of step:
8x144 144 36 36 6 1
Figure 6.04 Reagents used in Library 4
Positions 1 and 2 provided a selection of lipophilic side chain amino acids, while the 
omission step and inclusion of p-alanine afforded the possibility of a variable inclusion 
and spacing of these from the tyrosine. The native lysine was included adjacent to the 
tyrosine. Phospho-tyrosine was present in all library members by coupling to the total 
mixture after coupling layer 3. The phospho-tyrosine was followed by a choice of either 
the native Gly or some artificial turn mimics.
160
Results 6  -  SH2 Directed Library
Fig. 6.04 Reagents Used in Library 4
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The final division of the library into eight portions permitted the inclusion of a broad set 
o f residues, including acid, basic, heterocyclic and aromatic sidechains or an omission 
step, resulting in 8 sub-libraries of 144 compounds in each. All sub-libraries were capped 
with Cys(Trt) to allow on-resin cyclisation in the manner of L ibrary 3.
6.4 Synthesis of L ibrary 4
The synthesis was performed by hand on the manifold apparatus using 3.00g (1.65mmol) 
o f Wang polystyrene resin pre-loaded with Fmoc Cys(Trt). Conventional Fmoc chemistry 
was used as before with TBTU activation in the presence of HOBT and 4-6 equivalents of 
amino acid. Deconvolution samples of around lOOmg were saved from each step, and 
small analytical portions of the resin were saved for future scrutiny. Final resin portions 
from the 8 sub-libraries weighed 180mg +/-5mg, very close to the mass estimated by the 
calculator program. 150mg from each portion was exposed to lOeq. iodine for 2 hours in 
DMF. After repeated washing until the supernatant appeared clear of iodine colouration, 
both the cyclic and linear resin portions were cleaved from the resin using 90% TFA (aq.) 
for 3 hours. After lyophilisation, the cyclic sub-libraries yielded 50mg +/- lOmg product 
(79% yield +/-15%, at an average molecular weight of 800Da). Linear versions of the 
sub-libraries yielded 2.5-5mg (20-40%). The libraries were dissolved to lOmg/ml in 
DMSO and diluted with water to 500pM for assay by competitive binding under the SPR 
assay.
6.5 Analysis of Library 4
Bromophenol blue dye (119) was used to ascertain coupling success by disappearance of 
of blue colouration after coupling N-protected residues, though residues 4, p, and B 
would be expected to give a negative response anyway as they lack a primary amine on 
loss of Fmoc. As for previous libraries, flow - injection MS was used to analyse small 
mixtures (up to 36 compounds), then LC-MS was employed to hunt for expected mass
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ions by displaying the chromatogram as a function of each expected mass in turn, then 
selecting spectra from peak apex, Figure 6.09. Peptide samples were cleaved from ~5mg 
resin using 50pl 90%TFA (aq.) for 3 hours then methanol added (1ml descending to 
200pl as the number of expected compounds increased). After filtration through a
0.45pm membrane, the samples were injected directly onto a 3mm x 100mm column 
running a gradient of 0.5ml/min 10% - 95% methanol from lOmM ammonium acetate 
pH 4. Latterly, the solvent system was changed to 50%-95% over 8 min to effect greater 
separation of the relatively lipophilic library members Figures 6.10,11,12. The solvent 
front was switched to waste until k’ 0.6, and 4 second scans were collected from k’ 0.6 -
8. Eluent was simultaneously monitored by diode array detector between 200 - 400nm.
Fig. 6.05 Mixtures Sampled After Coupling Steps of Library 4 




















1 6 6 5 5 83
2 36 25 22 unresolved 88
3 36 25 23 66 92
4 144 80 24/30 66 80
5 144 80 23/30 66 77
After the first coupling one mass ion (340.1) was missing, Figure 6.06b, however it 
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Fig. 6.06a Sampling directly after the first coupling. Trityl cation is strongly evident 
in samples cleaved before on-resin oxidation.







Fig 6.06b Sampling after first mix and deprotection step. Unreacted Cys from the 
carried through binary synthesis portion is visible at m/z 121.9
165
Results 6 -  SH2 Directed Library
Analysis of the precursor molecules was complicated by the presence of trityl cation at 
m/z 243. The appearance of the ion when viewed as a single ion chromatogram paralleled 
some of the HPLC peaks, though was separate from the peptides in the mass spectrum. 
The results suggests that the Trt cation was transiently attached to some compounds as 
they travelled through the column. Interestingly, peptide samples removed prematurely 
from Library 3, also containing Trt protecting groups, showed the 243+ ion as a single 
chromatogram peak at the tail end of the gradient.
For the final sub-libraries, 30 expected mass ions from the total of 144 were searched for 
in each total mass chromatogram. The ions of m/z +2 corresponding to the uncyclised 
versions of the chosen set were also searched, though a reduced subset of 22 were 
searched in this case as for each group of 80 possible ions, 14 pairs of ions differ by 2Da
anyway.
Fig. 6.07 Final Cyclic Sub-libraries of Library 4, 80 different masses expected from 
144 compounds







% Confirmed Number of 
linear m/z +2 
found from set 
of 22
% Confirmed
a 27 90 8 36
J _ 28 93 3 14
5 25 83 1 5
K 26 87 0 0
P 27 90 2 9
a 26 87 4 18
2 24 80 5 23
zero 29 97 3 14
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Fig. 6.08 Mixture from second coupling layer, showing m/z 341 which was absent in 
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Fig. 6.09 Final sub-library Alpha, selected ion HPLC chromatogram of m/z 783.7, 
showing two resolved peaks - expecting 2 isobaric compounds. Extracted from the 
total ion chromatogram (bottom)
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6  c o m p o u n d s Trt
A . J
4  6  8  10
Fig. 6.10a HPLC 10%-95% MeOH in 8 rain monitoring at UV254. The relatively
lipophilic products are grouped at the latter end of the elution gradient
36 compounds
T97 10se4 s
Fig. 6.10b HPLC 50%-95% MeOH in 8 min monitoring at U V 254 . 36 compounds, 
wider spread of the peak set with a shallower gradient.
Final sublibrary Z - 
144 compounds
Fig. 6.10c HPLC 50%-95% MeOH in 8 min monitoring at U V 254 144 compounds
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Fig. 6.11 Rapid gradient LC-MS of final sub-library Alpha, the scan selected shows 
several mass ions from coeluting LC peaks. Of the 9 largest peaks shown, m/z 652 is 
unassigned, and 861.6 is attributed to a lack of resolution between 860.4 and 862.5.
9 0 2 .46
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7 6 0 . 4 0
6 8 9 . 5 0
Fig. 6.12a Single scan from shallow gradient LC-MS of final sub-library Beta, 
resolving 1/2 compounds (expecting 760.6)
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Fig. 6.12a Selecting a different single scan from LC-MS of final sub-library Beta, 
(expecting 847.55)
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The results suggest that some 90% of the intended products were present on average, and 
that the products were predominantly in the oxidised form. Separate experiments 
scanning at high molecular weights revealed no significant signals attributable to dimers.
6.6 Biological Assay of L ibrary 4
The sub-libraries (500jliM per sample) were incubated with recombinant Stat-6 (2.8pM) 
for 30min before flow injection over a SPR chip coated with peptide 43. Response was 
measured against that seen in the absence of competing library. No attenuation of normal 
binding of Stat-6 to the chip was demonstrated by any of the sub-libraries in either cyclic 
or linear form.
6.7 Conclusions from Library 4
That no inhibition of binding occurred under the SPR assay conditions despite each sub- 
library member being present in a theoretical excess of 1.2 fold w.r.t. the protein indicates 
that no ligand exists within the library of comparable affinity to that of peptide 43. It is 
most notable compared to our other efforts to date that no non-specific inhibition of the 
protein binding was observed. It would appear that the SPR assay is as hoped resistant to 
the bulk mixture effects seen with the previous ELISA assays. The feature may be a 
consequence of only one protein binding event required as opposed to a multiple 
component “sandwich” needed for the ELISA, or that the flow conditions quickly remove 
any weakly binding ligands allowing the native interaction to prevail.
The lack of any activity was initially regarded as odd since any phospho-tyrosine 
containing peptide was anticipated to offer some binding affinity. Suspicion fell upon the 
solubility of the libraries, since a high proportion of the residues used featured 
hydrophobic side chains. Inspection of the post-assay solutions indicated some 
precipitation. The samples were filtered through 0.45pm membrane and re-analysed by 
LC-MS. The majority (90%) of the ions found in the first analysis were still present.
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Since the majority of the library appears to have been in solution for assay, a ligand of 
reasonably high affinity existed for positive control, and that the assay appears immune 
from non-specific effects the reluctant conclusion has to be that there were no active 
molecules present in the library.
The lack of activity may be attributable to the small size of the library members, as recent 
work by ourselves and others (265) indicate that the minimum active sequence for 
peptides based upon peptide 43 is 8 residues (Kd 2.1pM) all of which are C-terminal to 
the phospho-tyrosine. No smaller or cyclic peptides have been reported. Other workers 
have adopted a similar combinatorial approach to discover ligands for the SH2 proteins. 
Muller et al. (93) describe a 9 residue combinatorial library of 6.4x105 peptides, as 
opposed to our 1.15x10 where phosphotyrosine is featured as a constant residue and 
selected positions are varied with only a few different residues to bias toward the known 
preferred residue types. On-bead fluorescence assay was performed, and pool sequencing 
used to determine most-preferred residues. Single sequences were designed from the data 
and synthesised singly. Tantalisingly, the epitope discovered has only 5 residues, well 
within the size range of our library, but no investigation is made as to whether the 
additional 4 residues can be deleted completely. It would appear from the result that our 
library features a membership of too small molecules or molecules insufficiently diverse 
to present the correct functionality. The constraint of the peptides into rings has no 
precedent in SH2 binding work and further reduces the conformational diversity 
compared to Muller and Songyang’s linear peptide approach. The benefit of 
conformational constraint against the risk posed by potentially denying the peptides 
access to the correct conformation has already been discussed. At the last coupling step of 
Library 4, the resin was divided into double the number of portions of previous division 
steps, allowing a greater number of compounds to be achieved without increasing the
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number of compounds per sub-library. The feature is an improvement over the rather 
limited division protocol of Library 3. The wide final division also permitted the 
coupling of a broad range of amino acids covering acid, base, lipophilic sidechains and 
turn mimics, much along the lines of the representative residue approach of Lowe et al. 
(29).
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7. Mass Spectrometry as a Library Screening Tool
7.1 Aims
Throughout the previous library syntheses, a key difficulty has been the absence of 
consistent evidence from biological assay that any single compound or subset of the 
designed ligand family was actually binding to the protein target in a specific functional 
manner. The difficulty is perhaps inherent in attempting to derive the identity of a single 
active molecule from the bulk behaviour of a group of molecules. The concept has been 
much discussed and while recursive deconvolution has been validated under some 
circumstances (143) the problem has given rise to a variety of systems to avoid 
deconvolution using indexed (145) or orthogonal systems (144). Similarly, sublibrary kits 
(85), representative libraries (29) and divide-only protocols (266, 267) are all essentially 
strategies for avoiding the need to deconvolute in one step from large-population 
libraries. The deconvolution challenge is a significant reason for the widespread adoption 
of single compound rather mixture generating technology in recent times.
At this stage in the work, we concluded that for mixture approaches to succeed, an assay 
system was required which could in some way isolate or otherwise differentiate protein 
binding ligands from a mixture of inactive compounds or from weak non-specific binding 
effects, as opposed to observing the bulk effect of a whole mixture. On-bead assay 
protocols conform to the requirement, however the proximity of the polymer may distort 
the performance of ligands especially when intended for protein surface binding. We 
supposed that if a protein target is present in solution with many different candidate 
ligands, one of which has a strong affinity for the protein, then the predominant state is 
likely to be the ligand in a bound state with the target, whilst the others remain in free 
solution, or transiently attached to the protein by non-specific interactions. In these 
circumstances, one clear differential between the active ligand and it’s passive neighbours
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is the huge difference in molecular weight created by the attachment of the protein. 
Figure 7.00
Fig. 7.00 Molecular mass of a ligand/protein complex is 1 or 2 orders of magnitude 
greater than unbound ligands
The phenomenon is essentially that which is exploited by the Biacore assay (Chapter 6), 
though the SPR principle can only detect the change in molecular size occurring over 
time rather than quantify it. Three distinct approaches have been reported for exploiting 
size difference to screen pools of potential ligands.
One system uses a physical size separation of the target/ligand complex before 
dissociation of the selected ligands from the complex and identification by MS analysis. 
Gel filtration chromatography (150) and ultrafiltration membranes (149) have been used 
for the separation system.
Alternatively, direct mass-spectroscopic visualisation of protein/ligand complexes from 
mixture libraries has been reported. Loo et al. explored the selectivity of SH2 protein 
(13kDa) for a set of 10 example ligands, where observed mass ion abundance of the 
complexes compared well with known relative binding affinities (152).
Another selective assay technique for mixture libraries involves the anchoring of the 
protein target to polymer beads and selecting the active ligands after incubation with a 
library by exposing the beads (perhaps in a flow-through column) to progressively 
denaturing conditions which dissociate the ligands in reverse order of binding strength
M +m
□
»  l o i
9 9 9
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(147). The latter technique of affinity chromatography can perhaps be viewed as an 
augmented size separation, where addition of a bead permits mechanical separation.
In all the above procedures, LC-MS has been applied in the identification of the selected 
ligands.
After the frustrating ambiguities of previous assay systems, we were anxious to visualise 
the protein/ligand complex directly. Whilst other workers have used high resolution FT- 
MS to investigate protein/ligand complexes, we explored the utility of recent 
improvements in benchtop MS for a library screening system.
7.2 Experimental Plan
It was decided to approach the task in the following manner:
1. Obtain clear mass spectra of the target proteins Stat-6 and Factor FVIIa.
2. Replicate the MS spectra under solvent conditions known to preserve the biochemical 
function of the proteins in vitro.
3. Introduce a known peptide binding ligand to the protein targets and differentiate the 
MS signal due to the bound peptide/protein complex.
4. Demonstrate that the interaction observed is specific functional binding by competition 
experiments with known inactive peptides or non-functional protein targets.
4. Expose the protein target to a mixture combinatorial library and identify by mass 
difference any binding ligands.
7.3 Mass Spectrometry of Proteins
The protein targets used for the work were commercially produced recombinant Factor 
FVIIa, and recombinant Stat-6, produced in-house by Dr. C. Jones. Both proteins were in 
extremely short supply at the time of the work, so more readily available proteins were 
used to develop methods. Thrombin (36kDa) and bovine trypsin (23kDa) were chosen as 
close relatives to FVIIa (49kDa), while bovine serum albumin (BSA) (67kDa) was
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selected as a protein closer to the size of Stat-6 (95 kDa). Horse heart myoglobin (17kDa) 
was also studied as the protein with which we were most familiar under MS conditions. 
All proteins were obtained in the highest available commercial grade from Sigma 
Chemicals.
7.3.1 Thrombin Analysis
Thrombin was initially selected as a model system because the enzyme had been the 
subject of a previous drug design project and inhibitors were available including 
antibodies, peptides, low molecular weight drugs, irreversible inhibitors and even a non­
peptide combinatorial library. Thrombin was dissolved in water (1 mg/ml) and infused 
into the ESI source of the mass spectrometer at lOpl/min. Despite variation of all 
fundamental tuning parameters, only a raised ion background was observed. When 
thrombin in 50% methanol (aq.) (1 mg/ml) was analysed, an indistinct hump of signals 
resulted between m/z 700 and 2100. A similar result was obtained from 1% formic acid 
(aq.) Close examination of the signals revealed a regularly spaced repeating pattern of 
signals, with intervals of A m/z 23 and 58 and were attributed to sodium and sodium 
chloride clusters. The presence of the stated amount of protein was confirmed by Biorad™ 
assay against a BSA standard curve (268). The poor quality spectrum was judged to be a 
result of salt adduction and concomitant ion suppression. The supplied thrombin was 
quoted as 60% NaCl by weight, and included some detergent. lOOpl thrombin solution 
(2mg/ml) was applied to a commercial gel filtration cartridge pre-washed with 3 x 1ml 
lOmM ammonium acetate (Biorad Biospin P-6, 6kDa m.w. cut-off) and spun in a 
centrifuge (4min x lOOOg) until lOOpl, the quoted exclusion volume, was collected. MS 
analysis of the resulting solution was very similar to the original. The void volume was 
confirmed experimentally by the use of a small-molecule dye at varying spin times. An 
alternative desalting technique was employed, using dialysis cassettes (Pierce Slidealyzer,
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cut-off lOkDa.). After dialysis of 0.5ml of 3mg/ml thrombin against 21 of water for 2 
days, the sample was diluted with an equal volume of methanol and MS analysis 
performed. After infusing for 5 min at 2pl/min a few distinct signals were resolved above 
the general signal background, which when reconstructed gave 36.5kDa, Figure 7.01.
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Fig. 7.01 ESI-MS of thrombin after dialysis and long acquisition at low flowrate, 
showing some evidence of the anticipated m/z envelope
An alternative analysis method was sought to determine the integrity of the thrombin 
sample and identify the cause of the signal multiplicity. HPLC of the sample over a 
water/methanol gradient buffered with lOmM ammonium acetate pH 6 gave no peaks at 
all with several commonly used reverse-phase columns. Assuming the protein was being
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mechanically trapped in or excluded by the packing, 300A pore columns were tried which 
gave very poorly resolved signals. Eventually 300A Vydac columns run over a gradient of 
water/acetonitrile with 0.2% TFA gave a resolution of some 8 peaks, Figure 7.02.
Fig. 7.02 Gradient HPLC of 
thrombin after dialysis against 
ammonium acetate lOmM pH 6.9. 
Resolution of the 6-8 peaks visible 
was only possible using Vydac C18 
300A packing and TFA containing 
solvent.
2 6 to4
It was concluded that the thrombin as supplied was a heterogeneous protein which, on 
electrospray analysis produced such a complex spectrum of overlapping multi-charged 
species that it could not be used to demonstrate ligand binding. Thrombin was abandoned 
as a model system, though the experiments contributed the useful information that the 
envisaged screening system would only be practical with a high quality homogeneous 
protein, or at least one without significant impurities of closely related mass.
7.3.2 Analysis of Myoglobin, BSA and Trypsin
The above proteins were dissolved in water, then acetonitrile added to give 20pmol/pl in 
50% acetonitrile (aq.). The samples gave clear mass spectra which when reconstructed 
gave mass values close to those expected.
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ESI-MS Spectra of proteins in 50% methanol (aq.)








Myoglobin 848-1885 (998) 20-9(17) 16,954 16,952
BSA 1291-2780(1850) 52-23 (36) 66,590 67k
Trypsin 1167-2329(1792) 20-10(13) 23,286 22,722
When analysed from aqueous solution, similar quality spectra were obtained, but 
generally mass envelopes shifted to higher mass, having attracted fewer charges. Addition 
of 1% formic acid reverted the spectra to that obtained in organic solvent. Spectra in 
lOmM ammonium acetate pH 6.9 were slightly superior to those in aqueous solution,
with a similar level of protonation.
ESI-MS Protein spectra in lOmM ammonium acetate pH 6.8
Protein m/z range of envelope 
(largest peak)
Charges Reconstructed mass
Myoglobin 1061-2438 19-7 17,013
and
1463-2513 12-7 17,550
BSA 1298-2785 (1852) 52-23 (36) 66,616
Trypsin 1677-2918(2337) 14-6(10) 23,358
It seems likely that the addition of organic solvent or acid to the proteins causes 
disruption of folding structure, allowing greater solvent access to the surface of the 
protein and results in the higher degree of charging. In the case of myoglobin, two mass 
envelopes were seen concurrently, attributed to folded and unfolded (solvent accessible) 
states. Trypsin additionally showed a smaller impurity (reconstructed mass 17,913) when 
run in aqueous buffer. BSA was unaffected by the solvent environment, though the degree 
of charging is significantly higher than other proteins even in buffer, suggesting an 
inherently more solvent accessible structure. The conclusion is consistent with the 
experimental observation that weak acid or organic solvent denatures proteins. It is
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noticeable that a certain amount of salt adduction is apparent in the aqueous buffered 
spectra, raising the nominal reconstructed mass value, Figure 7.03.
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Fig. 7.03 ESI of Trypsin in 50% aqueous methanol/1 % formic acid (top) and in 
lOmM ammonium acetate pH 6.9. The buffered spectrum shows a lower degree of 
charging and slightly raised m/z values from salt adduction.
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Addition of an equal mass of NaCl rendered the spectra a morass of low-intensity peaks, 
exhibiting A m/z 23 and 58 salt clustering. It became clear at this stage that mass spectra 
of the proteins would not be obtained from solutions in usual assay buffer media, which 
consists of 20mM salt, Tris buffer and detergent. It was proposed to subject the target 
proteins to desalting conditions to remove these low molecular weight contaminants, and 
replace the pH and ionic strength conditions using volatile buffer.
7.4 Desalting and Buffer Substitution
A number of techniques for the removal of salt and small molecule contaminants were 
investigated for efficiency of salt removal and mass recovery. Salt removal was assessed 
by recovery of MS signal quality against a salt-free standard. Mass recovery was assessed 
by HPLC and spectrophotometric assay as described against an untreated sample. 
Samples of myoglobin, BSA and trypsin at 2mg/ml in water spiked with 4mg/ml NaCl 
were used in the experiments.
7.4.1 Gel Filtration Centrifuge Columns
The columns were thoroughly washed by re-suspending the packing in 1 OmM ammonium 
acetate (x 4) and spinning. lOOpl samples of the proteins were processed, collecting 
lOOpl of eluent which was diluted with an equal volume of methanol before MS analysis.
Protein MS Signal quality % Recovery
Myoglobin unaffected by salt 42
BSA salt effects apparent 85
Trypsin salt effects apparent 75
The size exclusion chromatography resulted in good recovery of the proteins, though 
somewhat reduced in the case of myoglobin where the molecular weight of 17kDa is 
closest to the nominal molecular weight cut-off of 6kDa. The remaining salt apparent 
could be due to salt from the column packing remaining after washing, from carry
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through with the protein, or diffusion into the slurry after sample loading. Collecting only 
the first 30pl of eluent immediately after sample loading still resulted in salted products.
7.4.2 Dialysis Cassettes
Dialysis cassettes were used as previously described, suspended in a gently stirred 
solution of 21 lOmM ammonium acetate, for periods varying from 1 to 6 days. More than 
1 day exposure was found to be unnecessary.
Protein MS Signal quality % Recovery
Myoglobin unaffected by salt 70
BSA desalting complete 90
Trypsin desalting complete, though spectrum 
complicated with additional signals at 500- 
1200 Da.
57, with further time 
dependent loss
The rapid loss of trypsin sample was assumed to be autodegradation, since an undialysed 
control sample exhibited similar spectra.
7.4.3 Floating Membrane Dialysis (269)
The filters were balanced on the surface of distilled water, and 50pl samples of trypsin 
solution carefully placed on top. After 1 hour, the size of the meniscus had noticeably 
increased, and the samples were assessed by MS and HPLC. Although salt removal 
appeared efficient, the sample volumes handled were deemed to small for the required 
application and the method prone to accidental sample loss.
7.4.4 Ultrafiltration Centrifuge Tubes
Ultrafiltration centrifuge tubes with 3kDa molecular weight cut-off were loaded with 
200pl of protein solution, and spun for 12 min at lOOOg leaving approximately 30pl 
remaining volume. 170 pi ammonium acetate solution was added, the tube agitated for a 
few seconds, and the solution spun once again to the smaller volume. The process was 
repeated for a total of 3 spins before analysing by MS and HPLC.
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Protein MS Signal quality % Recovery
Myoglobin unaffected by salt 65
BSA desalting complete 80
Trypsin desalting complete 74, some degradation evident
More than 3 spins resulted in considerable sample loss, presumably through adherence to 
the membrane.
7.4.5 Summary of Desalting Techniques
The persistence of salt in the size-exclusion experiments remained a puzzle, though the 
technique gave fast reliable recovery. Dialysis proved efficient and reliable, but time 
consuming and hence unsuitable for unstable proteins. Hydrophobic membrane dialysis 
was evidently a small-scale technique for those more dextrous than the author. 
Membrane separation was a very convenient and robust method though the requirement 
for repeated re-dilution to remove enough of the salt was tiresome, and, like the dialysis, 
would preclude the method for desalting pre-formed complexes.
7.5 MS Analysis of Stat - 6
500pl of Stat 6 protein solution at approx. 2.3 mg/ml (Biorad assay) in storage buffer 
(20mM NaCl, K2HPO4 buffer, 1% Tween 20) was dialysed for 20 hours against lOmM 
ammonium acetate, pH 6.9. The sample was diluted to 1ml using the ammonium acetate, 
and concentration measured as 1.2 mg/ml (12.6 pmol/pl). The sample was infused into 
the ESI source at 4pl/min using a syringe pump. No signals representing an ion envelope 
were observed. A 50pl sample was diluted with an equal volume of methanol/2% formic 
acid, and the new sample infused into the spectrometer. Several faint signals were 
observed between m/z 2400 and 3000, the limit of the spectrometer range. It was 
presumed that in common with the example proteins, Stat-6 protonated more readily 
when unfolded in organic solvent/acid, and showed some signals, attributed to the
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extreme low end of the mass envelope, just below m/z 3000. In the buffered aqueous 
media, the ion envelope was apparently entirely outside the mass range of the instrument. 
An ESI-MS instrument of higher m/z range was required. Access to a prototype 
electrospray instrument with a time-of flight mass analyser was kindly provided by Dr. S. 
Jarvis, Micromass UK, and a sample dialysed against ammonium acetate as above was 
infused into the ESI source at 2pl/min and scanned over m/z 3000-7000. A clear ion 
envelope was evident, which reconstructed to a mass of 94,119 +/- 17 Da (expected 
94,957 Da). A second envelope indicated a dimer of the protein (found 186,115 Da) 
Figure 7.04, an observation which confirmed previous electrophoresis experiments.
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Fig. 7.04 ESI-TOF mass spectra of Stat-6 dialysed against ammonium acetate pH6.9
7.6 Stat-6 / Peptide 43 Complex Analysis
Dialysed Stat-6 protein solution from the experiment above was mixed with peptide 43 in 
a molar ratio of 1:1 and 1:10. The samples were applied to the ESI-TOF analyser as
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previously. The sample containing 1 equivalent of peptide showed clear signals, while 
the 1:10 example gave a weak indistinct spectrum, at a lower average m/z, indicating salt 
adduction and unfolding. At 1:1 peptide:protein, four m/z series envelopes were clearly 
visible, Figure 7.05.









1 4,962(19) 15 94,120 Stat-6 monomer
2 4,801 (20) 100 95,824 Stat-6 plus 1 bound 
peptide 43
3 4,879 (20) 35 97,587 Stat-6 plus 2 bound 
peptide 43
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Figure 7.05 ESI-TOF of Stat-6 with 1 equivalent of peptide 43.
186









Figure 7.06 Comparative spectra of 
Stat-6 with and without (top) peptide 
43 clearly showing shift of m/z signals 
on peptide binding. Signals due to 1 
and 2 bound peptides are visible
I n  i
A high proportion of the protein was observed in the peptide-bound state, despite the 
modest amount of the ligand present. A majority signal with an average shift of 1704 Da 
was attributed to the addition of peptide. The signal due to unbound peptide was still 
strong however, when low mass ranges were viewed. The experiment established that a 
binding event between Stat-6 and peptide 43 could be preserved and observed in the gas 
phase of the electrospray ion analyser. The failed spectrum of the sample containing
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tenfold excess peptide resembled that of a salt-contaminated protein, the source of the 
contamination likely to be the added peptide. The signals due to the dimer are 
complicated by the underlying monomer peaks, and broadened by sodium adduction, but 
no peptide appears to be bound to the dimer. Having established binding of the Stat-6 
protein and peptide 43, a second experiment was devised to investigate the specificity of 
the interaction.
7.7 Competition Studies with Stat-6 Binding
Another peptide, 44 Biotin-ASSGEEGYKPFQDLI (m.w. 1867 Da) became available 
from external sources, and is a biotinylated, non-phosphorylated version of peptide 43. 
To the sample containing Stat-6 plus peptide 43 1:1, was added an equivalent of peptide 













Fig. 7.07 ESI-TOF mass spectrum of Stat-6 + peptide 43 + peptide 44
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The spectrum is of considerably poorer quality than the previous example, perhaps a 
reflection of degradation during the considerable interval between the two experiments. 
The entire mass envelope occurs at a lower average value (4.1 kDa) than the previous 
results (4.8 kDa), indicative of lower pH or unfolding. Two partly overlapping ion series 
are evident, the most distinct of which occurs toward the lower mass end of the range
(3677, 3769 .... ) and is representative of 94,200 Da, very close to the value originally
obtained for the uncomplexed protein. Toward the higher mass side of the spectrum there 
is evidence of the ion series identified previously as the Stat-6 protein with one associated 
peptide 43. The ion 4571 is plainly visible as part of that series.
The result is consistent with some denaturation of the protein after the interval described, 
yielding signals from partly unfolded, non-functional Stat-6 at comparatively low m/z 
(high protonation) values which has no peptide associated. Functional protein with 
peptide attached appears at similar protonation range to the original experiment. The 
spectrum is thus the partial overlap of signals due to higher z values from denatured 
protein and lower z values from functional protein+ligand.
At the charge value of z = 18, the difference in signals from protein with peptide 43 or 44 
would be only 8.2 Da. Whilst the measurement of the differential is within the accuracy 
capability of the instrument, the interval between the experiments and the different quality 
of the signals means that it is not possible to judge with certainty whether the observed 
signals were from either or both peptides, though the value attributed to + peptide 43 is 
within 0.6 Da of the original value.
The original aim of the experiment was to examine the specificity of the binding observed 
by comparison between a functional and non functional peptide, however the accidental 
part-denaturation of the protein has permitted an orthogonal comparison between peptide 
and functional/non-functional protein. The occurrence is some indication that the original
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binding observed was due to true functional interaction. Because of the serendipitous 
inclusion of two forms of the protein, the conclusion could be made without having to 
differentiate very similar signals between the two peptides. The results could be 
confirmed in a more controlled manner by mixing peptides 43 and 44 with patent and 
heat-shocked protein in various combinations. Titration experiments to indicate a 
particular stoichiometry could also indicate specificity rather than hydrophobic 
association.
Parallel experiments with FVIIa were abandoned due to the heterogeneous nature of the 
protein.
7.8 Physical Separation by Size of Protein/Ligand Complexes and Subsequent LC- 
MS Quantitation of ligands.
It became clear at this stage that although direct mass analysis could prove useful in the 
identification of ligands of Stat-6, the size of the protein meant that the method was 
beyond the reach of our own mass spectrometer. It was decided to adapt one of the 
desalting techniques to effect a size-dependent separation on a protein/ligand mixture in 
solution, and then use to MS to identify the ligand after dissociation. The approach has 
been described by other workers as outlined above. The method has the added advantage 
of allowing the incubation to be performed in metallic buffers and solubilising agents in 
which the protein was already known to be functional. The dissociation step of any 
complex by HPLC prior to MS analysis was expected to simultaneously desalt the ligand, 
and divert the undesired components to waste.
A solution (120jul) of Stat-6 protein (0.1 mg/ml, 0.1 nmol) in storage buffer was 
incubated for 30 min with a mixture of 1 equivalent of each of peptides 43 and 44 
(200ng). The solution was applied to an ultrafiltration centrifuge cartridge as previously 
detailed and spun until 90pl (assessed by weight) was collected. To the remaining sample
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above the membrane methanol (60pl) was added, the mixture agitated and the membrane 
again spun dry.
Measurement of the peptides was performed using integral values from gradient LC-MS. 
Single ion monitoring was set analysing simultaneously at the values for the doubly- 
charged ions of peptides 43 and 44. Initial work at pH 6 and 3 yielded very poor peak 
shape. 0.2% formic acid in the running solvent gave improved peak shape, but ionisation 
of peptide 43 was very poor under these circumstances. The spectrum was further 
complicated by co-eluting peaks from the detergent in the protein buffer. Eventually, a 
method employing 10-60% ammonium acetate pH 8 / methanol at 0.5 ml/min through a 
Hypersil Elite column, split 5:1 and detecting using doubly charged negative ions was 
found satisfactory, and a calibration curve from 2-300 ng was produced using the stock 
mixture solution..
Excluded and retained components from the membrane experiments were quantified.
Fig. 7.08 Quantitative results from ultrafiltration separation of unbound ligands 













% Retained by 
binding
43 128 43 171 43 50%
44 115 93 208 52 30%
* The amount expected to be left based on starting concentration and residual volume 
over the membrane.
The theoretical quantity of each peptide was 200ng. The results show that considerably 
more of both peptides was retained over the membrane than would be expected from the 
residual volume. Further, some selectivity of the phosphorylated peptide 43 was evident. 
However, non specific interactions with either protein or membrane are sufficiently large
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to render the system unusable for binding affinities in the range between peptides 43 and 
44, which represent the extremities of activity in solution assay.
A similar experiment was performed using an incubation mixture consisting of 10-fold 
excess of each peptide, but effecting the separation with centrifuge gel filtration columns 
as previously applied for desalting. No peptide was detected in the exclusion volume of 
the column. It appears that either the affinity of peptide 43 was insufficient to preserve a 
significant amount of binding in the absence of an equilibrium pool of the peptide, or 
the peptides bound to the column.. The gel method differs from the membrane separation 
in that the concentration of the surrounding ligands reduces as the separation proceeds. 
However, the experiment showed no carry through of non-specifically bound peptide (44) 
and as such the method would perhaps be suitable for the extraction of any very high 
affinity ligands from a mixture. Availability of a wider range of ligand affinities would 
allow a threshold value for selection to be deduced.
7.9 Conclusions
On Whole Complex Visualisation: It is evident from our work and from recent literature 
examples that the method of MS visualisation of complexes can be used under restricted 
circumstances to show specific binding of ligands to target proteins. We were not able to 
directly screen our synthetic peptide libraries against the chosen target proteins due to 
poor quality protein in the case of Factor FVIIa, and insufficient instrument access in the 
case of Stat-6. The method offers the ability to quickly observe binding specificity and 
stoichiometry of a ligand directly from the incubation solution without the need to 
develop antibodies or other biological assay tools. The results are generated directly from 
a simple solution and do not suffer the influence of surface anchoring or antibody 
“sandwiches” found in other assay systems. Useful characterisation of Stat-6 was also 
provided by the ESI-TOF experiments. It is clear from these experiments that the
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technique suffers from a number of serious drawbacks as a routine screening technique. 
Complexes cannot be shown under electrospray conditions in the presence of metal-salt 
buffers commonly used for their production and function in vitro. The exchange with 
volatile buffer allowed the visualisation of the Stat-6/peptide 43 complex, but the 
function of the protein in vitro under these conditions was not confirmed by alternative 
means. The need to exclude metal ions may preclude the use of the method for calcium- 
dependent interactions for example. To screen a mixture, the m/z signals of the parent 
protein must be resolved to a degree sufficient to differentiate small changes in mass due 
to the adherence of low molecular weight ligands, and the even smaller differences 
between library members. The requirement excludes all but predominantly single-product 
proteins analysed in high resolution instruments. The pH conditions suitable for 
functional binding of the protein result in only moderate protonation under ESI, which 
means that high mass range instruments only just becoming available are needed to 
analyse proteins over perhaps 50kDa. Finally, the method employs an analysis technique 
which is destructive of the complex, and thus rather consumptive of protein. Given that 
the primary utility of the method would be the ability to identify ligands in advance of the 
development of conventional assay tools, the excessive consumption of protein at such an 
early stage in a drug discovery project is undesirable. Recent reports of electrospray 
performed at nanolitre/min flowrates indicate a tolerance of metallic buffers. The feature, 
combined with the very low sample consumption of such a technique may offer the 
possibility of a facile screen at a very early stage in a lead identification project.
On Physical Separation Techniques: The high non-specific binding witnessed in the 
ultrafiltration experiment suggests the method would not be useful as an assay. The 
method would also probably be limited to sub-equimolar amounts of each potential ligand 
as selectivity was low and demonstrating altered populations in a mixture library in
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excess after such selection would be very difficult. In a recent paper, Zhao et al. (149) 
describe an on-line version of the system which did not appear to suffer the same effects, 
and a comment is even made as to the possible recycling of the protein.
The affinity of peptide 43 was inadequate to demonstrate affinity selection after gel 
filtration. The exchange rate of the peptide is known to be fast, and probably causes 
dissociation of the complex during the period of the chromatography (4 min). The same 
phenomenon is possibly responsible for the lack of non-specific binding, which in 
conjunction with the ability to use excess ligands would make the system the method of 
choice for extracting high affinity ligands from a mixture. A positive control in the form 
of an existing potent ligand would be essential.
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8. Final Conclusions and Further Work
8.1 Utility of the Present Work.
The work in Chapter 3 indicates that peptide cyclisation via the metal binding method 
used cannot be regarded as a general case, if at all. Later work by others reviewed in 
Chapter 2 supports that view. For all later libraries, conformational constraint was 
imposed via covalent bonds.
The synthesis and subsequent homogeneous biological activity of our first 19 x 19 
random peptide library parallels the difficulties cited in the literature of recent years of 
differentiating between the activity of large collections of candidate molecules using 
conventional solution assay. All later experiments concern methods to overcome the 
problem, either by focusing library membership to the target or by selecting actives out of 
the pool.
The design of library 1 represents an attempt to bias the membership using knowledge of 
protein structure. The attempt is in contrast to literature reports biasing libraries to known 
ligand structure. Also, the design represents the first attempt at making a presentation 
scaffold the primary source of diversity rather than the putative pharmacophores. The 
work is the first application of binary synthesis to achieve variable peptide ring sizes. 
L ibrary 2 was an improved version of library 1 where adjustments made to the split and 
mix protocol resulted in a greatly increased proportion of molecules which met the design 
specification. The observation of duplicate structures arising from different synthetic 
sequences upon cyclisation is a feature common to all head to tail cyclic libraries, and the 
aspect of the design 2 which overcomes it could have general utility (245). The use of D 
amino acids in library 2 adds considerable conformational diversity to the ring structures 
as described by Kessler et al (83).
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Library 3 is a library design to extract a small molecule representing the minimum 
functional elements of a large active peptide. An attempt to validate the approach by 
chromatographic extraction of the original active was frustrated by the inactivity of the 
original compound on re-test. Later work by Banner et al (273) shows the interaction of 
TF/FVIIa to be spread over a wide contact area and unlikely to be disrupted by small 
molecules, suggesting the original observed activity was artefactual.
The utility and limitations of LC-MS in the analysis of mixtures is illustrated, including 
a rapid method for the analysis of peptide mixtures after brief separation from acid 
cleavage products with accompanying improvement in signal/noise.
Library 4 uses some known elements of a known peptide ligand as in Library 3, but 
introduces new functionality of unnatural amino acids to escape the limited functional 
variation of Library 3. Binary synthesis was again applied, on this occasion to frameshift 
the crucial pharmacophore (phospho-tyrosine) within a combinatorially varied sequence. 
No active molecules were discovered, though the assay chosen appeared more tolerant of 
mixture candidates.
Finally, some methods for direct visualisation of ligand target complexes were explored, 
and include the first high resolution spectra of Stat-6 complexes. As an observation of an 
accident of the experiment, an alternative system of differentiating non-specific binding 
under such conditions is proposed. Some limitations of both MS and affinity selection 
systems are discussed.
8.2 Future Work
The metal ion co-ordination idea may still have a useful role if applied to the stabilisation 
of peptide rings (Chapter 3, conclusions).
The future of mixture combinatorial synthesis is likely to be confined to very diverse 
libraries since conventional assays lack the ability to differentiate similar activities.
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However, it may be profitable to approach the elucidation of actives in stages by applying 
some of the principles above to avoid duplicates and a high “background” of undesired 
molecules. The principles described could complement the Sublibrary Kit approach of 
Furka et al. (85) where information from random approaches could be fed into designs 
for smaller libraries. As above the libraries would explore orientation possibilities of 
chosen residues while leaving out extraneous sequences.
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9. Experimental
9.1 Instrumentation and General Techniques
9.1.1 Solvents and Reagents Solvents were obtained from Aldrich or Fluka, in 
anhydrous form for moisture sensitive applications. Anhydrous solvents were handled by 
cannulae under zero-grade nitrogen. Amino acids were obtained from Novabiochem, 
Bachem (Switzerland), or Neosystem. Mass spectroscopy standards were obtained from 
Sigma. Peptide coupling reagents were obtained from Senn Chemicals. Other chemicals 
and deuterated NMR solvents were obtained from Aldrich Chemicals. Purities were the 
highest commercially available, unless otherwise stated.
9.1.2 Laboratory Techniques Measurement of pH (or pD) was performed using an 
Orion 710A digital pH meter with a 5mm glass electrode (3mm for NMR samples), 
calibrated at two points. Melting points were determined using Gallenkamp apparatus and 
are uncorrected. Glassware for moisture sensitive applications was heated in an oven 
overnight at 110°C and cooled in a desiccator over silica gel. Solvents were evaporated in 
a Buchi rotary evaporator at below 40°C. Lyophilisation was achieved by freezing 
samples using a cardice/acetone bath and applying to a Christ freeze drier at - 
50°C/0.05bar absolute. Samples were as aqueous or /-butanol solutions, occasionally 
containing acetic acid or acetonitrile.
9.1.3 Spectroscopy
Nuclear Magnetic Resonance All NMR spectra were recorded on a Bruker ARX400 
400MHz Spectrometer by Dr. V. Alikhani; NOESY and variable temperature experiments 
were recorded at the University of Bath Dr. R. Kinsman using a Bruker 500MHz 
instrument. 5mm sample tubes were used with a sample volume of 0.6ml unless 
otherwise stated. Deuterated organic solvents containing 0.1% TMS as a reference were 
employed throughout. Spectra recorded in deuterated water were referenced to DSS or
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normalised to the water signal at 4.80 ppm. Chemical shifts are expressed as ppm from 
TMS. Multiple resonances are described in the tables as singlet(s), doublet(d), triplet(t), 
multiplet(m). Qualitative expressions employed are broadened (br). Shifts in signals due 
to chelation effects are compared to previous spectra and the difference in signals denoted 
Appm.
Circular Dichroism CD spectra were recorded by Dr. A. Drake at Birkbeck College. 
Mass Spectrometry Laser Desorption Time-of-Flight mass spectra were recorded by 
Mr. J. Keyte at the University of Nottingham on a Finnigan LaserMat instrument. ESI 
mass spectra were recorded using VG Trio 2000 or Micromass Platform instruments. 
Samples were prepared at 20 pmol/pl unless otherwise stated. Calibration was performed 
over the range 100-1500m/z using horse heart myoglobin (positive and negative mode) or 
a mixture of PEG 300,600,1000. Low sample cone potentials of 30-50 Volts were used to 
discourage compound fragmentation.
Ultra -Violet Spectroscopy Scanning UV spectra and static absorbency measurements 
for reaction monitoring were performed on a Pye Unicam PY880 UV/Visible instrument. 
10mm path length quartz cuvettes were used throughout.
Infra - Red Spectroscopy Scanning IR spectra were recorded on a Perkin Elmer 882 
instrument. Samples were dissolved in chloroform and introduced into a fluid cell. 
Latterly, samples were adsorbed by evaporation onto a PTFE film (3M Type 62). 
Polarimetry An Optical Activity Polaar 21 polarimeter with a path length of 1dm was 
regulated at 20°C.
9.1.4 Chromatography
High Performance Liquid Chromatography HPLC was performed on reverse phase on 
a Gilson Medical Instruments binary gradient system. Unless otherwise described, signals 
from UV detection at 220nm and 254nm were recorded and purities quoted by integration
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of the signal at 220nm. Early in the work, 20pl samples of 0.5mg/ml sample were 
manually injected via a Rheodyne 7125 injector. Later a Gilson model 231 autosampler 
was used to inject similar samples. Latterly, a Hewlett Packard 1100 gradient HPLC was 
employed using diode array detection.
Column:
a Spherisorb ODS2 lOp, 100A, 4.6 x 250mm 
b  Hyperpep C l8 lOp, 300A, 4.6 x 250mm 
c Spherisorb ODS2 5p, 100A, 3.2 x 150mm 
d Prodigy ODS3 5p, 100A, 4.6 x 150mm 
e Prodigy ODS3 5p, 100A, 2.0 x 100mm 
f  Hypersil Elite ODS 5p, 100A, 3.0 x 100mm 
g Spherisorb ODS2 lOp, 100A, 21.4 x 250mm 
h Prodigy ODS3 5p, 100A, 21.4 x 150mm 
i Vydack ODS 5p 300 A 4.6 x 150mm 
j Prodigy ODS3 5p, 100A, 2 x 50mm 
Flowrates:
21.4mm i.d. - lOml/min.
4.6mm i.d. - lml/min.
3.0, 3.2mm i.d. - 0.5ml/min.
2.0mm i.d. - 0.2ml/min.
Solvent systems:
I  Water (0.1%TFA) to acetonitrile (0.05%TFA) over 30 min.
I I  Water (0.1%TFA) to acetonitrile (0.05%TFA) over 20 min.
I I I  Water (0.1%TFA) to 50% acetonitrile (0.05%TFA) over 30 min.
IV  Water (0.1%TFA) to 50% acetonitrile (0.05%TFA) over 30 min
V  Water (0.1%TFA) to 40% acetonitrile (0.05%TFA) over 30 min.
V I Water/10%MeOH/10mM NH4AC pH6.0 to 95%MeOH in 8 min.
V II Water (0.1%TFA) to acetonitrile (0.05%TFA) over 12 min.
V III Water/10%MeOH/10mM NH4AC pH3.0 for 1 min, then straight to 100% methanol 
for 2 min.
Other systems as described in the text.
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Preparative HPLC Preparative reverse phase HPLC was used to purify all single 
synthetic peptides during the course of the work. A Gilson binary gradient system as 
described above was employed. Samples were loaded in l-2ml water or methanol, 
occasionally adding acetic acid for initial dissolution, followed by filtration through 
0.45pm membrane. Gradients beginning with between 0% and 40% methanol progressing 
linearly to 100% methanol over 1 hour were applied, collecting fractions in a Gilson 214 
autosampler at 0.5 minute intervals. After examination of the UV output, likely fractions 
were selected and a preliminary identification was made by ESI-MS. After analysis by 
gradient analytical HPLC as above, fractions of sufficient purity were recombined and 
lyophilised.
Thin Layer Chromatography Merck Kieselgel 60 F254 silica coated glass or 
aluminium plates (200-400 mesh) were spotted with the reaction mixtures and dried in 
vacuo. Compound presence was revealed using UV254nm, starch/KI/chlorine or ninhydrin 
in butanol with heating. TLC spots were investigated by mass spectroscopy. The 
appropriate area of a TLC plate was scraped free of silica, and the silica powder collected 
in a sample vial. The material was sonicated in solvent for 30 min, filtered through 0.2pm 
PTFE membrane and diluted tenfold before ESI-MS.
Flash Chromatography Flash chromatography was employed for the purification of 
protected amino acids, particularly during the solution phase synthesis of the 
chromogenic substrate. Merk Kieselgel silica (200-400 mesh) was packed into a glass 
column in a solvent slurry, and a bed of coarse silica applied to the top. Samples were 
loaded directly onto the column in a small volume of the running solvent or preabsorbed 
from a different solvent onto silica in vacuo. Elution was achieved by hand-bulb air 
pressure, while fractions were collected manually and monitored by TLC.
201
Experimental 9  —  General Techniques
Amino Acid Analysis (AAA) was performed on an LKB 4151 (Pharmacia) amino acid 
analyser using the proprietary system of ion exchange chromatography with post-column 
derivatisation using ninhydrin. Samples were dissolved to 1 mg/ml in concentrated HC1 
and sealed in glass ampoules. The samples were heated in an oven to 110°C for 20h, 
alongside a similarly treated sample of commercial amino acid mixture standard 
(Pharmacia). Amino acid residues were quantified against the external standard, assuming 
the oxidation of Asn to Asp, Gin to Glu. Total peptide content was estimated using the 
value from lysine determination.
Liquid Chrom atography - Mass Spectrometry (LC-MS) For the identification of 
products in a reaction mixture and the inspection of complex multi-component peptide 
libraries, a linked HPLC-MS system was devised. An HPLC as described above was 
fitted with a simple flow diverting device immediately subsequent to the UV detector 
flowcell. The splitting device consisted of a T-piece, which was arranged to divide the 
flow from the UV detector outlet to 1) PEEK tubing (0.0025” i.d.) to the mass 
spectrometer, and 2) a length of balancing tubing. The length and i.d. of the balance 
tubing was varied to offer sufficient back-pressure to the system to divert the desired 
proportion of the HPLC eluent into the mass spectrometer. Typically, 60-100pl/min of the 
eluent was directed into the mass spectrometer, giving a split flow ratio of between 10:1 
(4.6mm i.d. column) and 1:1 (2mm i.d. column). Compounds eluting from the HPLC 
column were recorded in series by the UV detector and the mass spectrometer. An 
appropriate time delay measured using a standard compound was used to tie HPLC 
elution times to the appearance of mass ions in the spectrometer. The MS recorded 
centroid data, scanning at 200 - 500 m/z/second. Ammonium acetate solvent systems 
were used with the LC-MS. A pneumatically driven valve system was designed to divert 
the column eluent to waste during wash periods and to avoid salt or TFA laden solvent
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fronts from entering the source. A similar procedure was adopted to preserve N2 drying 
gas.
9.1.5 Peptide Synthesis
Equipm ent All single peptides described below were synthesised on an Applied 
Biosystems (ABI) 430A automatic synthesiser using 0.25 mmol scale, with a four-fold 
excess of Fmoc-amino acids. HBTU/HOBT/DIEA (1:1:2 eq. w.r.t. amino acid) activation 
chemistry was used in NMP. The standard instrument was modified to add 20% DMSO 
to the reaction vessel during coupling. Dissolution times were extended by 50% (to 32 
min.) and coupling times by 30% (to 50min) over the standard ABI protocols 
(FASTMOC™). Arginine, leucine and isoleucine were routinely double-coupled. Wang 
polystyrene resin (p-benzyloxybenzyl alcohol, polystyrene/1% divinylbenzene, 100-200 
mesh, Novabiochem 01-64-0001) was loaded with the first amino acid using the 
proprietary DCC/DMAP protocol unless otherwise stated. Capping of unreacted resin 
was performed after loading of the first amino acid using 8 eq of benzoic 
anhydride/DMAP. N-terminal Fmoc deprotection was achieved using 20% piperidine in 
NMP (two exposures, 3min, 9min).
Cleavage of the peptides was achieved using 95% aqueous TFA at lOml/g peptide resin at 
room temperature. The addition of phenol (2.5%), thioanisole (2.5%), and 1,2- 
ethanedithiol (5%) was made if Trt or Pmc protecting groups were present. After 2.5 - 4h, 
the supernatant was removed, filtered through glass wool, and the crude peptide 
precipitated by dropping the liquor into chilled diethylether at lOml/ml acid liquor. The 
product was spun in a centrifuge to form a pellet, resuspended into ether by whirlimixing 
and the wash repeated six times in fresh ether. Products were lyophilised prior to 
preliminary characterisation and preparative HPLC.
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Final peptides were converted to hydrochloride salt form by passing through a small 
column of ion exchange resin (Dowex-chloride) and lyophilised, or lyophilised twice 
from a solution of IN HC1. Preparative HPLC was invariably performed.
Disulphide Formation To synthesise disulphide bridged cyclic peptides, peptides were 
synthesised as above, using cysteine with trityl protected thiol group. Trityl protection 
was removed during the standard cleavage conditions, liberating the free thiol. The 
peptides were kept at low pH during workup and purification, and stored at 0°C. Crude 
peptides were stored in the presence of trace dithiothreitol. Peptides for cyclisation were 
dissolved at 0.1-0.5mg/ml in water and pH corrected to 8.5 using dilute ammonia. The 
solutions were left to stand for several days, and the course of the oxidation monitored by 
HPLC and mass spectroscopy. Final products were obtained by the direct lyophilisation 
of the solution. Usually, preparative chromatography was repeated after oxidation. A 
spectrophotometric assay was performed to confirm the absence of free thiol.
Fmoc Protection of Amino-Acids (adapted from  Lapatsanis (243) The amino acid was 
stirred in 9% aqueous sodium carbonate, cooled in an ice bath. Fmoc-N-succinimide (1 
eq.) in DMF was added over 5 minutes. The mixture was allowed to stir at room 
temperature for 1 hour. Cold water added, and the resulting suspension acidified to pH 2 
with concentrated HC1. The suspension was extracted x 3 with ethyl acetate and the 
organic layer dried with anhydrous MgSC>4. The solvent was removed in vacuo and the 
product was recrystallised from hot ethyl acetate/hexane.
9.1.6 Chemical Assay
Thiol determination A proprietary chemical assay for free thiol was chosen, the Aldrich 
Chemicals Aldrithiol™ (2,2-dithiodipyridine) procedure (270). A known weight of 
peptide samples were dissolved at approximately 0.5 mg/ml in water. Aldrithiol™ was 
dissolved to ImM stock solution. A background UV absorbency at 343 nrn was recorded
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for both samples and stock reagent, diluted with an equal volume of water. Peptide 
samples were mixed with an equal volume of stock reagent and incubated at room 
temperature for 15 minutes. UV343 absorbency was recorded for the samples, and 
corrected for the background values. Quantity of free thiol present in the peptide samples 
was calculated from the appearance of 2-thiopyridone (8343 8.08 x 103M_1) and expressed 
as a percentage of the theoretical total peptide present, correcting for the number of 
cysteine residues per peptide.
Fmoc determination To assess the yield of the attachment of the first amino acid to the 
solid phase synthesis resin, a chemical determination was made of the liberated Fmoc 
protecting group (120). Approximately 4mg of Fmoc-amino acid resin was accurately 
weighed into sample tubes. The background UV absorbency of a 20% (v/v) solution of 
piperidine in NMP was recorded at 290nm. 2ml of the piperidine solution was added to 
the resin samples, and the tubes placed on a table shaker for 20min. 1ml of the resulting 
solution was removed using a pipette and filtered through a glass wool plug directly into a 
cuvette in the UV spectrometer. Absorbency at 290nm was used to quantify the released 
dibenzofulvene/piperidine adduct after correcting for no-resin background (8290 4.95 x 
103M ‘)
Amine determination To determine the success of amino acid coupling or head-to-tail 
amide cyclisation during manual peptide library synthesis, visual tests for the absence of 
primary amine groups was employed. Bromophenol blue (119): A few resin beads were 
removed from the reaction vessel and placed in a conical-bottom vial. A solution of 
bromophenol blue was added and the beads agitated for a few minutes. If any bright blue 
colouration was observed, the coupling was repeated. Ninhydrin determination: A 
proprietary (Applied Biosystems) Kaiser test (118) was used. A few resin beads were
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treated with the reagent solutions and the vials placed in an oven at 120°C for lOmin. If 
any purple colouration was observed, the coupling was repeated.
9.1.7 Library Synthesis
Synthesis of libraries was performed by hand on a classical peptide synthesis rig where 
the resin was supported on a fine sintered frit in a high sided funnel. A three-way valve 
was arranged to allow the alternate application of vacuum (solvent removal) and nitrogen 
(solvent agitation). Nitrogen was regulated to 0.1 bar by a diaphragm valve (Norgen). 




1 70 140 Mix step, bulk resin loading
2 30 120 Split steps
3 15 80 Later split steps
In order to rapidly perform the split and mix protocols, a manifold was designed to allow 
the parallel treatment of several funnels, Figure 9.00. The collection vessel was fitted with 
a drainage tube to permit the periodic displacement of waste by gas pressure. Several 
designs of funnel were tried to obtain even flow of gas through all vessels on the 
manifold. A restriction valve on the top of the flask proved cumbersome and unreliable as 
the porosity of the frits often changed as synthesis progressed. Latterly, loose fitting glass 
lids proved satisfactory. In an effort to prevent the gas propelling compacted resin cakes 
out of the flasks, wire prods were fitted replaced later by a bulged funnel wall above the 
resin cake to destroy the gas seal. Funnels of size #3 were found too inconsistent in flow 
to use in multiples, and library syntheses on resin weights below ~200mg were performed 
in 4ml glass vials with PTFE coated septa (Chromacol). In this case, wash steps were 
performed with 50% NMP/MeOH, causing the resin to shrink and sink, allowing solvent 
aspiration using a Pasteur pipette attached to a vacuum line and waste trap. Amino acids 
were added as weighed solids, while coupling agents were freshly dissolved prior to each
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coupling round and stated quantities were usually multiplied by the number of couplings 
to be performed at any one round, dissolved in bulk and distributed according to volume. 
Base was added separately. Deconvolution and analytical samples were removed as Fmoc 
peptide-resins after NMP and methanol washes. Recombination of resin aliquots was 
conducted by agitating the mixed Fmoc resins in a large volume of NMP for 20’. The 
clumping of deprotected resin observed in early work suggested that mixing and 
redistribution was best performed on resin in the Fmoc protected state, despite the small 
increase in labour required for the separate piperidine treatments. Redistribution (split- 
step) was performed by cutting the compacted wet resin cake into geometric segments, 
according to graduations marked on the periphery of the flask. Deprotection was 
performed with 20% piperidine in NMP. Standard wash protocol was x 6 NMP followed 
by x 3 MeOH or IP A, using twice the coupling solvent volume. Prior to storage, all resin 
samples were washed repeatedly with alcohol, and pumped overnight in a vacuum 
desiccator. Cleavage of the libraries was conducted in the vials, with the acid liquor 
filtered through a small glass wool plug in a Pasteur pipette to remove resin beads. A 
Gyrovap vacuum centrifuge was used to remove TFA, for lhour at 30°C at 1” Hg. 
Lyophilisation was performed from IN HC1 by freezing the vials in acetone/cardice bath 
and vacuum centrifuging at 0° C for 1.5h, 1” Hg.
During library synthesis, reaction success was monitored by chemical test (see above) and 
ESI-MS. l-4mg resin beads were removed from the reaction vessel and placed in a 
conical-bottom vial. 20-40pl of 90% aqueous TFA was added, and the vial sealed. After 
occasional agitating over 1 hour, 50-300 pi of methanol followed by equal amount of 
water was added, adjusting to approximately 20pmol/pl. After agitation, the resin beads 
were allowed to sink, and the supernatant filtered and injected directly into the mass
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spectrometer. Latterly, more complex mixtures were applied to the LC-MS system using 
column e,f system VI.
Fig. 9.00 Manifolded 
rig for library 
synthesis.
A- mix step vessel 
B- reaction vessel 
C- waste 





9.2.1 Procedures for Chapter 3
Conformational Constraint of Peptide Libraries by Metal Complexation 
Analytical procedures - Zinc/Glutathione Complexes
3.4 Glutathione in reduced form (GSH) was obtained from Sigma and diluted to 0.13M 
(40mg/ml) in D2O. pD was corrected to 6.0 (with NaOD/TFA). Zinc salts, 
Zn(Ch3COO)2.2H20; ZnC^; ZnSO4.7H20 were obtained from Adrich. Zinc titrants 0.1- 
2.0 eq. were made by addition of solid to the glutathione solution. Samples were mixed 
for 30 min. under a nitrogen blanket before analysis. Samples were referenced to the 
water signal at *H 4.80 ppm or Gly-Ca at 13C 45.8 ppm. !H spectra were accumulated for 
50 scans and 13C for 1000 scans.
Electrospray analysis was performed by diluting the above solutions to approx. 20 
pmol/pl (0.01 mg/ml) and injecting lOpl aliquots into a acetonitrile/water stream of 
20pl/min. Source temperature was optimised at 60°C for the appearance of complexes.
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Bath gas was similarly raised to 3001/h to suppress solvent/zinc clusters. Cone voltage 
was set to the minimum value for a significant signal, 28V. Negative ion spectra were run 
in isopropanol/water as above.
Analysis of Example Peptides
3.5 NMR experiments were performed at 20mg/ml peptide in D2O. Zinc salts were added 
as solids in a progressive manner from 0.1 eq. in 0.1 eq. steps to 1.0 eq., then 5 eq. and 20 
eq. to the same sample. pD correction to 6.5 was made using NaOD in D2O 1M.
1 3spectra were accumulated for 100 scans and C for 2000 scans.
VT and NOESY experiments were performed at 500MHz in H20/10%D20. For variable 
temperature experiments, temperature was varied 5°C, 10°C then in 10°C increments to 
50°C. NOE spectra were recorded at 100, 250 and 500ms mixing time.
3.6 Samples for laser desorption TOF-MS were prepared as 5mg in 1ml samples in 
water, zinc acetate added as a solid, then pH corrected using dilute NaOH. The samples 
were lyophilised before sending externally for mass analysis. Lyophilised sample was 
redissolved in 1ml water, and 2pl dried onto the laser target. A wash with dilute ammonia 
was performed before acquisition of the mass spectrum. Electrospray MS was performed 
as glutathione samples above, using acetate and chloride zinc salts at 0.5, 1.0 and 10 
equivalents.
3.7. Circular dichroism - samples for CD were prepared at 4.0mg in 1ml water with 1.0 
eq. ZnCL and pH corrected to 6.0 before lyophilisation and sending for external analysis. 
Samples were diluted in water to 0.5mg/ml for analysis.
3.8 Gel filtration - Pharmacia plastic column (1cm x 60cm) was packed with 300Da cut­
off dextran gel (Phamacia LH20) and pumped with methanol for lh  using a peristaltic 
pump. Acetic acid (0.5ml) was applied to the column using a syringe via a three-way tap. 
The eluent was monitored at UV 220nm using a Cecil Instruments detector at FSD 2Au.
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A peak appeared at 40min and lasted for 8 min. Example peptides were used in separate 
experiments, dissolving lOmg in 2ml with 4 eq. (6mg) Zn(CH3COO)2. pH was corrected 
to 6.5 using NaOH (0.2M). Fractions were collected automatically at 2 min. intervals, and 
two peaks were observed on elution, the first beginning at 25 min and tailing for 15min, 
then a second beginning at 40min. The first 5 minutes of the first fraction were combined, 
lyophilised and dissolved in 0.6ml D2O before analysis by !H NMR for characteristic 
effects of Zn2+ chelation.
HPLC of example peptides/zinc mixtures was performed using column a with solvent 
system III, though modified with either lOmM ammonium acetate or KH2P04/K(HP04)2 
20mM at pH 4.0 , 6.0 or 7.0.
Metal affinity chromatography was performed using methyliminodiacetic acid (sodium 
salt) derivatised polystyrene resin (Sigma C7901). The resin was slurried into a 1cm x 
10cm plastic column and equilibrated with water using a peristaltic pump at 2ml/min. 
Peptide (5mg) applied to the column was observed to elute after 2.5 min monitoring at 
UV220- The column was washed with Zn(CH3COO)2 aq. 20mM for 2h, followed by water 
for lh. Peptides (lOmg) were dissolved in 1.5 ml water, and applied to the column. A 
strong signal was observed from 2.5 to 20 minutes. Collected material for the period 3-15 
minutes was lyophilised and reconstituted in D2O for *H NMR analysis.
Synthesis
All the peptides made for the metal binding study were synthesised by standard 
automated protocols, using Novabiochem Wang (polystyrene/1% divinylbenzene 200-400 
mesh) resin pre-loaded with Fmoc-LCys(Trt) (0.55mmol/g). Amino acid analysis results 




From 491 mg (0.271 mmol) resin 814mg peptide-resin was obtained. After applying 
standard cleavage procedure for 3h, 150mg o f crude product was obtained. The product 
was insoluble in all tried solvents, including TFA, and was not pursued.
Peptide 2 GluCysPheSerLysSerAlaLysGluCys
From 490mg, (0.270 mmol) of resin, 900mg peptide-resin was obtained. After applying 
standard cleavage procedure for 3.5h, 190mg (62%) crude product was obtained.
Preparative HPLC was performed on lOOmg sample dissolved in acetic acid (2ml), 
column g water (0.1%TFA) for 12 min. followed by gradient to 50% acetonitrile 
(0.1%TFA) over 60min, collecting fractions k’ 6.60-4.92. A further two separations were 
performed on reclaimed material. After recombination and lyophilisation of fractions 
35mg product was obtained, passed through a chloride ion exchange column and 
lyophilised. 25mg (16%) of the title product was obtained. 98.7% pure by HPLC column 
a system I, k’ 1.91; m/z (MALDI-TOF) [M+H]+expected 1132.3, found 1132.0. 80% 
peptide by AAA, 82% peptide by Aldrithiol assay.
Peptide 3 GluCysLysLysLysLysLysLysGluCys
From 450mg (0.248) mmol resin 810mg peptide-resin was obtained. After applying 
standard cleavage procedure for 3.5h, 115mg (37%) crude product was obtained.
Preparative HPLC was performed on the sample dissolved in 1M acetic acid (1.5ml), 
column g water (0.1%TFA) for 12 min. followed by gradient to 50% acetonitrile 
(0.1%TFA) over 60 min. After recombination and lyophilisation of fractions 95 mg 
product was obtained which was passed through a chloride ion exchange column and 
lyophilised. 90mg (29%) of the title product was obtained. 99.5% pure by gradient HPLC 
column a system I, k’ 1.32; m/z (MALDI-TOF) [M+H]+ expected 1252.6, found 1252.2.
211
Experimental 9 —Procedures
90% peptide by AAA, 81% peptide by Aldrithiol assay. The product proved unstable, and 
on storage an impurity appeared at k’ 1.41 attributed to the disulphide cyclopeptide. 
Peptide 4 GluCysLysLysLysLysLysGluCys
From 450mg (0.248 mmol) resin 795mg peptide-resin was obtained. After applying 
standard cleavage procedure for 4h, 210mg (75%) crude product was obtained.
Preparative HPLC was performed on 2x 105mg samples dissolved in 1M acetic acid 
(1.5ml), column g 0-50% acetonitrile in water (0.1% TFA) over 40min collecting 
fractions k ’ 2.00-2.83. After recombination and lyophilisation of fractions 160 mg 
product was obtained. Product was passed through a chloride ion exchange column and 
lyophilised. 159mg (57%) of the title product was obtained. 99.5% pure by gradient 
HPLC column a system I, k’ 1.26; m/z (MALDI-TOF) [M+H]+ expected 1124.4, found 
1124.6. 84% peptide by AAA, 78% peptide by Aldrithiol assay. The product proved 
unstable, and on storage an impurity appeared at k’ 1.14 attributed to the disulphide 
cyclopeptide.
Peptide 5 GluCysLysLysLysLysGluCys
From 460mg (0.253 mmol) resin, 729mg peptide-resin was obtained. After applying 
standard cleavage procedure for 4h, 210mg (83%) crude product was obtained.
Preparative HPLC was performed on the sample dissolved in acetic acid (1.5ml), column 
g 0-35% acetonitrile in water (0.1% TFA) over 60min collecting k’ 2.34-2.55. After 
recombination and lyophilisation of fractions 60 mg product was obtained. Product was 
passed through a chloride ion exchange column and lyophilised. 47mg (19%) of the title 
product was obtained. 99.0% pure by gradient HPLC column a system I, k’ 1.26; m/z 
(MALDI-TOF) [M+H]+ expected 996.2, found 997.0. 85% peptide by AAA, 87% 




From 490mg (0.270 mmol) resin 886mg peptide-resin was obtained. After applying 
standard cleavage procedure for 4.5h, 388mg (118%) crude product was obtained.
Preparative HPLC was performed on 175mg of the sample dissolved in acetic acid 
(1.5ml), column g 0-40% acetonitrile in water (0.1% TFA) over 40min, collecting 
fractions k’ 1.6-2.48 After recombination and lyophilisation of fractions 90 mg product 
was obtained. Product was passed through a chloride ion exchange column and 
lyophilised. 90mg (26%) of the title product was obtained. 99.0% pure by gradient HPLC 
column a system III, k’ 1.4; m/z (MALDI-TOF) [M+H]+expected 1290.6, found 1289.7. 




Peptide 6 was synthesised and purified by the method described. llOmg (32%) of 
product in excess of 95% pure resulted. lOOmg of product was dissolved in 11 of water 
containing 2ml acetic acid and pH adjusted to 8.0 with 0.2M ammonia. The solution was 
monitored daily by HPLC. After standing for four days, the entire solution was 
lyophilised. 96mg of product resulted. Preparative HPLC was performed on 54mg sample 
dissolved in 1.5ml acetic acid, column g 0-40% acetonitrile in water (0.1% TFA) over 
40min and again on 40mg reclaimed material, collecting fractions k’ 4.3-4.8 After 
combination of fractions, the product was passed through a chloride ion exchange column 
and lyophilised. 14mg (4%) of the title product was obtained. 94% pure by gradient 
HPLC column a system III, k' 5.83; m/z (MALDI-TOF) [M+H]+ expected 1287.7, found
1287.0. 87% peptide by AAA, Less than 1% thiol content by Aldrithiol assay. Treatment 





From 490mg (0.270 mmol) resin 856mg peptide resin was obtained. After applying 
standard cleavage procedure for 4h, 268mg (106%) crude product was obtained.
Preparative HPLC was performed on 170mg of the sample dissolved in 1M acetic acid 
(1.5ml) column g 0-40% acetonitrile in water (0.1% TFA) over 40min, collecting 
fractions k’ 2.78-3.91. After recombination and lyophilisation of fractions llm g  product 
was obtained. A further two preparative HPLC separations were performed on 60mg 
reclaimed material to yield a second crop. The products were passed through a chloride 
ion exchange column and lyophilised. 1 lmg (3%) cropl, 39mg (11%) crop 2 of the title 
product was obtained. 99.0% and 92% pure by gradient HPLC column a system II, k ’ 
2.04; m/z (MALDI-TOF) [M+H]+ expected 1290.6 found 1289.7. 80% peptide by AAA, 
75% peptide by Aldrithiol assay.
Peptide 9
GluCysPheLysLysLysLysPheGluCys
Peptide 8 was synthesised and purified by the method described. 160mg (46%) of 
product in excess of 95% pure resulted. lOOmg of product was dissolved in 11 of water 
containing 2ml acetic acid and pH adjusted to 8.5 with 0.2M ammonia. The solution was 
monitored daily by HPLC. After standing for six days, the entire solution was lyophilised 
resulting in 90mg of product. Preparative HPLC was performed on 55mg sample in acetic 
acid (1.5ml), column g 10-30% acetonitrile in water (0.1% TFA) over 40min and 
subsequently on 50mg remaining and reclaimed material, collecting fractions k ’ 2.22- 
2.96. After combination of fractions, the product was passed through a chloride ion 
exchange column and lyophilised. 35mg (10%) of the title product was obtained. 95% 
pure by gradient HPLC column a system II, k ’ 5.73; m/z (MALDI-TOF) [M+H]+
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expected 1287.7, found 1287.9. A major impurity isolated from the separation appeared 
to be des-Glu peptide, m/z 1159.2. 88% peptide by AAA, Less than 1% thiol content by 
Aldrithiol assay. Treatment of the HPLC sample with dithiothreitol overnight gave an 
HPLC peak which co-eluted with peptide 8.
Peptide 10 GluCysGlyOrnValSerLysAlaGluCys
From 490mg (0.270 mmol) of resin, 856mg peptide-resin was obtained. After applying 
standard cleavage procedure for 4h, 300mg (77%) crude product was obtained.
Preparative HPLC was performed on a 60mg sample dissolved in acetic acid (1.5ml) 
column g, 5% acetonitrile for lOmin, then to 30% acetonitrile in 50min in water (0.1% 
TFA). After recombination of fractions k ’ 3.78-4.30 and lyophilisation 1 lmg product was 
obtained. A further two preparative HPLC separations were performed on 70mg and 
48mg to yield subsequent crops. Products were lyophilised twice from 50ml IN 
hydrochloric acid. 27mg (3%) cropl, 24mg (11%) (crop2+3 combined) of the title 
product was obtained. 99.0% and 96% pure by gradient HPLC column a system I, k* 
2.63; m/z (ESI) [M+H]+ 1040.2, found 1040.4. 91% peptide by Aldrithiol assay.
Peptide 11 GluCys(Acm)GlyOrnValSerLysAlaGluCys(Acm)
Standard automated protocols were used to synthesise the peptide, using Novabiochem 
Wang resin pre-loaded with Fmoc-Cys(Acm) (0.55mmol/g) 490mg, 0.270 mmol from 
which 800mg peptide resin was obtained. After applying standard cleavage procedure for 
4h, 300mg (94%) crude product was obtained. Preparative HPLC was performed on a 
56mg sample dissolved in acetic acid (1.5ml) column g, 5% acetonitrile for lOmin, then 
to 30% acetonitrile in 50min in water (0.1% TFA). After recombination of fractions k’ 
5.00-6.39 and lyophilisation 30mg product was obtained. Products were lyophilised twice 
from 50ml IN hydrochloric acid. 30mg (9%) of the title product was obtained. 99.0%
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Crop 2 of peptide 10 above was dissolved in 150ml of water and pH was adjusted to 8.0 
using 0.2M ammonia. The solution was allowed to stand and monitored by HPLC. After 
two days the solution was lyophilised. Product was lyophilised again from 50ml IN 
hydrochloric acid. 13 mg (5%) of the title product was obtained. 99.0% pure by gradient 
HPLC column a system I, k ’ 2.53; m/z (ESI) [M+H]+ expected 1038.2, found 1037.5. 
Less than 1% thiol content by Aldrithiol assay. Treatment of the HPLC sample with 
dithiothreitol overnight gave an HPLC peak which co-eluted with peptide 10.
Peptide 13 y-GluCysGlyOrnValSerLysAlay-GluCys
From 490mg (0.270 mmol) resin 890mg of peptide-resin was obtained. After applying 
standard cleavage procedure for 4 hours, 270mg (50%) crude product was obtained. 
Preparative HPLC was performed on 164mg of the sample dissolved in acetic acid 
(1.5ml), column g, 5% acetonitrile for lOmin, then to 30% acetonitrile in 50min in water 
(0.1% TFA), after which fractions k ’ 3.33-4.16 were recombined and lyophilised. A 
second separation was performed on 113mg. 50 mg (cropl) and 33mg (crop2) of product 
was obtained. Products were lyophilised from 50ml IN hydrochloric acid. 44mg (16%) 
cropl, 31 mg (11%) crop2 of the title product was obtained. 99.0% and 96% pure by 
gradient HPLC column a system I, k’ 2.43; m/z (ESI) [M+H]+ expected 1040.2, found 
1039.8. 82% peptide thiol content by Aldrithiol assay. The product proved unstable, and 
on storage an impurity appeared at k* 2.41 attributed to the disulphide cyclopeptide.
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Peptide 14 y-GluCys(Acm)GlyOrnValSerLysAiay-GluCys(Aciii)
Standard automated protocols were used to synthesise the peptide, using Novabiochem 
Wang resin pre-loaded with Fmoc-Cys(Acm) (0.55mmol/g) 490mg, 0.270 mmol. 810mg 
peptide resin was obtained. After applying standard cleavage procedure for 4h, 330mg 
(98%) crude product was obtained. Preparative HPLC was performed on lOOmg and 
77mg samples dissolved in acetic acid (1.5ml), column g, 5% acetonitrile for lOmin, then 
to 30% acetonitrile in 50min in water (0.1% TFA), after which fractions k’ 3.26-3.85 
were recombined and lyophilised 54mg (cropl) and 44mg (crop2) of product was 
obtained. Products were lyophilised from 50ml IN hydrochloric acid. 54mg (17%) 
(cropl) and 44mg (14%) (crop2) of the title product was obtained. 99.0% and 93% pure 





Crop 2 of 13 above was dissolved in 150ml of water and pH was adjusted to 8.0 using 
0.2M ammonia. The solution was allowed to stand and was monitored by HPLC. After 
ten days the solution was lyophilised. Preparative HPLC was performed on the sample 
dissolved in water (1.5ml), column g, 5% acetonitrile for lOmin, then to 30% acetonitrile 
in 50min in water (0.1% TFA), after which fractions k’ 3.19-3.46 were recombined and 
lyophilised. Product was lyophilised again from 50ml IN hydrochloric acid. 16 mg (6%) 
of the title product was obtained.. 94.0% pure by gradient HPLC column a system I, k ’ 
2.41; m/z (ESI) [M+H]+ expected 1038.2, found 1037.5. Less than 1% thiol content by 
Aldrithiol assay. Treatment of the HPLC sample with dithiothreitol overnight gave an 
HPLC peak which co-eluted with peptide 13.
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9.2.2 Procedures for Chapter 4 
Libraries 1 and 2
16 Fmoc-DAsp(OH)OH
Fmoc-DAspfBu1) (5.56 g, 13.49 mmol) (Novabiochem) was added to 20 ml 80% aqueous 
TFA and stirred. 3ml DCM was added to achieve complete solution. After stirring for lh 
at room temperature, water (100ml ) was added to the solution and the entire flask 
contents lyophilised. 5.7g (118%) of the title compound was recovered as a fluffy white 
solid; Rp 0.15 in 10:1:0.1 chloroform, methanol, acetic acid, single spot by UV254 and 
chlorine/starch/KI, negative by ninhydrin. Single peak by gradient HPLC, column a 
system I k ’7.35 (starting material 9.70); m/z (ESI) [M+H]+ expected 356.1, found 355.9. 
Trace starting material detectable by LC-MS, below 1% by HPLC.
17 Fmoc-DAsp anhydride
Fmoc-DAsp(OH)OH, 16 (5.6g, 15.7 mmol) was added to acetic anhydride (20ml) and 
stirred at 50°C for 2h under nitrogen. After standing overnight at r.t., followed by 2hr at 
4°C, a fluffy white product was collected over a glass frit and washed with ether. The 
product was dried for 2h under vacuum. 4.07g (77%) of product was transferred 
immediately to the next reaction, as hygroscopic degradation had been observed with 
previous trial batches. ESI-MS in methanol yielded the expected molecular ion of m/z 
[M+H]+ 337.8, expected 338, also the starting material at m/z 335.9 and (majority) 
attributed to Fmoc-DAsp monomethyl ester at m/z 370.0 and the sodium [M+Na]+ adduct 
of the methyl ester m/z 391.9.
18 Fmoc-DAsp(OH)ODmb
17 (4g, 11.8mmol), Fmoc-DAsp anhydride and (3g, 17.8mmol) of 2,4-dimethoxybenzyl 
alcohol was stirred in 15ml dioxane under nitrogen. Solution occurred when 2.16g 
(17.6mmol) DMAP in ether was added dropwise over 10 min. After standing overnight, a
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white precipitate was collected, washed with ether and dried in vacuo over silica gel. 
After dissolving in ethyl acetate and washing with water and brine, the product was dried 
over MgSC>4, filtered and evaporated. 3.01g (50%) product was obtained. HPLC analysis, 
column a system II showed a considerable amount of starting material present, and a pair 
of closely associated peaks at k’ 8.36 and 8.44. LC-MS indicated that the pair of peaks 
both had the expected molecular ion of m/z [M+Na]+ expected 528, found 527.9. 
Recrystallisation from ethyl acetate/hexane 3:2 gave 180mg of an off-white powder, 
showing the split peaks on HPLC as above, and m/z [M+Na]+ 527.8. Rf 0.25 in 10:1:0.1 
chloroform, methanol, acetic acid, single spot by UV254 and Chlorine/Starch/KI, negative 
by ninhydrin.
19 Fmoc-LAspODmb(Wang Resin)
Wang polystyrene resin (1% divinylbenzene, 200-400 mesh) (lO.OOg, 0.64mmol/g, 6.4 
mmol hydroxyl groups; Novabiochem) was stirred in DMF (60ml) at room temperature. 
Pyridine ( l.lg , 14.1 mmol) was added. After stirring for 10 min., Fmoc-LAsp(OH)ODmb 
(6.46g,12.8mmol) and 2,6-dichlorobenzoyl chloride (2.7g,12.8mmol) was added. The 
suspension was stirred overnight. The resulting resin was transferred to a #1 sinter funnel 
and washed with DMF x 3, methanol x 3 (50ml). The resin was treated with acetic 
anhydride (50ml ) for 10 min. After washing, with DMF x 3, methanol x 3, the product 
was dried in vacuo overnight. The loading of amino acid was determined by Fmoc release 
as described. 11.76g of the title product was obtained at 0.307 mmol/g, average of two 
determinations.
Peptide 20 cyc/o(LysIleAlaAsp)
A sample of resin 19 (625 mg, 0.307mmol/g, 0.19mmol Fmoc-LAsp(OH)ODmb) was 
used with standard automated protocols to synthesise the protected, resin bound peptide. 
The peptide-resin was removed from the synthesiser vessel and placed in a sinter funnel.
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The resin was washed and swelled with two treatments of DCM (20ml). The resin was 
then treated with 1% (v/v) TFA in DCM (10ml) for 5 min. The acid was removed, and 
replaced immediately with fresh DCM. Care was taken to ensure the resin did not remain 
uncovered for more than a few seconds after acid treatment. The treatment was repeated 
five times, the resin was washed x 3 with DCM, with 10% (v/v) DIE A in DCM, and x 3 
with DMF (10ml).
The Fmoc protection was removed by two 30-minute treatments with 20% (v/v) 
piperidine in DMF, after which the resin was washed x 5 with DMF (10ml).
To the damp resin cake, 10 ml of DMF was added, containing HBTU (0.425g, l.lmmol) 
HOBT (0.172g, l.lmmol) and DIEA (0.30g, 2.2 mmol). The suspension was mixed for 
5h. After washing x 3 with each of DMF, DCM and methanol (10ml), the resin was dried 
in vacuo overnight.
A sample of the dry resin (500mg) was stirred with 80% TFA (aq.) (8ml ) for 3h at room 
temperature. After filtration through glass wool to remove the resin particles, water 
(100ml ) was added to the supernatant and the entire contents were lyophilised, yielding a 
white solid.
42mg (64%) of the title compound was obtained, 79.0% pure by gradient HPLC, k’ 2.50 
column a, system II, 6% linear peptide was evident, k’ 2.20; m/z (ESI) [M+H]+ expected
428.5 found 428.2. Trace linear peptide [M+H]+ expected 446.5 was apparent, though no 
dimer (m/z [M+H]+ expected 874) was detected.
Stored peptide resin (20mg) was Fmoc deprotected in a 3ml glass sample vial with 20% 
(v/v) piperidine in DMF (1.5ml), washed with alternating aliquots of DMF/methanol x 3, 
aspirated and then treated with 80% aqueous TFA (2ml) for 3h at room temperature. The 
supernatant was removed, added to water (30ml ) and lyophilised. 83.0% pure by gradient
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HPLC, column a system II k ’ 2.20; m/z (ESI) [M+H]+ expected 446.5 found 446.4. The 
sample was used as an analytical sample, peptide 20 linear, to compare with peptide 20. 
Peptide 21 cyc7o(AlaLysAlaIleAlaAsp)
Peptide 21 was synthesised in parallel with peptide 20. Identical materials, quantities and 
processes were used throughout.
39mg (45%) of the title compound was obtained, 83.0% pure by gradient HPLC, column 
a system II k ’ 2.65; m/z (ESI) [M+H]+ expected 570.7 found 570.4. No linear peptide 
[M+H]+ expected 588.7 or dimer [M+H]+ expected 1122.3 was apparent.
21 linear, as 20 linear, 86.0% pure by gradient HPLC, column a system II k’ 2.55; m/z 
(ESI) [M+H]+ expected 588.7, found 588.4
Peptide 22 cyc/o(AlaAlaLysAlaIleAlaAlaAsp)
Peptide 22 was synthesised in parallel with peptide 20. Identical materials, quantities and 
processes were used throughout.
51 mg (24%) of the title compound was obtained, 77.0% pure by gradient HPLC, column 
a system II k’ 2.60, m/z (ESI) [M+H]+ expected 712.8 found 712.5. Some linear peptide, 
k’ 2.70 (16%) [M+H]+ expected 730.8., found 730.5 was observed though no dimer 
([M+H]+ (expected 1122.3) was apparent.
22 linear, as 20 linear, 78.0% pure by gradient HPLC, column a system II k ’ 2.70; m/z 
(ESI) [M+H]+ expected 730.8, found 730.6
Synthesis of Library 1
Resin 19 (7.5g, 2.3mmol) was placed in a #1 sinter funnel and swelled using NMP 
(30ml). The compacted resin cake was divided into 6 parts, and five parts were placed in 
separate #2 sinter funnels. Fmoc protection was removed by two 20’ treatments with 20% 
piperidine in NMP (10ml). After washing x 6 NMP (10ml) and x 3 (10ml) methanol
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(10ml) and swelling in NMP, Dry amino acids were added, followed by coupling agents 
in NMP (10ml) and base in the following amounts:
7.5g resin divided into 6 = 0.383mmol/portion
Flask# Reagent m.w. Quantity/mg Equivalents
1 Fmoc-LAla 311 357 3
2 Fmoc-pAla 311 357 3
3 Fmoc-4-amino butyric acid 325 373 3
4 Fmoc-LAla 382 357 3
5 Fmoc-8amino-3,6-ethoxy-octanoic acid 385 442 3
each HBTU 379 435 3
each HOBT.H20 153 176 3
each DIEA 129 297 (=400pl) 6
After 1.5 h, the resins were washed x 3 NMP, x3 methanol (15ml). Flask 4 was Fmoc 
deprotected using two 20’ treatments with 20% piperidine in NMP (10ml), washed, and 
recoupled as above with Fmoc-LAla to created the di-L-alanine Spacer 4. A negative 
ninhydrin test was obtained, and approximately 2mg of resin from each coupled portion 
was analysed by flow-injection ESI-MS to verify the expected ions and absence of 
uncoupled Fmoc-Asp or double-coupled impurities. lOOmg resin was saved from each 
vessel before all six portions were recombined in the #3 funnel by agitating in NMP 
(30ml) for 2 h until no lumps remained. An analytical sample of 20mg was saved, 
denoted L ibrary 1 Layer 1.
The compacted resin cake was divided into 4 parts, and three parts were placed in 
separate #2 sinter funnels. Fmoc protection was removed by two 20’ treatments with 20% 
piperidine in NMP (10ml). After washing 3x NMP, 3x methanol (10ml) and swelling in 
NMP, Dry amino acids were added, followed by coupling agents in NMP (10ml) and base 
in the following amounts:
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7g resin divided into 4 = 0.537mmol/portion
Flask# Reagent m.w. Quantity/mg Equivalents
1 Fmoc-LAsp(Bul) 412 664 3
2 Fmoc-LLys(Boc) 469 756 3
3 Fmoc-Llle 353 569 3
each HBTU 379 611 3
each H0BT.H20 153 247 3
each DIEA 129 415 (=560pl) 6
After 1.3 h, the resins were washed x 3 NMP, x 3 MeOH (15ml). A negative ninhydrin 
test was obtained, and approximately 2mg of resin from each portion was analysed by 
flow-injection ESI-MS to verify the presence of the expected ions. After drying in vacuo, 
lOOmg resin was saved from each vessel before all four portions were recombined in the 
#3 funnel by agitating in NMP (30ml) for 15* until no lumps remained. An analytical 
sample of 20mg was saved, washed in methanol, dried in vacuo and denoted L ibrary 1 
Layer 2.
Repetition for Layers 3,4 and 5.
The resin cake was divided into 6 portions, and spacer molecules introduced according to 
the protocol above, followed by recombination, division by four and coupling of residues 
as above. A final set of spacers was introduced to complete the library. The quantities 
used remained the same throughout, such that the excess of reagents used increased 
gradually to 4.2 at Layer 5.
After washing x 3 NMP, x 3 MeOH (15ml) and drying in vacuo, lOOmg samples were 
saved from each of the six sub-libraries.
Remaining samples were swollen in DCM, then treated x 6 with 1%TFA in DCM (15ml) 
for 5min. A minimum period (approx. lmin.) was allowed between dosings, to prevent 
local concentration of TFA while drying. Only a very slight pinkening of the resin was 
observed, on the underside of the frit. Resin was washed x 3 DCM.
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After swelling in NMP, the samples were treated x 2 20% piperidine in NMP 15ml for 
30min to remove the terminal Fmoc group, followed by washing x 6 NMP and x 3 
methanol and swelling in NMP (10ml).
Coupling agents and base were added in the same quantities as for coupling Layer 5, and 
agitated in NMP (10ml) for 3 h. Solvents were drained, a wash was performed with NMP, 
and a fresh set of coupling agents added for a further 2h. After washing, lOOmg was 
removed from each flask and stored.
Remaining resin was placed in 50 ml round-bottom flasks and 5ml of 90% TFA (aq.) 
added and stirred for 4h.
The supernatant was removed with a pipette and filtered through glass wool directly into 
a pre-weighed 100ml flask. 30ml water was added to each. Some of the material appeared 
insoluble. The samples were lyophilised from the solution/part suspension, then 1M HC1 
(30ml) was added to the solid samples before lyophilising.
White flaky products were obtained of between 80 and lOlmg, representing 79-102% of 
the expected yield using an average molecular weight of 465.
23 Fmoc-LAspfBu^OAll
Fmoc-Asp(Bul)OH (2g, 4.86mmol) was dissolved in 15ml DMF and stirred under 
nitrogen. DIEA (0.86ml, 4.9mmol) was added, followed by allyl bromide (0.42ml, 
5.0mmol). The solution was stirred overnight before precipitation of the product by 50ml 
dilute citric acid and extraction with ether. The crude product was confirmed by TLC- 
mass spectroscopy; Rf 0.4 hexane/ethyl acetate, by UV254 and chlorine/starch/KI; m/z 
(ESI) [M+H]+ expected 452.2, found 452.2. The crude product was subjected to flash 
column chromatography, 3cm x30cm, ethyl acetate/hexane 1:4, sample preabsorbed onto 
silica from ether. Fractions selected by TLC were combined and evaporated. Products 
were dried in vacuo in a desiccator. 1.97g (90%) of the title product was obtained; Rf 0.4
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hexane/ethyl acetate, single spot by UV254 and chlorine/starch/KI, negative by ninhydrin. 
Single peak by gradient HPLC, column b system I k’ 7.69 (starting material 6.69); m/z 
[M+Na]+ expected 474.2, found 474.2, m/z [M+K]+ (confirmatory ion exchange) 490.2; 
[a]o +19.4 (20mg/ml, CHCI3). decomposed over 160°C. 8H (CDCI3) 7.2-7.8 (8H, m 
Fmoc Ar) 5.9 (2H, m AspNH, CH2CHCH2) 5.3 (2H, dd CHCH^ 4.6 (3H, m Aspa, 
OCIk) 4.3 (3H, m, Fmoc CI^CH ) 2.85 (2H, dd AspP) 1.4 (9H, s, Bul)
Previous attempts to make the title product according to the literature preparation utilising 
DBU base; yielded no product as the Fmoc protecting group proved labile to DBU. A 
further experiment using DMAP gave poor (35%) yield.
24 Fmoc-DAsp(Bu‘)OAll
Fmoc-DAsp(Bul)OH (2g, 4.86mmol) (Novabiochem) was dissolved in DMF (15ml) and 
stirred under nitrogen. DIEA (0.86ml, 4.9mmol) was added, followed by allyl bromide 
(0.42ml, 5.0mmol). The solution was stirred overnight before precipitation of the product 
by 50ml dilute citric acid and extraction with ether. The crude product was confirmed by 
TLC-mass spectrometry; Rf 0.4 Hexane/ethyl acetate, by UV254 and Chlorine/Starch/KI; 
m/z (ESI) [M+H]+ expected 452.2, found 452.2. Crude product was subjected to column 
chromatography, 3cmx30cm in DCM, sample preabsorbed onto silica from ether. 
Fractions selected by TLC were recombined and evaporated. Products were dried in 
vacuo. 2.08g (95%) of the title product was obtained; Rf 0.4 hexane/ethyl acetate, 0.36 
DCM, single spot by UV254 and chlorine/starch/KI, negative by ninhydrin. Single peak by 
gradient HPLC, column b system I k’ 7.69 (starting material 6.69); m/z [M+Na]+ 
expected 474.2, found 474.2, m/z [M+K]+ (confirmatory) 490.2; [a]o -15.43 (20mg/ml, 
CHCI3). 5H (CDCI3) 7.2-7.8 (8H, m Fmoc Ar) 5.9 (2H, m AspNH, CH2CHCH2) 5.3 (2H, 





Compound 23 (1.8g, 3.98 mmol) was stirred in 80% TFA (aq.) (50ml) at room 
temperature for 4h. 150ml water was added to the reaction mixture and the entire flask 
contents lyophilised. 1.54g (98%) of the title compound was recovered as a fluffy white 
solid; Rf 0.30 in 10:1:0.1 chloroform, methanol, acetic acid, single spot by UV254 and 
chlorine/starch/KI, negative by ninhydrin. Single peak by gradient HPLC, column b 
system I k ’ 4.45; m/z (ESI) [M+Na]+ expected 418.1, found 418.1, m/z [M+K]+ 
(confirmatory ion exchange) 434.1;
26 Fmoc-DAsp(OH)OAll
Compound 24 (2.0g, mmol) was stirred in 80% TFA (aq.) (50ml) at room temperature for 
4h. 150ml water was added to the reaction mixture and the entire flask contents 
lyophilised. 1.7 lg  (98%) of the title compound was recovered as a fluffy white solid; Rf 
0.30 in 10:1:0.1 chloroform, methanol, acetic acid,, single spot by UV254 and 
chlorine/starch/KI, negative by ninhydrin. Single peak by gradient HPLC, column b 
system I k* 4.45; m/z (ESI) [M+Na]+ expected 418.1, found 418.1, m/z [M+K]+ 
(confirmatory) 434.1;
27 Fmoc-LAspOAll(Wang Resin)
Fined Wang polystyrene resin (3.00g, 0.74mmol/g, 2.22 mmol hydroxyl groups; 100-200 
mesh, Advanced Chemtech Inc.) was stirred in DMF (15ml) at room temperature. 
Pyridine (145mg,1.83mmol) was added. After stirring for 10 minutes, compound 25 
(457mg, 1.15mmol) and 2,6-dichlorobenzoyl chloride (232mg,l.llmmol) was added. The 
suspension was stirred overnight. The resulting resin was transferred to a #1 sinter funnel 
and washed x 3 each with DMF, methanol .(20ml). The product was dried in vacuo in a 
desiccator overnight. The loading of compound 25 on the resin was determined by Fmoc
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release as described. 3.30g of the title product was obtained at 0.152 mmol/g, average of 
two determinations.
28 Fmoc-DAspOAll(Wang Resin)
Fined Wang polystyrene resin (3g, 0.74mmol/g, 2.22 mmol hydroxyl groups; Advanced 
Chemtech Inc.) was stirred in DMF (15ml) at room temperature. Pyridine 
(145mg,1.83mmol) was added. After stirring for 10 minutes, compound 26 (438mg,
1.11 mmol) and 2,6-dichlorobenzoyl chloride (232mg, 1.11 mmol) was added. The 
suspension was stirred overnight.
The resulting resin was transferred to a glass sinter funnel and washed with DMF x 3, 
methanol x 3 (20ml). The product was dried in vacuo in a desiccator overnight. The 
loading of compound 26 on the resin was determined by Fmoc release as described. 3.2 lg 
of the title product was obtained at 0.169 mmol/g, average of two determinations.
29 Fmoc-LAspOAll(Wang Resin)
A second batch of product 27, designated 29 was synthesised. Fined Wang polystyrene 
resin (5g, 0.74mmol/g, 3.7 mmol hydroxyl groups; Advanced Chemtech Inc.) was stirred 
in DMF (25ml) at room temperature. Pyridine (214mg, 2.75mmol) was added. After 
stirring for 10 minutes, compound 25 (730mg,1.85mmol) and 2,6-
dichlorobenzoylchloride (386mg, 1.85 mmol) was added. The suspension was stirred 
overnight.
The resulting resin was transferred to a #1 sinter funnel and washed with DMF x 3, 
methanol x 3 (30ml). The product was dried in vacuo in a desiccator overnight. The 
loading of compound 25 on the resin was determined by Fmoc release as described. 5.30g 
of the title product was obtained at 0.10 mmol/g, average of two determinations.
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30 Fmoc- DAspOAll(Wang Resin)
A second batch of product 28, designated 30 was synthesised. Fined Wang polystyrene 
resin (5g, 0.74mmol/g, 3.7 mmol hydroxyl groups; Advanced Chemtech Inc.) was stirred 
in DMF (25ml) at room temperature. Pyridine (214mg, 2.75mmol) was added. After 
stirring for 10 minutes, compound 26 (730mg,1.85mmol) and 2,6-dichlorobenzoyl 
chloride (386mg, 1.85 mmol) was added. The suspension was stirred overnight.
The resulting resin was transferred to a glass sinter funnel and washed with of DMF x 3, 
methanol x 3 (30ml). The product was dried in vacuo in a desiccator overnight. The 
loading of compound 26 on the resin was determined by Fmoc release as described. 5.35g 
of the title product was obtained at 0.064 mmol/g, average of two determinations.
Peptide 31 cyc/o(LysIleAlaAsp)
500 mg of resin 29 (O.lOmmol/g, 0.05 mmol Fmoc-LAsp(OH)OAll) was used with 
standard automated protocols to synthesise the protected, resin bound peptide. The 
peptide-resin was removed from the synthesiser vessel and placed in a sinter funnel. 
300mg of the resin was washed and swelled with two treatments of DCM (10ml) 
followed by PdCl2(PPh3)2 (l.lm g, 0.05eq), acetic acid, (6pl, 3eq.), S11BU3H, (18mg, 2eq.) 
in DCM/DMSO (3ml) in a glass vial. The solution turned yellow, then red on shaking. 
After lh, methanol (3ml) was added and after standing, the solvent was aspirated. Some 
solid material was observed in addition to the resin, believed to have formed on addition 
of the tin. The resin was washed with methanol, THF and DCM successively to remove 
the precipitate.
The Fmoc protection was removed by two 30-minute treatments with 20% (v/v) 
piperidine in NMP (3ml), after which the resin was washed x 5 with methanol. After 
drying, half of the resin was treated with HBTU (23mg, 4eq.), HOBT (lOmg, 4eq), DIEA, 
(21 pi, 8eq.) in NMP/20%DMSO (1.5ml). The suspension was agitated for 5h.
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After washing, both the cyclic and linear resin portions were treated with 90% TFA (aq.) 
(2ml) for 4 h. Acid liquor was removed from the beads using a fibre-plugged pipette, and 
transferred to a new vial for solvent removal by vacuum centrifugation. When dry, IN 
HC1 (1m l) was added to the samples, which were lyophilised in the vacuum centrifuge. 
lOmg (78%) of the title compound was obtained, 68.0% pure by gradient HPLC, column 
b system I k ’ 2.50, m/z (ESI) [M+H]+ expected 428.3 found 429.1. No linear peptide was 
evident by HPLC comparison with 20, or in the mass spectrum, however a significant 
impurity at k’ 2.35 and an additional mass ion of 357.3 and was attributed to 
cyc/oLysIleAsp.
Peptide 31 Linear yielded 5mg, (111%), 72.0% pure by gradient HPLC, k’ 2.20; m/z 
(ESI) [M+H]+ expected 446.25 found 446.4. Sample also displayed a significant impurity 
at k ’ 2.28 and an additional mass ion of 375.8 attributed to LysIleAsp.
Peptide 32 cyc/o(LysAlaIleAlaAlaAsp)
Peptide 32 was synthesised in parallel with peptide 31. Identical materials, quantities and 
processes were used throughout.
10.2mg (60%) of the title compound was obtained, 83.0% pure by gradient HPLC, 
column b system I k’ 2.85 no linear peptide found; m/z (ESI) [M+H]+ expected 570.7 
found 570.4. No linear peptide (M+H expected 588.7) or dimer (M+H expected 1122.3) 
was apparent.
32 linear, as 31 linear, 86.0% pure by gradient HPLC, k’ 2.75; m/z (ESI) [M+H]+
expected 588.7, found 588.4
Peptide 33 cyc/o(AlaAlaIleAlaLysAlaAlaDAsp)
Peptide 33 was synthesised in parallel with peptide 31 and 32, using resin 30, otherwise 
identical materials, quantities and processes were used throughout.
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14mg (65%) of the title compound was obtained, 66.0% pure by gradient HPLC, column 
b system I k’ 2.45. m/z (ESI) [M+H]+ expected 712.8 found 712.5. No linear peptide 
[M+H]+ expected 730.8 and no dimer [M+H]+ expected 1122.3 was apparent.
33 linear, as 31 linear, 78.0% pure by gradient HPLC, k’ 2.75; m/z (ESI) [M+H]+ 
expected 730.8, found 730.6
34 Fmoc-LAlaLAla
The unprotected LAlaLAla peptide was purchased from Sigma.
5g (31.2 mmol) of LAlaLAla was treated with Fmoc-N-succinimide in base as described 
in section 9.1. An initial trituration of product in a minimum volume of ethyl acetate by 
hexane (~ 60%) only effected a partial cleanup. Subsequent recrystallisations from 400ml 
and 200ml of ethyl acetate/hexane (1:3) yielded two crops of the title product. Products 
were dried in vacuo.
Cropl (4.304g, 36%); m.p.l84-189°C; Rf 0.40 (chloroform:methanol:acetic acid 
10:1:0.1) single spot by UV254 and chlorine/starch/KI, negative by ninhydrin. Single peak 
by gradient HPLC, column d system I k’ 2.82; m/z (ESI) [M+H]+ expected 383.4, found
383.1.
Crop 2 (2.04g,17%); m.p.l48-150°C; two spots Rf 0.40 and 0.70,
(chloroform:methanol:acetic acid 10:1:0.1) second spot strongly fluorescent by UV254, 
negative by chlorine/starch/KI and ninhydrin. m/z (ESI) [M+H]+ found 383.1, 375.9,
360.1.
Synthesis of Library 2D
Resin 28 (2.99g, 0.505mmol) (Fmoc-DAsp(OH)OAll, 0.169 mmol/g) was placed in a #1 
glass sinter funnel on the peptide synthesis manifold, and agitated in NMP (20ml). N- 
terminal Fmoc protection was removed by two 20* treatments with 20% piperidine 
(15ml). After washing and swelling in NMP, the compacted resin cake was divided into 5
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parts and distributed to separate #2 funnels. Dry amino acids were added, followed by 
coupling agents in NMP/20%DMSO (12ml) and base in the following amounts:
2.99g resin divided into 5 = O.lOlmmol/portion
Flask# Reagent m.w. Quantity/mg Equivalents
1 Fmoc-LAla 311 95 3
2 Fmoc-pAla 311 95 3
3 Fmoc-4-amino butyric acid 325 98 3
4 Fmoc-LAlaLAla 47 382 116 3
5 Fmoc-8amino-3,6-ethoxyoctanoic acid 385 117 3
each HBTU 379 114 3
each H0BT.H20 153 46 3
each DIEA 129 78 (=105pi) 6
Agitation of the suspension was continued for 2h. After washing, a negative ninhydrin 
test was obtained, the resins were pumped dry then 80mg and lOmg samples were 
removed from each vessel. Later, the amounts of saved resin were estimated by tamping a 
glass tube into the wet resin cake until a predetermined height was reached, with 
methanol washing and drying performed in the sample vial.
The remaining resin was combined in solvent, and divided into two portions. One portion 
was used for each half of the branching protocol shown in Chapter 4, Fig. 4.18. The 
branch containing the residue order DAsp-X-L/DLys-X-L/Dlle-X only is described, with 
the other half of the library synthesised in parallel.
The portion for the described branch was further divided into two, and Fmoc deprotected 
for two treatments of 30’ 20% piperidine in NMP. After washing x 6 and reswelling in 
NMP (10ml), dry amino acids and coupling agents were added in NMP/20%DMSO 




Resin (2.54g/2) 1.27g divided into 2 = 0.107 mmol/portion
Flask# Reagent m.w. Quantity/mg Equivalents
1 Fmoc-lXysine(Boc) 469 151 3
2 Fmoc-DLysine(Boc) 469 151 3
each HBTU 379 122 3
each H0BT.H20  153 49 3
each DIEA 129 83(=112pl) 6
After 3h, the resins were washed, a negative ninhydrin test was obtained, and 80mg + 
lOmg samples were removed from each. The resins were combined by agitating in NMP 
(10ml), and distributed to five sample vials. Fmoc deprotection was performed using two 
treatments of 20% piperidine in NMP (10ml) for 30’. After washing x 6 in 50% 
methanol in NMP, then methanol, followed by pumping dry and reswelling in NMP 
(10ml), dry amino acids and coupling agents were added in NMP/20%DMSO (3ml).
Resin 1.09g divided into 5 = 0.037 mmol/portion
Flask# Reagent m.w. Quantity/mg Equivalents
1 Fmoc-LAla 311 35 3
2 Fmoc-PAla 311 35 3
3 Fmoc-4-amino butyric acid 325 36 3
4 Fmoc-LAlaLAla 382 42 3
5 Fmoc-8amino-3,6-ethoxy octanoic acid 385 43 3
each HBTU 379 42 3
each HOBT.H2O 153 17 3
each DIEA 129 28 (=38pi) 6
After 3 h, the resins were washed, a negative ninhydrin test was obtained, and 80mg + 
lOmg samples were removed from each. The resins were combined in solvent, and 
distributed equally between two tubes as previously. Fmoc deprotection was performed 
using two treatments of 20% piperidine in NMP for 30’. After washing and swelling in 
NMP, the following dry amino acids and coupling agents were added in 
NMP/20%DMSO (3ml):
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Resin 0.64 g divided into 2 = 0.054 mmol/portion
Flask# Reagent m.w. Quantity/mg Equivalents
1 Fmoc-Llsoleucine 353 57 3
2 Fmoc-Dlsoleucine 353 57 3
each HBTU 379 61 3
each HOBT.H20 153 25 3
each DIEA 129 42 (=56pl) 6
After 3 h, the resins were washed, a negative ninhydrin test was obtained, and 80mg + 
lOmg samples were removed from each. The resins were combined in solvent (7ml), and 
distributed to six tubes as previously. Fmoc deprotection of tubes 1-5 was performed 
using two treatments of 20% piperidine in NMP (2 ml) for 30*. Tube 6 was washed, 
dried and stored. After washing and swelling in NMP, dry amino acids and coupling 
agents were added to tubes 1-5 in NMP/20%DMSO (1.5ml):
Resin 0.46g divided into 6 = 0.013 mmol/portion
Flask# Reagent m.w. Quantity/mg Equivalents
1 Fmoc-L-Ala 311 12 3
2 Fmoc-pAla 311 12 3
3 Fmoc-4-amino butyric acid 325 13 3
4 Fmoc-LAlaLAla 382 15 3
5 Fmoc-8amino3,6ethoxy-octanoic acid 385 15 3
each HBTU 379 15 3
each HOBT.H2O 153 6 3
each DIEA 129 10 (=14pl) 6
After 2 h, the resins were washed, a negative ninhydrin test was obtained and the final 
resins dried. Final products weighed between 68mg and 83mg, corresponding well with 
the advance estimate of remaining resin weight of (348mg/6) = 58mg, as the weight gain 
due to residue accumulation had been ignored in the initial calculation. Weight gain on 
58mg at 0.169 mmol/g for peptides of m.w. 800 = 7.8mg, giving an expected total of 
66mg. From the synthesis o f both branches, twelve sub-libraries were generated, denoted
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L2D-K-S1 L2D-I-S1 Where:
L2D-K-S2 L2D-I-S2 K,I = penultimate residue
L2D-K-S3 L2D-I-S3 S1,2,3.. = the spacer number
L2D-K-S4 L2D-I-S4 Z = zero, or no spacer
L2D-K-S5 L2D-I-S5
L2D-K-SZ L2D-I-Z
Prior to the commencement of each new synthetic step, part of the resin analytical 
samples were analysed by ESI-MS by the protocol described.






The solvents were mixed, then the solid catalyst was briskly weighed and added to the 
solvents stirred under nitrogen. After a few minutes a greenish yellow solution was 
obtained which was added in aliquots of 1ml to the dry resin samples. The vials were 
capped and agitated at r.t. for 3h, after which three alternate methanol - methanol/NMP 
(lml) washes were performed before drying. Fmoc deprotection was performed with 20% 
piperidine/NMP (lml) for two treatments of 30*. After washing and drying a 5 mg linear 
deprotected peptide resin sample was preserved, and the remainder used to form the 
cyclic amide products under the following protocol:
Reagent Quantity Equivalents for lml aliquot to sub-library @
0.013mmol






Vials were agitated for 4h, followed by two methanol/NMP (lml) washes. Significant 
colouration was observed on ninhydrin test, so a fresh addition of an aliquot of the above 
was made for a further 2h treatment. The samples were washed x 4 in methanol/NMP 
(lml), then methanol, and dried.
All samples were treated with 90% aqueous TFA for 4h, the library samples in 700pl and 
the linear analytical examples in 200pl. Acid liquor was removed from the beads by a 
fibre-plugged pipette, and transferred to a new vial for solvent removal by vacuum 
centrifugation. A 50jal analytical sample was removed and treated separately. When dry, 
IN HC1 (lml) was added to the samples, which were then lyophilised in the vacuum 
centrifuge.
Recovered sub-library weights ranged from 6.8-8.9mg, compared to a theoretical yield of 
6.8mg peptide. Analytical samples appeared in the range 0.4-1.2mg, though the figures 
are outside the accuracy of the measure. The samples were submitted for ELISA assay. 
Synthesis of L ibrary 2L
Library 2L was synthesised as above, using 3.34g (0.507mmol) of resin 27 (Fmoc- 
AspOAll, 0.152 mmol/g). The quantity of resin was increased to allow for the lower 
initial loading of aspartic acid, whilst using the same reagent quantities as above. Similar 
yields were experienced.
Deconvolution of Library 2D
From Library 2D, the sub-library terminating in D/LLys-Spacer4 (di-alanine) was 
selected for deconvolution. The preceding pair of saved samples terminating in DLys and 
LLys respectively were cycled and cleaved as for the final step above, yielding 6mg and 
8mg product.
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9.2.3 Procedures for Chapter 5 
Tissue Factor Fragments and Library 3 
Peptide 35 (rTF 154-173)
YILTYRKDSSTGRKTNTTHT
Standard automated protocols were used to synthesise the peptide, using Novabiochem 
Wang resin (0.64mmol/g, 414mg, 0.265 mmol). The first amino acid was loaded onto the 
resin followed by capping with benzoic anhydride. Double-coupling was applied to 
residues I,L and R. 1150mg peptide-resin was obtained. After treating 650mg peptide- 
resin under standard cleavage procedure for 4h, 180mg (57%) crude product was
obtained. Preparative HPLC was performed on 92mg and 80mg samples dissolved in 
water/acetic acid (1.5ml), column g 5% acetonitrile (0.05%TFA) in water (0.1% TFA) for 
lOmin, then to 30% over total 60 min. Fractions were collected between k’ 9.28 and
11.40. A workup of the remaining resin was performed and two further preparative runs 
of 76mg and 52mg (reclaimed material) were performed. After recombination and 
lyophilisation of fractions 54mg (8.6%) of the title product was obtained. 90% pure by 
gradient HPLC system V, column a, k ’ 2.44 column b 3.33; m/z (ESI) [M+nH]n+ 
(reconstructed) expected 2342.2 found 2345.1. Also observed m/z 2447.4 and 2259.4, 
attributed to +Boc protection and des-Ser respectively.
Peptide 36 (rTF 39-68)
SDRSRNWKYKCTGTTDTECDLTDEIVKDVN
I_______ I
Standard automated protocols were used to synthesise the peptide, using Novabiochem 
Wang resin (0.64mmol/g, 420mg, 0.27 mmol). The first amino acid was loaded onto the 
resin followed by capping with benzoic anhydride. Double-coupling was applied to 
residues I,L,V and R. 1126mg peptide-resin was obtained. After treating 521 mg peptide- 
resin under standard cleavage procedure for 4 hours, 220mg (50%) crude product was
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obtained. Preparative HPLC was performed on three 70mg samples dissolved in 
water/acetic acid (1.5ml), column g 20% acetonitrile (0.05%TFA) in water (0.1% TFA) 
for 10 min, then to 30% over total 60 min. Fractions between k’ 7.08 and 11.58 were 
collected, and analysed by ESI-MS to confirm the presence of the expected product at m/z 
(ESI) [M+nH]n+ expected 3491.6 found 3493.6. Discarded fractions were pooled, treated 
with dithiothreitol (5mg) for 12h, and re-applied to the preparative column. After 
recombination and lyophilisation of fractions 22mg of product was obtained. The sample 
was dissolved in water (200ml), and corrected to pH 8.5 with dilute ammonia (aq.). The 
solution was left for 1 week, with daily pH correction. After lyophilisation, 18mg (4%) of 
the title product was obtained, 80% pure by gradient HPLC column b system IV, k’ 4.85. 
m/z (ESI) [M+nH]n+ (reconstructed) expected 3489.6 found 3491.6. Also minor signals 
observed at m/z 3363.3 and 3261.3 attributed to des-Lys and des-2Asp respectively. The 
product was less than 1% free thiol form by Aldrithiol assay.
Peptide 37 (rTF 10-35)
FNLTWISTDFKTILEWQPKPTNYTYT
Standard automated protocols were used to synthesise the peptide, using Novabiochem 
Wang resin (0.64mmol/g, 415mg, 0.27 mmol). The first amino acid was loaded onto the 
resin followed by capping with benzoic anhydride. Double-coupling was applied 
throughout, as previous attempts had yielded no correct product. Two resin portions of 
300mg each were removed prematurely to yield rTF 24-35 and rTF 17-35. 598mg peptide- 
resin was obtained on completion of the sequence. After treating 340mg peptide-resin 
with standard cleavage procedure for 4h, 155mg (63%) crude product was obtained. 
Preparative HPLC was performed on 82mg sample dissolved in water/acetic acid (1.5ml) 
column g 30% acetonitrile (0.05%TFA) in water (0.1% TFA) for 8 min, then to 70% over 
total 50 min. Fractions between k’ 5.4 and 7.6 were collected. After recombination and
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lyophilisation of fractions 12mg (4.9%) of the title product was obtained, 80% pure by 
gradient HPLC system I column a k’ 4.4 column b 5.5 m/z (ESI) [M+nH]n+ 
(reconstructed) expected 3206.6 found 3208.2.
Peptide 38 (rTF 125-150)
VTVKDSFTLVRKNGTFLTLRQVFGND
Standard automated protocols were used to synthesise the peptide, using Novabiochem 
Wang resin (0.9mmol/g, 278mg, 0.25 mmol). The first amino acid was loaded onto the 
resin followed by capping with benzoic anhydride. Double-coupling was applied to 
residues L,V and R. 710mg peptide-resin was obtained. After treating 320mg peptide- 
resin with standard cleavage procedure for 4h, 230mg (69%) crude product was obtained. 
The crude product was poorly soluble in water/acetic acid or organic solvents, and 
eventually lOOmg was dissolved in glacial acetic acid/methanol (5ml), filtered through 
glass wool and injected in two aliquots onto the preparative HPLC with a 20 second 
interval, column g 15% acetonitrile (0.05% TFA) in water (0.1% TFA) for lOmin, then to 
60% over total 60min. Fractions between k’ 5.46 and 8.33 were collected. Only one tube 
was found to contain the expected mass of 2954.5 (found). Two further preparative runs 
of 50mg and were performed dissolved in acetonitrile/20% acetic acid (aq.) (5ml), on a 
steeper gradient, 20% acetonitrile for 10 min then to 80% over 60 min. After 
recombination and lyophilisation of fractions 48mg of product was obtained. 17.2mg 
(5%) of the title product was obtained. 95% pure by gradient HPLC system I, column b 




Peptide 39 (rTF 13-33)
TWISTDFKTILEWQPKPTNYT
Standard automated protocols were used to synthesise the peptide, using Novabiochem 
Wang resin (0.9mmol/g, 286mg, 0.26 mmol). The first amino acid was loaded onto the 
resin followed by capping with benzoic anhydride. Double-coupling was applied to 
residues I and L. 650mg peptide resin was obtained. After treating 350mg peptide-resin 
with standard cleavage procedure for 4 hours, 120mg (33%) crude product was obtained. 
Analytical HPLC column b system III showed 8 peaks between k’ 3.38 and 4.06, with a 
major peak at 3.93. Preparative HPLC was performed on a 54mg sample dissolved in 
water/acetic acid (2ml), column g 30% acetonitrile (0.05% TFA) in water (0.1% TFA) to 
60% over total 60 min. Fractions between k’ 2.55 and 2.81 were collected, and analysed 
by ESI-MS to confirm the presence of the expected product at m/z 2569.6. After 
combination of fractions and lyophilisation, 7mg of the (4%) of the title product was 
obtained, 92% pure by gradient HPLC column b system III, k ’ 3.94; m/z (ESI) [M+nH]n+ 
(reconstructed) expected 2568.3 found 2569.6. A minor peak at m/z 2625 was attributed 
to remaining Bu* protection.
Peptide 42 
CTKSGDWKSKC
Standard automated protocols were used to synthesise the peptide, using Novabiochem 
Wang resin pre-loaded with Fmoc-LCys(Trt) (0.55mmol/g) 472mg, 0.25 mmol. 900mg 
peptide resin was obtained. After applying standard cleavage procedure to 536mg peptide 
resin for 4 hours, 96mg (52%) crude product was obtained. Analytical HPLC column d 
system II showed a major peak at k ’ 3.64 and a series of later peaks between k’ 4.70 and 
5.58. ESI-MS showed the expected product at m/z [M+nH]n+ (reconstructed) 1241.6,
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expected 1241.55, along with m/z 1297.6 and m/z 1353.6 attributed to + 1 and 2 Bul. The 
peptide was dissolved in water (200ml) and corrected to pH 8.5 with ammonia. After 2 
days, analytical HPLC showed absence of the peak at k’ 3.64, and appearance of a new 
peak at k’ 3.23. After lyophilisation, 117mg peptide was recovered. Preparative HPLC 
was performed on 117mg dissolved in 2ml water (2ml), column h using water (0.1% 
TFA) for 7min, then to 100% acetonitrile (0.05% TFA) over total 50 min Two major 
peaks were resolved at k’ 2.73 and 3.09. Fractions within k ’ 2.7 and 2.88 were collected., 
and analysed by ESI-MS to confirm the presence of the expected product at m/z [M-nH]"' 
(reconstructed) 1237.5. After combination of fractions and lyophilisation, 8mg of the title 
product was obtained, 98% pure by gradient HPLC column d system II, k’ 3.64. m/z 
(ESI) [M+nH]n+ (reconstructed) expected 1239.55 found 1239.5. Also present was a 
minor peak at 1294.5 attributed to the butylated cyclic peptide. Re-working of preparative 
peak 2 by stirring 50mg of the peptide with 90% TFA(aq) (5ml) for 3 hours followed by 
lyophilisation showed appreciable appearance of the expected product. The regenerated 
product was added to the products from workup of the remaining crude resin and again 
applied to the preparative HPLC. 12mg of the title product resulted, 95% pure by HPLC. 
Works 1 and 2 were combined to yield 20mg (6.5%) of the title compound, 97% pure by 
HPLC.
Synthesis of Library 3
Fmoc-LCys(Trt)-Wang resin (4.00g, 0.55mmol/g, 2.2mmol) (200mesh, Novabiochem) 
was placed in a #1 sinter funnel and swelled using NMP (30ml). Fmoc protection was 
removed by two 20min treatments with 20% piperidine in NMP (30ml). After washing x 
6 NMP and x 3 methanol (30ml) and swelling in NMP, the compacted resin cake was 
divided into 3 parts, and two parts were placed in separate #2 sinter funnels. Dry amino
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acids were added, followed by coupling agents in NMP/20%DMSO (12.5ml) and base in 
the following amounts:
4.00g resin divided into 3 = 0.733mmol/portion
Flask# Reagent m.w. Quantity/mg Equivalents
1 Fmoc-LLys(Boc) 469 1031 3
2 Fmoc-LAla 311 684 3
each PyBOP 520 1144 3
each H0BT.H20  153 336 3
each DIEA 129 568(=810pl) 6
After lh  a negative ninhydrin test was obtained and the resins were washed x 3 NMP, x 3
IPA (15ml). 200mg resin was saved from each vessel before all three portions were
recombined in the #3 funnel by agitating in NMP (30ml) for 15min. An analytical sample
of 20mg was saved, denoted Library 3 Layer 1. Fmoc deprotection was performed as
above using 20% piperidine in NMP (30ml). After washing x 3 NMP and x 3 IPA (30ml)
and swelling in NMP, the resin cake was again divided into three portions and two placed
in separate funnels for coupling to the following residues:
Using starting molarity value for convenience:
Flask# Reagent m.w. Quantity/mg Equivalents
1 Fmoc-LSerfBu*) 383 843 3
2 Fmoc-LAla 311 684 3
each Coupling agents as above
After 1 hour a negative ninhydrin test was obtained and the resins were washed x 3 
NMP, x 3 IPA (15ml). 200mg resin was saved from each of the three portions before the 
resins were recombined in the #3 funnel by agitating in NMP (30ml) for 15min. An 
analytical sample of 20mg was saved, denoted Library 3 Layer 2. Fmoc deprotection 
was performed as above using 20% piperidine in NMP (30ml). After washing x 6 NMP 
and x 3 IPA (30ml), the resin was exposed to each the next three amino acids in 30ml 
NMP/20%DMSO for 1.5h without variation at any stage. After each coupling a negative
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ninhydrin test was obtained before progressing and analytical samples of 20mg dry 
Fmoc-peptide-resin were conserved for analytical purposes, denoted Library 3 Layer 3,
4 ,5 .
3.0g resin, no divisions, 1.65 mmol
Layer Reagent m.w. Quantity/g Equivalents
3 Fmoc-LLys(Boc) 469 2.32 3
4 Fmoc-LTrp(Boc) 527 2.62 3
5 Fmoc-LAsp(Bul) 412 2.11 3.1
each PyBOP 520 2.57 3
each HOBT.H2O 153 0.76 3
each DIEA 129 1.28(= 1.72ml) 6
No deconvolution sample was saved after the coupling of the aspartic acid, the resin 
being straightaway Fmoc deprotected, washed and divided into four equal portions in #2 
funnels. To each of three of the portions were coupled one of the following residues in 
NMP/20%DMSO (8ml):
3g resin divided into 4 = 0.41 mmol/portion
Flask# Reagent m.w. Quantity/mg Equivalents
1 Fmoc-Gly 297 490 4
2 Fmoc-LAla 311 513 4
3 Fmoc-LCys(Trt) 586 967 4
each PyBOP 520 858 4
each H0BT.H20  153 252 4
each DIEA 129 426(=591pl) 8.1
After 1.8 h a negative ninhydrin test was obtained and the resins were washed x 3 NMP, x
3 IPA (15ml). 200mg resin was saved from each of the Gly, Ala and uncoupled portions,
before they were recombined in a #2 funnel by agitating in NMP (20ml) for 15min. An
analytical sample of 20mg was saved, denoted Library 3 Layer 6. The Fmoc-Cys
peptide-resin was stored intact, denoted Library 3 #6.
Fmoc deprotection was performed as above using 2 x 20min 20% piperidine in NMP 
(10ml). After washing x 3 NMP and x 3 IPA (10ml), a lOOmg portion was removed and
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exposed to Fmoc-LCys in 2ml solvent, and the remainder divided into three equal 
portions. One of the remaining portions was kept aside, while to the other portions were 
exposed to either of the following in 8ml solvent:
2g resin divided into 4 = 0.28mmol/portion
Flask# Reagent m.w Quantity/mg Equivalents
1 Fmoc-LSer(Bul) 383 361 3.4
2 Fmoc-LAla 311 342 3.9
lOOmg/portion Fmoc-LCys(Trt) 586 130 4
each PyBOP 520 572 4
each HOBT.H20 153 168 4
each DIEA 129 284 8.1
(=394pl)
After 1.2 h a negative ninhydrin test was obtained and the resins were washed x 3 NMP, x 
3 IPA (15ml) and dried overnight. lOOmg resin was saved from each of the Ser, Ala and 
uncoupled portions, before they were recombined in the #2 funnel by agitating in NMP 
(20ml) for 15*. An analytical sample of 20mg was saved, denoted Library 3 Layer 7. 
The Fmoc-Cys- peptide resin was stored intact, denoted Library 3 #7. An identical 
procedure of unequal division was performed to generate the next layer using the 
following residues in 6ml solvent:
1.5g resin divided into 4 = 0.21 mmol/portion
Flask# Reagent m.w Quantity/mg Equivalents
1 Fmoc-LLys(Boc) 469 550 5
2 Fmoc-LAla 311 342 5
lOOmgportion Fmoc-LCys(Trt) 586 130 5
each TBTU 321 350 5
each HOBT.H20  153 168 5
each DIEA 129 284 10.5
(=394pl)
After 1.5 h a negative ninhydrin test was obtained and the resins were washed x 3 NMP, 
x 3 IPA (6ml) and dried. lOOmg resin was saved from each of the Lys, Ala and
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uncoupled portions, before they were recombined in the #2 funnel by agitating in NMP 
(15ml) for lOmin. An analytical sample of 20mg was saved, denoted Library 3 Layer 8. 
The Fmoc-Cys- peptide resin was stored intact, as the truncated library set L ibrary 3 #8. 
Fmoc deprotection was performed as above using 2 x 20min 20% piperidine in NMP 
(20ml). After washing x 6 NMP and x 3 IPA (10ml), the resin was divided into three 
equal portions and exposed to one of the following residues in 7ml solvent.
1 g resin divided into 3 = 0.18mmol/portion
Flask# Reagent m.w. Quantity/mg Equivalents
1 Fmoc-LThrfBu1) 398 215 3
2 Fmoc-LAla 311 171 3
3 Fmoc-LCys(Trt) 586 322 3
each TBTU 321 270 3
each HOBT.H20 153 84 3
each DIEA 129 71 (=98pl) 6
After 2.2h a negative ninhydrin test was obtained and resins were washed, dried and the 
Cys terminal resin stored as stored as Library 3 #9. fThe remaining portions were kept in 
their separate funnels, Fmoc deprotected with 2 x 20min 20% piperidine in NMP (10ml) 
and capped with 241 mg (4eq) Fmoc-LCys(Trt) using the coupling agents above. After 2h 
a negative ninhydrin test was obtained; the resins were washed and dried and denoted 
Library 3 #9T and Library 3 #9A.
Peptide-resin products Library 3 (6,7,8,9,9A,9T) 200mg (0.11 mmol) were each exposed 
to iodine 140mg (1.1 mmol, lOeq) in 2ml DMF in vials. The suspensions were shaken for 
2h, after which they were washed x 10 MeOH/NMP (3ml ) whereupon the supernatant 
appeared clear, though a reddish tint was still apparent within the resin. The libraries were 
Fmoc-deprotected using 2 x 30min 20% piperidine in NMP (2ml). After 6 methanol 
washes (3ml), the resins were pumped dry. Cleavage of the peptide mixtures was effected 
by exposing the resins to 90% aq. TFA (2ml) and agitating for 4h. #6 tinged yellow
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during the process, while #7-#9 became bright purple. Each suspension was filtered 
through glass wool into a round-bottom flask, water added (30ml) and the solution 
lyophilised. The products were lyophilised twice more from IN HC1 to produce flaky off-













The products were dissolved in DMSO to lOmg/ml and submitted for ELISA assay. 
Deconvolution: 1st Iterative Cycle:
The three saved resin portions from Layer 6 (200mg) were Fmoc-deprotected, treated 
with Fmoc-LCys(Trt), oxidised with iodine and cleaved according to the protocol and
scale above (f).
















The products were dissolved in DMSO to lOmg/ml and submitted for ELISA assay.
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9.2.4 Procedures for Chapter 6 
Stat-6 Peptide Ligand and Library 4 
Peptide 43, IL-4Ra derived peptide 
ASSGEEGY(P03H2)KPFQDLI
Standard automated protocols were used to synthesise the peptide, though HBTU solution 
was replaced by TBTU/HOBT 1:1. At step 7, Fmoc-Tyr(P03H2) was incorporated to 
yield the phosphorylated peptide. Novabiochem Wang resin pre-loaded with Fmoc-Llle 
(0.45mmol/g 550mg, 0.248 mmol) was used, resulting in l.OOg dry peptide resin. After 
treating the peptide-resin with TFA/ethanedithiol/water 90/5/5 (8ml) for 4 hours, the 
solution was filtered through glass wool, precipitated into cold ether, resuspended and 
washed x 5 and freeze dried from IN HC1. (100ml). 180mg (42%) crude product was 
obtained. Analytical HPLC column d system V, showed 3 peaks between k’ 6.38 and 
6.63, with a major peak at 6.50. ESI-MS showed the expected product at m/z (M-nH)n‘ 
(reconstructed) 1720.3, along with signals attributed to des-Gly, des-2Gly, des-GlyGlu, 
des-2GlyGlu. Preparative HPLC was performed on 117mg of crude product dissolved in 
2ml water, column h gradient water (0.1%TFA) for 7 min then to 60% acetonitrile 
(0.05%TFA) in a total of 60 min. Fractions between k’ 12.0 and 12.3 were collected., and 
analysed by ESI-MS to confirm the presence of the expected product at m/z 1720.4. After 
combination of fractions and lyophilisation, 21 mg (4%) of the title product was obtained, 
95% pure by gradient HPLC (220nm), k ’ 6.09. m/z (ESI) [M-nH]n_ (reconstructed) 
expected 1720.8 found 1720.63, plus a minor peak attributed to desGXy at m/z 1663.5. 
Synthesis of Library 4
Fmoc-LCys(Trt)-Wang resin (3.00g 1.65mmol) (200mesh, 0.55mmol/g ,Novabiochem) 
was placed in a #1 sinter funnel and swelled using NMP (20ml). Bromophenol blue test 
was performed to confirm absence of blue colouration under these solvent conditions.
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Fmoc was removed by two 20 min treatments with 20% piperidine in NMP (20ml). 
Bromophenol blue test confirmed the presence of free amine. After washing x 6 in NMP 
the compacted resin cake was divided into 6 parts, and 5 were placed in separate #2 sinter 
funnels. Dry amino acids were added, followed by coupling agents in NMP/20%DMSO 
(4ml) and base in the following amounts:
3.00g resin divided into 6 = 0.275mmol/portion
Flask# Reagent m.w. Quantity/mg Eq.
1 Fmoc-p(3-pyridyl)L-alanine (1) 388.4 307 3
2 Fmoc-3(4-thiazolyl)L-alanine (2) 458.1 313 3




5 Fmoc-tranexamic acid (5) 379.5 314 3
each TBTU 321 265 3
each HOBT.H20 153 126 3
each DIEA 129 213
(=290pl)
6
After addition, and extra 2ml solvent per flask was added to enable full mobility of the 
suspension.
After 1.5h, the resins were washed x 3 NMP, x 3 IPA (10ml). A satisfactory negative 
bromophenol blue test was performed, and a lOOmg sample was conserved from each 
vessel along with a lOmg analytical sample. After the expected product mass ions and the 
absence of uncoupled cysteine was confirmed, the resins were combined with the 
unreacted portion in NMP (20ml). Another small analytical sample was saved, denoted 
L ibrary 4 Layer 1. Fmoc removal was performed using two aliquots of 20% piperidine 
in NMP (20ml) for 20min each. After washing x 6 with 20ml NMP, the resin cake was 
again divided into six portions and five placed in separate #2 funnels for coupling to the 
following residues. Dry amino acids were added, followed by coupling agents in 
NMP/20%DMSO (4ml) and base in the following amounts:
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using quantities as above:
Flask# Reagent m.w. Quantity/mg Eq.
1 Fmoc-LLys(Boc) 468.5 387 Approx.
4
2 Fmoc-p(3-pyridyl)L-alanine (1) 388.4 307 66
3 Fmoc-3(4-thiazolyl)L-alanine (2) 458.1 313 66




6 Fmoc-tranexamic acid (5) 379.5 314 64
each TBTU 321 265 66
each HOBT.H20 153 126 64
each DIEA 129 213 (=290pl) 8
After 2h, the resins were washed x 3 NMP, x 3 IPA (10ml). A light blue colour was 
observed on bromophenol blue test. 5mg analytical samples were cleaved to confirm the 
presence of the expected molecular ions by flow-injection ESI-MS.
The samples were dried in vacuo overnight. lOOmg deconvolution samples were 
conserved, and the resins were recombined as above. An additional analytical sample was 
saved, L ibrary 4 Layer 2. Fmoc removal was performed using two aliquots of 20% 
piperidine in NMP for 10 min and 30 min respectively (20ml). After washing x 6 with 
NMP (20ml), The entire resin was exposed to Fmoc-LTyr(P03H2), with coupling agents 
in NMP/20%DMSO (15ml) and base in the following amounts:
2g resin = 1.1 mmol scale
Flask# Reagent m.w. Quantity/mg Eq.
1 Fmoc-LTyr(P03H2) 483 1062 2
each TBTU 321 706 2
each HOBT.H2O 153 337 2
each DIEA 129 570 (=765pi) 4
After 4h, the resin was washed x 3 NMP, x 3 IPA (20ml). A very pale blue colour was 
observed on bromophenol blue test. A 5mg analytical sample was cleaved to confirm the 
presence of the expected molecular ions by LC-MS, Library 4 Layer 3. Fmoc removal
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was performed using two aliquots of 20ml 20% piperidine in NMP for 35min and 15min 
respectively. After washing x 6 with 20ml NMP, The entire resin cake was divided into 
four equal portions and placed in separate #2 funnels for coupling to the following 
residues. Dry amino acids were added, followed by coupling agents at NMP/20%DMSO 
and base in the following amounts: 
nominal 2g resin divided into 4 = 0.275mmol/portion
Flask# Reagent m.w. Quantity/mg Eq.
1 Fmoc-Gly 297.3 326 4
2 Fmoc-(3-aminomethyl)benzoic acid (A) 373.4 410 4
3 R,S-Fmoc-(2-carboxy)morpholine (B) 353.4 388 4
4 Fmoc-(8-amino)-3,6-dioxaoctanoic acid 
(C)
385.2 423 4
each TBTU 321 353 4
each HOBT.H20 153 168 4
each DIEA 129 283 (=3 82pi) 8
Reagents were added as 4ml of lOOmg/ml TBTU, after which an additional 1ml of 
solvent was required for full resin mobility. After 3h, the resins were washed x 3 NMP, x 
3 IPA (10ml). A satisfactory negative bromophenol blue test was performed, and lOOmg 
sample was conserved from each vessel along with a lOmg analytical sample. After the 
expected product mass ions and the absence of selected previous products was confirmed, 
the resins were combined NMP (20ml). After washing x 3 with IPA, the resin was dried 
in vacuo overnight. The dry resin weighed 1.4g, matching the calculated value of 
1380mg. Another small analytical sample was saved, denoted Library 4 Layer 4. Fmoc 
removal was performed using two aliquots of 15ml 20% piperidine in NMP for 20min 
each. After washing x 6 with NMP (15ml), the resin cake was again divided into eight 
final sub-library vials. One vial was kept aside, while dry amino acids were added to the 
remaining 7, followed by coupling agents in NMP/20%DMSO (3ml) and base in the 
following amounts:
1.42g resin divided into 8 = 0.1 mmol/portion
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Flask# Reagent m.w. Quantity/mg Eq.
1 Fmoc-p(2-thieneyl)L-alanine (a) 393.5 157 4
2 Boc-(Fmoc)L-diaminopropionic acid (P) 426.5 170 4
3 Fmoc-3-aminobenzoic acid (5) 359.4 143 4
4 Fmoc-LAsp (Bul) ( k ) 411.5 165 4
5 Fmoc-4-(carboxymethyl)piperazine (p) 366.4 146 4
6 Fmoc-(3,4-dichloro)L-phenylalanine-OH (a) 456.3 180 4
7 Fmoc-3(4-thiazolyl)L-alanine (2) 458.1 180 4
each TBTU 321 130 4
each H0BT.H20 153 61 4
each DIEA 129 103
(=139pl)
8
After agitating on a shaker table for 3h, the resins were washed alternately x 3 with 
MeOH, x 3 NMP (3ml). 5mg analytical samples were cleaved and a selected set of 
expected molecular ions were identified within each sub-library. The samples were Fmoc- 
deprotected in-situ using two 20* treatments with 3ml 20% piperidine in NMP. The 
samples were washed x 6 with methanol, with a single NMP wash after each 3 washes. 
All 8 sub-libraries were capped with Fmoc-LCys(Trt) using the following reagents in 
24ml NMP/20%DMSO divided equally between the vials.
1.4g resin = 0.78 mmol scale
Flask# Reagent m.w. Quantity/mg Eq.
shared Fmoc-LCys(Trt) 585.7 2750 6
TBTU 321 1151 6
HOBT.H2O 153 714 6
DIEA 129 1208(=1700pl) 12
After agitating for 3h, The samples were washed x 3 MeOH, x 3 NMP, x 3 MeOH, 
(3ml) and dried in vacuo. Final samples weighed 177mg+/- 5mg for vials 1-7, vial 8 
155mg.
30mg samples were removed from each sub-library, before each exposed to iodine lOOmg 
(0.8 mmol,10eq) in DMF (2ml) in vials. The suspensions were shaken for 2h, after which
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they were washed x 10 3ml MeOH/NMP until the supernatant appeared clear, though a 
reddish tint was still apparent within the resin. The libraries were Fmoc-deprotected using 
2 x 30min treatments of 20% piperidine in NMP (2ml). After 6 methanol washes (3ml), 
the resins were pumped dry. Cleavage of the peptide mixtures was effected by exposing 
the resins to 90% aq. TFA (2ml) and agitating for 4h. The linear peptide samples were 
deprotected and cleaved in the same way, using 0.75ml volumes. Each suspension was 
filtered through glass wool into a round-bottom flask, 30ml water added and the solution 
lyophilised. The products were lyophilised twice more from IN HC1 to produce flaky
light brown products.
L ibrary 4 Products
Cyclic sub-libraries Linear version
sub-library # product / mg yield / % sub-library # product / mg yield /
%
a 52 82 a -1 2.5 19
3 52 82 3-1 3.9 30
5 60 95 5-1 4 30
K 44 69 K - l 4.6 35
P 50 79 p-1 5.2 40
0 42 66 O’—1 4 30
2 56 88 2-1 3.6 27
Z 45 71 Z -l 3.4 26
79% +/- 15% 110% + /-10%
The products were dissolved lOmg/ml in DMSO and submitted for SPR assay.
9.2.5 Procedures for Chapter 7
Mass Spectrometry as a Library Screening Tool
Thrombin Analysis
A Micromass Platform mass spectrometer was cleaned and tuned using myoglobin signal 
at m/z 808. Mass resolution was adjusted to 0.75 Da signal width at half height using and 
an in-house drug-candidate peptidomimetic at m/z 610. The instrument was calibrated 
between 100 and 2000 Da, to +/- 0.2 Da using an equal mixture of PEG 300, 600, 1000
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(lOpmol/pl each) in 50% methanol (aq.) infusing at 8pl/min. Cone voltage 50V, counter 
electrode 0.4kV, source temperature 100°C, nebulising gas 301/h, bath gas 2501/h. 
Thrombin (Sigma Chemicals) was dissolved in water to 1 mg/ml (20pmol/pl), and infused 
into the instrument at 8pl/min for 30 seconds scanning between 100 and 3000 at 400 
Da/sec. Thrombin at the same concentration in 50% methanol (aq.) and 1% formic acid 
(aq.) were analysed under the same conditions.
Desalting Procedures
Gel filtration Centrifuge Columns (Biorad Biospin™ P-6 polyacylamide gel permeation 
columns #732-6002) The columns were drained of packing buffer, refilled with 500pl 
lOmM ammonium acetate pH 6.9 (uncorrected), shaken and drained x 4. After spinning 
in a centrifuge for 2 min at lOOOg to remove excess buffer, the packing was loaded with 
100pi of aqueous protein solution and spun for 4 minutes in a centrifuge at lOOOg, 
resulting in the collection of lOOpl of fluid, the indicated void volume. After initially 
disappointing desalting performance, the void volume was checked by spinning lOOpl 
methyl orange for the same period, no colour appeared in the collection volume. 
Hydrophobic Membrane Dialysis (129) (Millipore hydophobic filters, 2cm diameter; 
0.025pm; Millipore corporation MA USA #VSWP 02500) The filters were placed shiny 
side up on wells of 20ml lOmM ammonium acetate. A 50pl aliquot was placed on the 
surface of the floating membrane. After 2 hours, the enlarged droplet was withdrawn 
using a pipette.
Ultrafiltration Spin Tubes (Amicon Centricon-3™ tubes, m.w. cut-off 3kDa, #4203 
Amicon Ltd). 200pl of protein solution was added to the top of the tubes, and the vessel 
spun in a centrifuge at lOOOg for 12 minutes resulting in a remaining volume of
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approximately 30pl. 200pl ammonium acetate was added, the tube capped and shaken, 
and the process repeated twice.
Dialysis Cassettes (Pierce Slidealyzer™ m.w. cut-off lOkDa ) were injected with 500pl 
protein solution and floated in a bucket containing 2 litres of gently stirred ammonium 
acetate lOmM pH 6.9. After 20h at 5°C, the samples were withdrawn using a 1ml plastic 
syringe and hypodermic needle.
Protein Quantitation Biorad™ Microassay, a commercial preparation using Coomassie 
Brilliant Blue (268) was used according to manufacturer’s instructions. Absorbency of 
samples in duplicate at UV595 were compared against a standard curve made using serial 
dilutions of Bovine Serum Albumin (Sigma).
HPLC of Proteins Proteins discussed in Chapter 7 were analysed on a Vydack C l8 
4.6mm x 150mm 300A 5pm column, using a solvent system of water (0.1%TFA) to 
acetonitrile (0.05% TFA) over 12 minutes at lml/min flowrate. Signals were observed at 
UV 220nm, 254nm and 280nm for quality and comparative quantitations were made by 
peak area of the largest signal at 280nm.
ESI-MS Analysis of Stat-6 Trypsin, BSA and Myoglobin
MS conditions were essentially as for Thrombin. Addition of small volumes of 10% 
formic acid (aq.) or methanol was made directly to the sample vial to revert aqueous 
samples to yield directly comparative acid/organic solvent spectra. Salt was added as an 
aliquot of lOOmg/ml NaCl (aq.) to approximately twice the mass of protein in the sample 
vial to assess desalting techniques.
Stat-6 Analysis by ESI-TOF MS
Stat-6 500pi (2.3 mg/ml) was dialysed as above, and diluted to 1ml using additional 
ammonium acetate. The protein content was measured as 1.2mg/ml against a BSA 
standard. Three aliquots were prepared, and to two were added 1 and 10 equivalents of
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peptide 43 by adding 4pl and 40pl of a 1 mg/ml solution 43 in water. The samples were 
analysed by ESI-TOF by infusing at 4pl/min. To a second vial prepared as above, 1 
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Appendix
I Microsoft Excel™ Library Calculators
Several spreadsheet calculators were written to facilitate the design and analysis of the 
mixture libraries.
L ibrary Synthesis Calculator allowed the quantitative planning of a split-and-mix 
library synthesis. Variables such as resin loading, number of steps, number of residue 
choices, and desired quantities of resin to be saved after each cycle are juggled to arrive 
at the desired final yield for the library products. The required mass of peptide from any 
conserved step is used to calculate the amount of resin to reserve, and the cumulative 
effect o f that loss on the total. The example shows the calculation for Library 3.
Library Mass Calculator was designed to calculate all the possible molecular weights 
of compounds generated during successive synthetic steps of a split-and-mix library. The 
output was compared to mass spectra of synthesised libraries as an indicator of synthetic 
success. The progress of the synthesis is outlined across the top of the sheet, such that 
each residue forms a column heading, with the relevant residue mass underneath. The 
residue masses are carried across to be added to each of the new residues of the next 
coupling. A table of expected masses is generated for each step. The calculations became 
very large (5Mb for one library) so the final output tables were copied to new sheets for 
manipulation into mock mass spectra.
Mock Mass Spectra The expected mass lists from above were analysed for duplicates 
(within intervals of 0.3Da) using IF and FREQUENCY tests. The number of repeats of 
any one mass value was listed against the value, allowing the plotting of a chart of mass 
against relative abundance, essentially an artificially generated mass spectrum. The plot 
was used for examination of libraries with a high number of isobaric compounds, notably 
2L and 2D.
II Assay Procedures
TF/FVIIa assay procedures were developed by Ruth Wilkins.
Appendix
TF/FVIIa Inhibition ELISA Assay
An Immulon 2 hydrophobic plate was coated using 50nM recombinant human FVIIa 
(Novo-Nordisk 740 8919) in 200pl coating buffer (0.1M Na2CC>3, 0.1M NaHC03 at pH 
9.5) overnight at 4°C. Remaining active plate was blocked by treating for 1 hour with 
1 mg/ml BSA in base buffer and 5mM CaC^. lOpl of candidate compounds dissolved in 
50% DMSO aq. were added to the well added followed by lOOpl recombinant human 
Tissue Factor (American Diagnostica 4500B) (5nM in base buffer with 50nM C aC y, 
giving a final concentration of 180pM total library peptide. Incubation was continued for 
90 minutes at room temperature followed by wash with 0.05% Tween 20 in 5mM CaCk 
at pH 8.0. Primary antibody, anti-TF monoclonal was added at 0.25pg/ml in wash buffer 
and incubated for 90 minutes. After washing, the secondary antibody antimouse IgG 
conjugated to alkaline phosphatase was added in blocking solution and incubated for 90 
minutes. After washing, 150pl of a chromogenic substrate, p-nitrophenylphosphate 
(0.5mg/ml) was added and incubated until colour developed after 40 minutes. Optical 
density readings collected by an automatic plate reader at 405nm were converted to % 
inhibition using a solvent control as 100%, subtracting no-FVUa controls to account for 
non-specific binding. Average values quoted are those of assays conducted in duplicate to 
within 10% variation.
base buffer = 0.1M Tris, 0.15M NaCl, pH 8.0 
TF/FVIIa Direct Enzyme Inhibition Assay
Inhibitors were dissolved in DMSO, water or a mixture, then diluted 1 in 20 with water 
to give a range of final working concentrations. A 1 in 20 solution of the chosen solvent 
was used for no-drug controls. 20pl of the stock solution was then added to a Dynatech 
microtitre plate. To each well was also added 80pl of chromogenic substrate, DlleProArg 
/7-nitroaniline ( 2.16mM). The plate was warmed to 37°C before the addition of lOOpl
Appendix
TF/FVUa complex. To make the complex, recombinant human Factor FVIIa (Novo 
Nordisk 7408919) was diluted to lOOnM in working buffer (0.05M Tris, 2.5mM CaCk, 
BSA 2mg/ml at pH 8.5). Recombinant Tissue Factor (American Diagnostica 4500B) was 
diluted to lOOnM in 0.1% Triton X-100. Equal volumes of each solution were mixed, 
then diluted 1 in 5 with working buffer immediately prior to use. All solutions were 
handled in siliconised vials. Immediately the complex was introduced into the plate, 
optical density at 405nm was read with an automatic plate reader, followed by a final 
constant reading after 4 hours. Readings were converted to % inhibition after correcting 
for no-drug controls and initial background reading. The average of quadruple data is 
quoted.
Factor FVIIa Chromogenic Substrate
The substrate DlleProArg p-nitroaniline was synthesised by the published solution method 
(271) without significant change, resulting in 9.4g of product, 93% pure by gradient 
HPLC. The product was dissolved in 0.41 water, and 24.4g D-mannitol added. The 
solution was lyophilised to produce a fine white powder, 27.7% active ingredient verified 
by HPLC comparison with the original. Bioassay indicated a weight-for weight activity 
level of 91% of a commercial standard.
Surface Plasmon Resonance Assay
The assay was developed by Mrs. D. Head. A Biacore 1000™ instrument from Phamacia 
Biosensor AB was used for the study, with a running buffer of lOmM HEPES 150mM 
NaCl, 3.4mM EDTA, 0.05%P20 pH 7.4. A strepavidin coated chip was exposed to 
biotinylated peptide 43 and washed. Each sub-library of Library 4 (500pM based on 
average component molecular weight) was mixed with recombinant Stat-6 (2.8pM) and 
incubated at 30 min. at r.t. lOpl aliquots of the mixes were injected into the running 
buffer at 5pl/min and SPR measured for 7 minutes. Results were compared to no­
inhibitor controls.
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DISPLAY O F FIXED RESIDUES ON VARIABLE CYCLIC SCAFFOLDS: A NOVEL 
APPROACH TO PEPTIDE COMBINATORIAL LIBRARY SYNTHESIS
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Abstract: A synthetic peptide library is described which displays three nominated residues in varied spacing 
around cyclic peptides. Diversity of ring size was achieved by the use of binary combinatorial synthesis, and 
the inclusion of hydrophilic spacer molecules. The order of residue occurrence and chirality was fully varied 
while duplication was avoided using a modified split-and-mix protocol. © 1997 Elsevier Science Ltd.
Combinatorial libraries have become a significant tool in the pursuit and optimisation of new drug 
candidates. Synthetic peptide libraries particularly have been widely applied to probe the binding requirements 
of proteins and receptors.1 More recently, methods of imposing conformational constraint upon such libraries 
have been sought to improve the potency of active members and to facilitate the subsequent design of small 
molecule mimics.2 Peptide libraries have been cyclised,3 incorporated into proteins of known topography4 or 
residues displayed upon rigid scaffolds5 which may themselves be cyclic peptides.6 Examples include variable 
residues attached to the side chains of a constant cyclic lysine scaffold,7 or additional diversity achieved by 
first introducing variable spacer molecules onto the side chains.8 Originally peptide libraries comprised 
random combinations of all natural amino acids. Latterly, the membership of libraries has been focused toward 
the target in question by the selection of a synthetic template,9 inclusion of known significant residues10 or by 
pre-selection using sub-library kits.11
We present for the first time a library whose central element of diversity is a variable template, whilst 
the displayed residues remain constant.
Three sequentially disparate residues of Tissue Factor, thought to be significant in the binding of Tissue 
Factor to Factor V ila,12 were chosen for display in the library. The three residues were incorporated into cyclic 
peptides. Diversity was achieved by varying the order of inclusion, the mix of chirality and the distances 
between each of the chosen residues within the cyclic scaffold (Figure 1).
A,B,C = L-or D- 
Lysine, Isoleucine, 
Aspartic acid, in any 
order without 
duplication.
S = One of five spacer 
molecules, or no 
coupling "skip codon"
Fig. 1 Library Membership
All order variants 
are generated from 
the exchange of 
two residues, B and 
C from the 
structure in fig. 1.
Fig. 3 Strategy for diversity of residue occurrence 
without duplication
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The variable residue spacing was achieved by random inclusion of different spacer molecules, which 
also bestowed diverse ring size on the peptides. Additional diversity was conferred by the complete deletion of 
a spacer molecule (skip codon) from the synthetic sequence. The latter technique has been applied to linear 
peptide libraries by Furka et al13 as Binary Combinatorial Synthesis. The molecules occupy the spatial 
equivalent of one to three a-linked amino acids. The size range was selected by inspection of the published 
crystal structure of Tissue Factor “binding patch”.14 Spacer molecules (1-5) were chosen for hydrophilicity and 
modest side chain functionality. Amino ethoxy acids15 and similar16 have been employed successfully as 
hydrophilic spacer molecules in peptidomimetics.
H,N
OH H,N OH OH
The Split and Mix protocol17 was employed for the library synthesis (Figure 2). Within the scheme, all 
possible order variants of the chosen residues were generated by allowing variation at only two residue 
positions (Figure 3). The system minimises the number of components in each sub library by eliminating 
repeated residues. The principle was discussed by Furka et al.11 in their use of an Occurrence Library. The 


































Fig. 2 Synthetic scheme
The fortuitous inclusion of aspartic acid among the three residues of interest allowed the synthesis to be 
achieved by anchoring the side chain of aspartic acid a-allyl-ester to the resin followed by library synthesis and 
on-resin cyclisation in the reported manner.18 Good generality is reported on cyclisation of a library of aspartic 
acid side-chain anchored peptides. ^  A subset of the intended library synthesised singly using the chemistry 
described achieved 90% cyclic monomeric products by LC-MS. The synthesis was performed in glass scinter 
funnels using 8g Wang resin. FMOC-DAsp-OAll was synthesised according to published methods20 for the
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L-amino acid. Resin loading was achieved at 0.2 mmol/g by the method of Sieber 21 FMOC amino acids were 
activated by HBTU/HOBT/DIEA(l:l:2). Resin (lOOmg) from each synthetic step was preserved for future 
deconvolution and analysis. After synthesis, the allyl-ester protection was removed with Pd(0),22 before 
cyclisation with HBTU for 5 hours.
Synthetic progress was monitored by electrospray mass spectrometry and reverse phase HPLC after 
cleavage of the small resin samples removed after each synthetic step.23 Initially, the relatively low number of 
compounds per sub library permitted observation of the discrete calculated mass ions and expected number of 
HPLC peaks. Later in the synthesis, coupled LC-MS was employed to separate the components and 
successively identify the expected ions. Impurities attributed to incomplete and linear sequences were observed 
at less than 15% base peak abundance. Ten sub libraries with 144 members each were produced. A separate set 
of sub libraries was synthesised beginning with D-Asp-OAll. Inhibitory activity was measured by ELISA 
assay.24 Example results from the first round of screening are shown below. Figure 4.
Fig. 4
cyclo D-AspXXX(D/L)-Lys-Spacer Cyclo D-AspXXX(D/L)-lle-Spacer
1 2 3 4 5  1 2 3 4 5
Spacer Number
In conclusion, we have synthesised a peptide library where three fixed residues of interest are presented 
at many different distances and orientations from one another by merit o f a highly diverse scaffold. The 
scaffold is conformationally constrained by ring formation. A modification of the split and mix procedure 
eliminates unwanted sequences containing repeated residues or duplicate sequences, maximising differences 
between sub libraries. The protocol generates library members widely variant in ring size, whilst retaining a 
constant number of synthetic steps. The general principle may also be applicable to the optimisation of 
pharmacophore display within biologically active peptides.
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